JP6508540B2 - Pyridine compound and use thereof - Google Patents
Pyridine compound and use thereof Download PDFInfo
- Publication number
- JP6508540B2 JP6508540B2 JP2016529594A JP2016529594A JP6508540B2 JP 6508540 B2 JP6508540 B2 JP 6508540B2 JP 2016529594 A JP2016529594 A JP 2016529594A JP 2016529594 A JP2016529594 A JP 2016529594A JP 6508540 B2 JP6508540 B2 JP 6508540B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- unsubstituted
- alkyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 Pyridine compound Chemical class 0.000 title claims description 218
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title description 15
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title description 13
- 150000001875 compounds Chemical class 0.000 claims description 122
- 125000000217 alkyl group Chemical group 0.000 claims description 70
- 125000000623 heterocyclic group Chemical group 0.000 claims description 67
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 62
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 56
- 125000003118 aryl group Chemical group 0.000 claims description 53
- 125000005843 halogen group Chemical group 0.000 claims description 47
- 125000003545 alkoxy group Chemical group 0.000 claims description 37
- 239000003795 chemical substances by application Substances 0.000 claims description 35
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 32
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 29
- 241000607479 Yersinia pestis Species 0.000 claims description 27
- 125000001424 substituent group Chemical group 0.000 claims description 21
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 20
- 230000000895 acaricidal effect Effects 0.000 claims description 20
- 239000004480 active ingredient Substances 0.000 claims description 20
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 20
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 20
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 19
- 125000001188 haloalkyl group Chemical group 0.000 claims description 19
- 125000002947 alkylene group Chemical group 0.000 claims description 17
- 125000005530 alkylenedioxy group Chemical group 0.000 claims description 17
- 125000004104 aryloxy group Chemical group 0.000 claims description 17
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims description 17
- 239000000417 fungicide Substances 0.000 claims description 16
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 15
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 15
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 14
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 13
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 claims description 12
- 125000005110 aryl thio group Chemical group 0.000 claims description 12
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 11
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 11
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 10
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 10
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims description 10
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 10
- 239000000642 acaricide Substances 0.000 claims description 9
- 125000005529 alkyleneoxy group Chemical group 0.000 claims description 9
- 125000000304 alkynyl group Chemical group 0.000 claims description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 9
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 9
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 8
- 125000000676 alkoxyimino group Chemical group 0.000 claims description 8
- 125000000962 organic group Chemical group 0.000 claims description 8
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 7
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 6
- 125000004749 (C1-C6) haloalkylsulfinyl group Chemical group 0.000 claims description 6
- 125000004741 (C1-C6) haloalkylsulfonyl group Chemical group 0.000 claims description 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000004995 haloalkylthio group Chemical group 0.000 claims description 6
- 239000002917 insecticide Substances 0.000 claims description 6
- 125000004434 sulfur atom Chemical group 0.000 claims description 6
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 5
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims description 5
- 125000001118 alkylidene group Chemical group 0.000 claims description 5
- 125000000262 haloalkenyl group Chemical group 0.000 claims description 5
- 125000000232 haloalkynyl group Chemical group 0.000 claims description 5
- 125000004468 heterocyclylthio group Chemical group 0.000 claims description 5
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 claims description 5
- 125000006624 (C1-C6) alkoxycarbonylamino group Chemical group 0.000 claims description 4
- 125000006714 (C3-C10) heterocyclyl group Chemical group 0.000 claims description 4
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000005129 aryl carbonyl group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000005724 cycloalkenylene group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000004043 oxo group Chemical group O=* 0.000 claims description 4
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 3
- 125000006625 (C3-C8) cycloalkyloxy group Chemical group 0.000 claims description 3
- 125000005090 alkenylcarbonyl group Chemical group 0.000 claims description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 3
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 claims description 3
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 claims description 3
- 230000000855 fungicidal effect Effects 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 3
- 125000005276 alkyl hydrazino group Chemical group 0.000 claims description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 73
- 229910052739 hydrogen Inorganic materials 0.000 description 53
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 37
- 230000015572 biosynthetic process Effects 0.000 description 36
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical group OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 35
- 201000010099 disease Diseases 0.000 description 34
- 239000003112 inhibitor Substances 0.000 description 32
- 239000000203 mixture Substances 0.000 description 32
- 230000000704 physical effect Effects 0.000 description 28
- 238000003786 synthesis reaction Methods 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 27
- 238000005160 1H NMR spectroscopy Methods 0.000 description 26
- 239000002904 solvent Substances 0.000 description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 230000000749 insecticidal effect Effects 0.000 description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 20
- 241000209140 Triticum Species 0.000 description 20
- 235000021307 Triticum Nutrition 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 125000000041 C6-C10 aryl group Chemical group 0.000 description 17
- 239000000839 emulsion Substances 0.000 description 17
- 241000221785 Erysiphales Species 0.000 description 16
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 16
- 206010039509 Scab Diseases 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 14
- 239000012044 organic layer Substances 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 241000123650 Botrytis cinerea Species 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 125000004076 pyridyl group Chemical group 0.000 description 11
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 150000001721 carbon Chemical group 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 125000004844 (C1-C6) alkoxyimino group Chemical group 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 7
- 125000006719 (C6-C10) aryl (C1-C6) alkyl group Chemical group 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 241000233679 Peronosporaceae Species 0.000 description 6
- 241000813090 Rhizoctonia solani Species 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 6
- YXEJGSYGSMZOPE-UHFFFAOYSA-N 3-acetyl-2,5,6-trimethyl-1H-pyridin-4-one Chemical compound OC1=C(C(=NC(=C1C)C)C)C(C)=O YXEJGSYGSMZOPE-UHFFFAOYSA-N 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 206010027146 Melanoderma Diseases 0.000 description 5
- 229930182558 Sterol Natural products 0.000 description 5
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 125000004438 haloalkoxy group Chemical group 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 description 5
- 125000003226 pyrazolyl group Chemical group 0.000 description 5
- 125000005554 pyridyloxy group Chemical group 0.000 description 5
- 150000003432 sterols Chemical class 0.000 description 5
- 235000003702 sterols Nutrition 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 241001600408 Aphis gossypii Species 0.000 description 4
- 241000239290 Araneae Species 0.000 description 4
- 241000193388 Bacillus thuringiensis Species 0.000 description 4
- 241001123536 Colletotrichum acutatum Species 0.000 description 4
- 102000015782 Electron Transport Complex III Human genes 0.000 description 4
- 108010024882 Electron Transport Complex III Proteins 0.000 description 4
- 239000012346 acetyl chloride Substances 0.000 description 4
- 125000002723 alicyclic group Chemical group 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 229940097012 bacillus thuringiensis Drugs 0.000 description 4
- 244000013123 dwarf bean Species 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 125000001072 heteroaryl group Chemical group 0.000 description 4
- 239000008155 medical solution Substances 0.000 description 4
- 230000005787 mitochondrial ATP synthesis coupled electron transport Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- OXPFUCURJIXEOM-UHFFFAOYSA-N o-[2-[4-(trifluoromethyl)phenyl]ethyl]hydroxylamine Chemical compound NOCCC1=CC=C(C(F)(F)F)C=C1 OXPFUCURJIXEOM-UHFFFAOYSA-N 0.000 description 4
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- 125000003367 polycyclic group Chemical group 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 125000002098 pyridazinyl group Chemical group 0.000 description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 125000000335 thiazolyl group Chemical group 0.000 description 4
- 125000001425 triazolyl group Chemical group 0.000 description 4
- ZCVAOQKBXKSDMS-PVAVHDDUSA-N (+)-trans-(S)-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-PVAVHDDUSA-N 0.000 description 3
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 description 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 3
- USZYNUFUDCTCGW-UHFFFAOYSA-N 2-[2-[4-(trifluoromethyl)phenyl]ethoxy]isoindole-1,3-dione Chemical compound FC(C1=CC=C(C=C1)CCON1C(C=2C(C1=O)=CC=CC=2)=O)(F)F USZYNUFUDCTCGW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000223602 Alternaria alternata Species 0.000 description 3
- 241001425390 Aphis fabae Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000895502 Blumeria graminis f. sp. tritici Species 0.000 description 3
- 241001465180 Botrytis Species 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 3
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241001133184 Colletotrichum agaves Species 0.000 description 3
- 241000223221 Fusarium oxysporum Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001518729 Monilinia Species 0.000 description 3
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 206010035148 Plague Diseases 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241001123569 Puccinia recondita Species 0.000 description 3
- 241000233639 Pythium Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 241000488589 Tetranychus kanzawai Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 241001669640 Venturia carpophila Species 0.000 description 3
- 235000010726 Vigna sinensis Nutrition 0.000 description 3
- 244000042314 Vigna unguiculata Species 0.000 description 3
- 125000004450 alkenylene group Chemical group 0.000 description 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 3
- 125000004419 alkynylene group Chemical group 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 3
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 3
- 125000004979 cyclopentylene group Chemical group 0.000 description 3
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 3
- 125000005879 dioxolanyl group Chemical group 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Aalpha Natural products C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 3
- QOIYTRGFOFZNKF-UHFFFAOYSA-N flupyradifurone Chemical compound C=1C(=O)OCC=1N(CC(F)F)CC1=CC=C(Cl)N=C1 QOIYTRGFOFZNKF-UHFFFAOYSA-N 0.000 description 3
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 3
- 235000021331 green beans Nutrition 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 230000010627 oxidative phosphorylation Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 150000003222 pyridines Chemical class 0.000 description 3
- 239000000018 receptor agonist Substances 0.000 description 3
- 229940044601 receptor agonist Drugs 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000004071 soot Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- CXBMCYHAMVGWJQ-CABCVRRESA-N (1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCN1C(=O)C(CCCC2)=C2C1=O CXBMCYHAMVGWJQ-CABCVRRESA-N 0.000 description 2
- KAATUXNTWXVJKI-NSHGMRRFSA-N (1R)-cis-(alphaS)-cypermethrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-NSHGMRRFSA-N 0.000 description 2
- RLLPVAHGXHCWKJ-MJGOQNOKSA-N (3-phenoxyphenyl)methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-MJGOQNOKSA-N 0.000 description 2
- XTTSANMIKMBNEK-UHFFFAOYSA-N (4-methoxy-2,5,6-trimethylpyridin-3-yl)methanol Chemical compound COC1=C(C(=NC(=C1C)C)C)CO XTTSANMIKMBNEK-UHFFFAOYSA-N 0.000 description 2
- 125000006636 (C3-C8) cycloalkylcarbonyl group Chemical group 0.000 description 2
- 125000005838 1,3-cyclopentylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:2])C([H])([H])C1([H])[*:1] 0.000 description 2
- NZEPEQVPVAXLSY-UHFFFAOYSA-N 2,2,5,6-tetramethyl-1,3-dioxin-4-one Chemical compound CC1=C(C)C(=O)OC(C)(C)O1 NZEPEQVPVAXLSY-UHFFFAOYSA-N 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- GPWNWKWQOLEVEQ-UHFFFAOYSA-N 2,4-diaminopyrimidine-5-carbaldehyde Chemical compound NC1=NC=C(C=O)C(N)=N1 GPWNWKWQOLEVEQ-UHFFFAOYSA-N 0.000 description 2
- LEIFXNSGRZZQKL-UHFFFAOYSA-N 2,5,6-trimethyl-4-oxo-1H-pyridine-3-carbaldehyde Chemical compound OC1=C(C(=NC(=C1C)C)C)C=O LEIFXNSGRZZQKL-UHFFFAOYSA-N 0.000 description 2
- CACOMUHPQMDEJQ-UHFFFAOYSA-N 2-amino-4-methyl-n-phenyl-1,3-thiazole-5-carboxamide Chemical compound N1=C(N)SC(C(=O)NC=2C=CC=CC=2)=C1C CACOMUHPQMDEJQ-UHFFFAOYSA-N 0.000 description 2
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical compound C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- MPOYBFYHRQBZPM-UHFFFAOYSA-N 3h-pyridin-4-one Chemical class O=C1CC=NC=C1 MPOYBFYHRQBZPM-UHFFFAOYSA-N 0.000 description 2
- YFCZMBLXQOUNLC-UHFFFAOYSA-N 4-methoxy-2,5,6-trimethylpyridine-3-carbaldehyde Chemical compound COC1=C(C(=NC(=C1C)C)C)C=O YFCZMBLXQOUNLC-UHFFFAOYSA-N 0.000 description 2
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 2
- 125000006163 5-membered heteroaryl group Chemical group 0.000 description 2
- 125000006164 6-membered heteroaryl group Chemical group 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 241001124076 Aphididae Species 0.000 description 2
- 0 CC(CC(*)(*)N)CN Chemical compound CC(CC(*)(*)N)CN 0.000 description 2
- NWLTVJPPVMKNFH-UHFFFAOYSA-N CC1=C(NC(=C(C1=O)C=NOCCC2=CC=C(C=C2)C(F)(F)F)C)C Chemical compound CC1=C(NC(=C(C1=O)C=NOCCC2=CC=C(C=C2)C(F)(F)F)C)C NWLTVJPPVMKNFH-UHFFFAOYSA-N 0.000 description 2
- HSDUCSMOLARMBA-UHFFFAOYSA-N CCc1c(CO)c(OCC=C)c(C)c(C)n1 Chemical compound CCc1c(CO)c(OCC=C)c(C)c(C)n1 HSDUCSMOLARMBA-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 108010002156 Depsipeptides Proteins 0.000 description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical group C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000790917 Dioxys <bee> Species 0.000 description 2
- 102000008013 Electron Transport Complex I Human genes 0.000 description 2
- 108010089760 Electron Transport Complex I Proteins 0.000 description 2
- CLBDQUGNANHRTC-UHFFFAOYSA-N FC(C1=CC=C(C=C1)CCON=C(C)C=1C(=NC(=C(C=1O)C)C)C)(F)F Chemical compound FC(C1=CC=C(C=C1)CCON=C(C)C=1C(=NC(=C(C=1O)C)C)C)(F)F CLBDQUGNANHRTC-UHFFFAOYSA-N 0.000 description 2
- FSRVWLNXIQKRCZ-UHFFFAOYSA-N FC(C1=CC=C(C=C1)CCON=C(C)C=1C(=NC(=C(C=1OC(C)=O)C)C)C)(F)F Chemical compound FC(C1=CC=C(C=C1)CCON=C(C)C=1C(=NC(=C(C=1OC(C)=O)C)C)C)(F)F FSRVWLNXIQKRCZ-UHFFFAOYSA-N 0.000 description 2
- ZFIBNMVGSGFCGU-UHFFFAOYSA-N FC(C1=CC=C(C=C1)ON=C(C)C=1C(=NC(=C(C=1O)C)C)C)(F)F Chemical compound FC(C1=CC=C(C=C1)ON=C(C)C=1C(=NC(=C(C=1O)C)C)C)(F)F ZFIBNMVGSGFCGU-UHFFFAOYSA-N 0.000 description 2
- HLEJZKJVIFQONC-UHFFFAOYSA-N FC(C1=CC=C(C=C1)ON=C(C)C=1C(=NC(=C(C=1OC(C)=O)C)C)C)(F)F Chemical compound FC(C1=CC=C(C=C1)ON=C(C)C=1C(=NC(=C(C=1OC(C)=O)C)C)C)(F)F HLEJZKJVIFQONC-UHFFFAOYSA-N 0.000 description 2
- DNWHVGSFGOQSTQ-UHFFFAOYSA-N FC(C1=CC=C(CON=C(C)C=2C(=NC(=C(C=2O)C)C)C)C=C1)(F)F Chemical compound FC(C1=CC=C(CON=C(C)C=2C(=NC(=C(C=2O)C)C)C)C=C1)(F)F DNWHVGSFGOQSTQ-UHFFFAOYSA-N 0.000 description 2
- MOXZKAGKQDDEMU-UHFFFAOYSA-N FC(C1=CC=C(CON=C(C)C=2C(=NC(=C(C=2OC(C)=O)C)C)C)C=C1)(F)F Chemical compound FC(C1=CC=C(CON=C(C)C=2C(=NC(=C(C=2OC(C)=O)C)C)C)C=C1)(F)F MOXZKAGKQDDEMU-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000896246 Golovinomyces cichoracearum Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001518731 Monilinia fructicola Species 0.000 description 2
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 2
- 206010067482 No adverse event Diseases 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 241001557902 Phomopsis sp. Species 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000233622 Phytophthora infestans Species 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- 239000005821 Propamocarb Substances 0.000 description 2
- 229940123573 Protein synthesis inhibitor Drugs 0.000 description 2
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 description 2
- 241000918585 Pythium aphanidermatum Species 0.000 description 2
- 241001300361 Sclerotinia borealis Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 241001454293 Tetranychus urticae Species 0.000 description 2
- 239000005842 Thiophanate-methyl Substances 0.000 description 2
- 241000007070 Ustilago nuda Species 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000002393 azetidinyl group Chemical group 0.000 description 2
- 125000004069 aziridinyl group Chemical group 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229960001901 bioallethrin Drugs 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- SCKHCCSZFPSHGR-UHFFFAOYSA-N cyanophos Chemical compound COP(=S)(OC)OC1=CC=C(C#N)C=C1 SCKHCCSZFPSHGR-UHFFFAOYSA-N 0.000 description 2
- 125000005725 cyclohexenylene group Chemical group 0.000 description 2
- 125000004956 cyclohexylene group Chemical group 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 230000017858 demethylation Effects 0.000 description 2
- 238000010520 demethylation reaction Methods 0.000 description 2
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 2
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 2
- 125000000532 dioxanyl group Chemical group 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 2
- KWZFCCHANYEWMZ-UHFFFAOYSA-N ethyl 2,5,6-trimethyl-4-oxo-1H-pyridine-3-carboxylate Chemical compound OC1=C(C(=NC(=C1C(=O)OCC)C)C)C KWZFCCHANYEWMZ-UHFFFAOYSA-N 0.000 description 2
- MYUKAAQSCNRUEV-UHFFFAOYSA-N ethyl 4-methoxy-2,5,6-trimethylpyridine-3-carboxylate Chemical compound COC1=C(C(=NC(=C1C(=O)OCC)C)C)C MYUKAAQSCNRUEV-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- FRCCEHPWNOQAEU-UHFFFAOYSA-N heptachlor Chemical compound ClC1=C(Cl)C2(Cl)C3C=CC(Cl)C3C1(Cl)C2(Cl)Cl FRCCEHPWNOQAEU-UHFFFAOYSA-N 0.000 description 2
- 125000005553 heteroaryloxy group Chemical group 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- WDWDWGRYHDPSDS-UHFFFAOYSA-N methanimine Chemical compound N=C WDWDWGRYHDPSDS-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000002757 morpholinyl group Chemical group 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000005029 naphthylthio group Chemical group C1(=CC=CC2=CC=CC=C12)S* 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- DSOOGBGKEWZRIH-UHFFFAOYSA-N nereistoxin Chemical compound CN(C)C1CSSC1 DSOOGBGKEWZRIH-UHFFFAOYSA-N 0.000 description 2
- 239000003865 nucleic acid synthesis inhibitor Substances 0.000 description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 125000003566 oxetanyl group Chemical group 0.000 description 2
- 125000000466 oxiranyl group Chemical group 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- URHWNXDZOULUHC-ULJHMMPZSA-N picarbutrazox Chemical compound CN1N=NN=C1\C(C=1C=CC=CC=1)=N/OCC1=CC=CC(NC(=O)OC(C)(C)C)=N1 URHWNXDZOULUHC-ULJHMMPZSA-N 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 125000005936 piperidyl group Chemical group 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 2
- 239000000007 protein synthesis inhibitor Substances 0.000 description 2
- 125000003373 pyrazinyl group Chemical group 0.000 description 2
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 description 2
- 125000005030 pyridylthio group Chemical group N1=C(C=CC=C1)S* 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- 125000005493 quinolyl group Chemical group 0.000 description 2
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- DRDVJQOGFWAVLH-UHFFFAOYSA-N tert-butyl n-hydroxycarbamate Chemical compound CC(C)(C)OC(=O)NO DRDVJQOGFWAVLH-UHFFFAOYSA-N 0.000 description 2
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 229960005199 tetramethrin Drugs 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 description 2
- 125000001984 thiazolidinyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical group COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 2
- 125000004306 triazinyl group Chemical group 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000004061 uncoupling agent Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000004563 wettable powder Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- WCJYTPVNMWIZCG-UHFFFAOYSA-N xylylcarb Chemical compound CNC(=O)OC1=CC=C(C)C(C)=C1 WCJYTPVNMWIZCG-UHFFFAOYSA-N 0.000 description 2
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- KAATUXNTWXVJKI-GGPKGHCWSA-N (1R)-trans-(alphaS)-cypermethrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-GGPKGHCWSA-N 0.000 description 1
- SBNFWQZLDJGRLK-RTWAWAEBSA-N (1R)-trans-phenothrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-RTWAWAEBSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 description 1
- YATDSXRLIUJOQN-SVRRBLITSA-N (2,3,4,5,6-pentafluorophenyl)methyl (1r,3s)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=C(F)C(F)=C1F YATDSXRLIUJOQN-SVRRBLITSA-N 0.000 description 1
- AGMMRUPNXPWLGF-AATRIKPKSA-N (2,3,5,6-tetrafluoro-4-methylphenyl)methyl 2,2-dimethyl-3-[(e)-prop-1-enyl]cyclopropane-1-carboxylate Chemical compound CC1(C)C(/C=C/C)C1C(=O)OCC1=C(F)C(F)=C(C)C(F)=C1F AGMMRUPNXPWLGF-AATRIKPKSA-N 0.000 description 1
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 1
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 1
- LZTIMERBDGGAJD-SNAWJCMRSA-N (2e)-2-(nitromethylidene)-1,3-thiazinane Chemical compound [O-][N+](=O)\C=C1/NCCCS1 LZTIMERBDGGAJD-SNAWJCMRSA-N 0.000 description 1
- URDNHJIVMYZFRT-KGLIPLIRSA-N (2r,3r)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pentan-3-ol Chemical compound C([C@H]([C@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1Cl URDNHJIVMYZFRT-KGLIPLIRSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 1
- IMLJLCJZQLGHJS-JEKSYDDFSA-N (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;dihydrate Chemical compound O.O.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O IMLJLCJZQLGHJS-JEKSYDDFSA-N 0.000 description 1
- MGRRXBWTLBJEMS-YADHBBJMSA-N (5-benzylfuran-3-yl)methyl (1r,3r)-3-(cyclopentylidenemethyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C([C@H]1C([C@@H]1C(=O)OCC=1C=C(CC=2C=CC=CC=2)OC=1)(C)C)=C1CCCC1 MGRRXBWTLBJEMS-YADHBBJMSA-N 0.000 description 1
- PPDBOQMNKNNODG-NTEUORMPSA-N (5E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentanol Chemical compound C1=NC=NN1CC1(O)C(C)(C)CC\C1=C/C1=CC=C(Cl)C=C1 PPDBOQMNKNNODG-NTEUORMPSA-N 0.000 description 1
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 description 1
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 1
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 1
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
- BKBSMMUEEAWFRX-NBVRZTHBSA-N (E)-flumorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(F)=CC=1)=C\C(=O)N1CCOCC1 BKBSMMUEEAWFRX-NBVRZTHBSA-N 0.000 description 1
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- IQVNEKKDSLOHHK-FNCQTZNRSA-N (E,E)-hydramethylnon Chemical compound N1CC(C)(C)CNC1=NN=C(/C=C/C=1C=CC(=CC=1)C(F)(F)F)\C=C\C1=CC=C(C(F)(F)F)C=C1 IQVNEKKDSLOHHK-FNCQTZNRSA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- OSLAYKKXCYSJSF-ARJAWSKDSA-N (Z)-4-aminopent-3-en-2-one Chemical compound C\C(N)=C\C(C)=O OSLAYKKXCYSJSF-ARJAWSKDSA-N 0.000 description 1
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- 125000006013 1,1-difluoroethoxy group Chemical group 0.000 description 1
- 125000005656 1,2-cyclobutylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C1([H])[*:2] 0.000 description 1
- 125000005654 1,2-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([*:2])C([H])([*:1])C1([H])[H] 0.000 description 1
- 125000005837 1,2-cyclopentylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([*:2])C1([H])[H] 0.000 description 1
- 125000005655 1,3-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([*:2])C1([H])[H] 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- IHGSAQHSAGRWNI-UHFFFAOYSA-N 1-(4-bromophenyl)-2,2,2-trifluoroethanone Chemical compound FC(F)(F)C(=O)C1=CC=C(Br)C=C1 IHGSAQHSAGRWNI-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- RURQAJURNPMSSK-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3-{[2-(4-ethoxyphenyl)-3,3,3-trifluoropropoxy]methyl}benzene Chemical compound C1=CC(OCC)=CC=C1C(C(F)(F)F)COCC1=CC=CC(OC=2C=CC(Cl)=CC=2)=C1 RURQAJURNPMSSK-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- IAQLCKZJGNTRDO-UHFFFAOYSA-N 1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone Chemical compound CC1=CC(C(F)(F)F)=NN1CC(=O)N1CCC(C=2SC=C(N=2)C=2CC(ON=2)C=2C(=CC=CC=2F)F)CC1 IAQLCKZJGNTRDO-UHFFFAOYSA-N 0.000 description 1
- IKSNDOVDVVPSMA-UHFFFAOYSA-N 1-(bromomethyl)-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(CBr)C=C1 IKSNDOVDVVPSMA-UHFFFAOYSA-N 0.000 description 1
- HVQHXBNMBZJPLK-UHFFFAOYSA-N 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methylprop-2-en-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound CC(=C)CNC1=C([S+]([O-])C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl HVQHXBNMBZJPLK-UHFFFAOYSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 1
- HILAYQUKKYWPJW-UHFFFAOYSA-N 1-dodecylguanidine Chemical compound CCCCCCCCCCCCN=C(N)N HILAYQUKKYWPJW-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- UNNNAIWPDLRVRN-UHFFFAOYSA-N 1-fluoro-4-(trifluoromethyl)benzene Chemical compound FC1=CC=C(C(F)(F)F)C=C1 UNNNAIWPDLRVRN-UHFFFAOYSA-N 0.000 description 1
- 125000004790 1-fluoroethoxy group Chemical group FC(C)O* 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- 125000006028 1-methyl-2-butenyl group Chemical group 0.000 description 1
- 125000006021 1-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- CCBICDLNWJRFPO-UHFFFAOYSA-N 2,6-dichloroindophenol Chemical compound C1=CC(O)=CC=C1N=C1C=C(Cl)C(=O)C(Cl)=C1 CCBICDLNWJRFPO-UHFFFAOYSA-N 0.000 description 1
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 description 1
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 1
- DNBMPXLFKQCOBV-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OCCOCCOCC)=NC2=C1 DNBMPXLFKQCOBV-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 description 1
- CPHXLFKIUVVIOQ-UHFFFAOYSA-N 2-(trifluoromethoxy)benzaldehyde Chemical group FC(F)(F)OC1=CC=CC=C1C=O CPHXLFKIUVVIOQ-UHFFFAOYSA-N 0.000 description 1
- FXJRDUKXWHFPND-NSHDSACASA-N 2-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=NC=CN1 FXJRDUKXWHFPND-NSHDSACASA-N 0.000 description 1
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 1
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 description 1
- ZDRBJJNXJOSCLR-YZKQBBCCSA-N 2-amino-2-[(2r,3s,5s,6r)-5-amino-2-methyl-6-[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxyoxan-3-yl]iminoacetic acid;hydron;chloride Chemical compound Cl.N[C@H]1C[C@H](N=C(N)C(O)=O)[C@@H](C)O[C@@H]1OC1[C@H](O)[C@@H](O)C(O)[C@H](O)[C@@H]1O ZDRBJJNXJOSCLR-YZKQBBCCSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- ZDOOQPFIGYHZFV-UHFFFAOYSA-N 2-ethyl-4-[(4-phenoxyphenoxy)methyl]-1,3-dioxolane Chemical compound O1C(CC)OCC1COC(C=C1)=CC=C1OC1=CC=CC=C1 ZDOOQPFIGYHZFV-UHFFFAOYSA-N 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- 125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 description 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 1
- OVFHHJZHXHZIHT-UHFFFAOYSA-N 3-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)quinazolin-4-one Chemical compound ClC1=CC(Cl)=CC=C1N1C(=O)C2=CC=CC=C2N=C1N1N=CN=C1 OVFHHJZHXHZIHT-UHFFFAOYSA-N 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 description 1
- RAMUASXTSSXCMB-UHFFFAOYSA-N 3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide Chemical compound C1CC1C(C)NC(=O)C1=CC(Cl)=CC(Br)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl RAMUASXTSSXCMB-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 1
- PGYDGBCATBINCB-UHFFFAOYSA-N 4-diethoxyphosphoryl-n,n-dimethylaniline Chemical compound CCOP(=O)(OCC)C1=CC=C(N(C)C)C=C1 PGYDGBCATBINCB-UHFFFAOYSA-N 0.000 description 1
- SBUKOHLFHYSZNG-UHFFFAOYSA-N 4-dodecyl-2,6-dimethylmorpholine Chemical compound CCCCCCCCCCCCN1CC(C)OC(C)C1 SBUKOHLFHYSZNG-UHFFFAOYSA-N 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- KIRTWJNAASMOKG-UHFFFAOYSA-N 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]-2-(1,2,4-triazol-1-yl)benzonitrile Chemical compound N=1OC(C(F)(F)F)(C=2C=C(Cl)C=C(Cl)C=2)CC=1C(C=C1C#N)=CC=C1N1C=NC=N1 KIRTWJNAASMOKG-UHFFFAOYSA-N 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- GOFJDXZZHFNFLV-UHFFFAOYSA-N 5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]pyrazole-4-carboxamide Chemical compound CC(C)CC(C)C1=CC=CC=C1NC(=O)C1=C(F)N(C)N=C1C GOFJDXZZHFNFLV-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 1
- GABNAHQQEVWYNS-UHFFFAOYSA-N 5-phenyl-2,3-dihydro-1,4-dithiine 1,1,4,4-tetraoxide Chemical compound O=S1(=O)CCS(=O)(=O)C(C=2C=CC=CC=2)=C1 GABNAHQQEVWYNS-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- VSVKOUBCDZYAQY-UHFFFAOYSA-N 7-chloro-1,2-benzothiazole Chemical compound ClC1=CC=CC2=C1SN=C2 VSVKOUBCDZYAQY-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 241001519451 Abramis brama Species 0.000 description 1
- 239000005875 Acetamiprid Substances 0.000 description 1
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 1
- 241001600124 Acidovorax avenae Species 0.000 description 1
- YRRKLBAKDXSTNC-UHFFFAOYSA-N Aldicarb sulfonyl Natural products CNC(=O)ON=CC(C)(C)S(C)(=O)=O YRRKLBAKDXSTNC-UHFFFAOYSA-N 0.000 description 1
- YRRKLBAKDXSTNC-WEVVVXLNSA-N Aldoxycarb Chemical compound CNC(=O)O\N=C\C(C)(C)S(C)(=O)=O YRRKLBAKDXSTNC-WEVVVXLNSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000005877 Alpha-Cypermethrin Substances 0.000 description 1
- 241001149961 Alternaria brassicae Species 0.000 description 1
- 241001157812 Alternaria brassicicola Species 0.000 description 1
- 241000352690 Alternaria kikuchiana Species 0.000 description 1
- 241000412366 Alternaria mali Species 0.000 description 1
- 241000123432 Alternaria padwickii Species 0.000 description 1
- 241000213004 Alternaria solani Species 0.000 description 1
- 241001558165 Alternaria sp. Species 0.000 description 1
- 239000005727 Amisulbrom Substances 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241001444083 Aphanomyces Species 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 241001530056 Athelia rolfsii Species 0.000 description 1
- 239000005878 Azadirachtin Substances 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 239000005735 Benalaxyl-M Substances 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 239000005884 Beta-Cyfluthrin Substances 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- 241000228438 Bipolaris maydis Species 0.000 description 1
- 241001450781 Bipolaris oryzae Species 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 241000555706 Botryosphaeria dothidea Species 0.000 description 1
- 241000994678 Botryotinia squamosa Species 0.000 description 1
- 241000499339 Botrytis allii Species 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- KWGUFOITWDSNQY-UHFFFAOYSA-N Bromophos-ethyl Chemical group CCOP(=S)(OCC)OC1=CC(Cl)=C(Br)C=C1Cl KWGUFOITWDSNQY-UHFFFAOYSA-N 0.000 description 1
- 239000005741 Bromuconazole Substances 0.000 description 1
- MYTVVMGUDBRCDJ-UHFFFAOYSA-N Bufencarb Chemical compound CCCC(C)C1=CC=CC(OC(=O)NC)=C1.CCC(CC)C1=CC=CC(OC(=O)NC)=C1 MYTVVMGUDBRCDJ-UHFFFAOYSA-N 0.000 description 1
- 239000005742 Bupirimate Substances 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- 241000589638 Burkholderia glumae Species 0.000 description 1
- 241000134107 Burkholderia plantarii Species 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- NLRDTTNNNGXFAM-UHFFFAOYSA-N CC(C)COC(NOc1ccc(C(F)(F)F)cc1)=O Chemical compound CC(C)COC(NOc1ccc(C(F)(F)F)cc1)=O NLRDTTNNNGXFAM-UHFFFAOYSA-N 0.000 description 1
- JFLRKDZMHNBDQS-UCQUSYKYSA-N CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C Chemical compound CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C.CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3C2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CC[C@@H]([C@H](O6)C)N(C)C JFLRKDZMHNBDQS-UCQUSYKYSA-N 0.000 description 1
- PJUJRXRKBMAARS-UHFFFAOYSA-N CCc1c(C(OC)=O)c(OCC=C)c(C)c(C)n1 Chemical compound CCc1c(C(OC)=O)c(OCC=C)c(C)c(C)n1 PJUJRXRKBMAARS-UHFFFAOYSA-N 0.000 description 1
- KFWPVKMFFBEJOB-UHFFFAOYSA-N CCc1c(C=O)c(OCC=C)c(C)c(C)n1 Chemical compound CCc1c(C=O)c(OCC=C)c(C)c(C)n1 KFWPVKMFFBEJOB-UHFFFAOYSA-N 0.000 description 1
- 239000006009 Calcium phosphide Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 241000530549 Cercospora beticola Species 0.000 description 1
- 241001658057 Cercospora kikuchii Species 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical group CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- STUSTWKEFDQFFZ-UHFFFAOYSA-N Chlordimeform Chemical compound CN(C)C=NC1=CC=C(Cl)C=C1C STUSTWKEFDQFFZ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229940123715 Chloride channel antagonist Drugs 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- 239000005747 Chlorothalonil Substances 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 239000005887 Chromafenozide Substances 0.000 description 1
- 241001414720 Cicadellidae Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000395107 Cladosporium cucumerinum Species 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 239000005888 Clothianidin Substances 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241000407098 Colletotrichum coffeanum Species 0.000 description 1
- 241001123532 Colletotrichum fragariae Species 0.000 description 1
- 241001466031 Colletotrichum gossypii Species 0.000 description 1
- 241001429695 Colletotrichum graminicola Species 0.000 description 1
- 241000152100 Colletotrichum horii Species 0.000 description 1
- 241001120669 Colletotrichum lindemuthianum Species 0.000 description 1
- 241000222235 Colletotrichum orbiculare Species 0.000 description 1
- 241000222239 Colletotrichum truncatum Species 0.000 description 1
- 241001087348 Coniella castaneicola Species 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- 241000609458 Corynespora Species 0.000 description 1
- 241000609455 Corynespora cassiicola Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 241000371648 Curvularia intermedia Species 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- LRNJHZNPJSPMGK-UHFFFAOYSA-N Cyanofenphos Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C(C#N)C=C1 LRNJHZNPJSPMGK-UHFFFAOYSA-N 0.000 description 1
- 239000005754 Cyazofamid Substances 0.000 description 1
- 239000005946 Cypermethrin Substances 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- 239000005758 Cyprodinil Substances 0.000 description 1
- 239000005891 Cyromazine Substances 0.000 description 1
- 108050008072 Cytochrome c oxidase subunit IV Proteins 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 229940124087 DNA topoisomerase II inhibitor Drugs 0.000 description 1
- 240000004585 Dactylis glomerata Species 0.000 description 1
- 239000005644 Dazomet Substances 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- 241001645342 Diaporthe citri Species 0.000 description 1
- WGOWCPGHOCIHBW-UHFFFAOYSA-N Dichlofenthion Chemical compound CCOP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl WGOWCPGHOCIHBW-UHFFFAOYSA-N 0.000 description 1
- 239000005760 Difenoconazole Substances 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- 239000005761 Dimethomorph Substances 0.000 description 1
- 239000005762 Dimoxystrobin Substances 0.000 description 1
- HDWLUGYOLUHEMN-UHFFFAOYSA-N Dinobuton Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)OC(C)C HDWLUGYOLUHEMN-UHFFFAOYSA-N 0.000 description 1
- 241001523339 Discula theae-sinensis Species 0.000 description 1
- 239000005765 Dodemorph Substances 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- AIGRXSNSLVJMEA-UHFFFAOYSA-N EPN Chemical compound C=1C=CC=CC=1P(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-UHFFFAOYSA-N 0.000 description 1
- 102000011687 Electron Transport Complex II Human genes 0.000 description 1
- 108010076322 Electron Transport Complex II Proteins 0.000 description 1
- 241000125117 Elsinoe Species 0.000 description 1
- 241000901048 Elsinoe ampelina Species 0.000 description 1
- 241001506775 Epicoccum nigrum Species 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- 241000510928 Erysiphe necator Species 0.000 description 1
- 239000005895 Esfenvalerate Substances 0.000 description 1
- FNELVJVBIYMIMC-UHFFFAOYSA-N Ethiprole Chemical compound N1=C(C#N)C(S(=O)CC)=C(N)N1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl FNELVJVBIYMIMC-UHFFFAOYSA-N 0.000 description 1
- 239000005961 Ethoprophos Substances 0.000 description 1
- 239000005896 Etofenprox Substances 0.000 description 1
- 239000005897 Etoxazole Substances 0.000 description 1
- 208000029728 Eyelid disease Diseases 0.000 description 1
- 239000005772 Famoxadone Substances 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005775 Fenbuconazole Substances 0.000 description 1
- 239000005776 Fenhexamid Substances 0.000 description 1
- HMIBKHHNXANVHR-UHFFFAOYSA-N Fenothiocarb Chemical compound CN(C)C(=O)SCCCCOC1=CC=CC=C1 HMIBKHHNXANVHR-UHFFFAOYSA-N 0.000 description 1
- 239000005778 Fenpropimorph Substances 0.000 description 1
- 239000005779 Fenpyrazamine Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- 239000005780 Fluazinam Substances 0.000 description 1
- 239000005901 Flubendiamide Substances 0.000 description 1
- 239000005781 Fludioxonil Substances 0.000 description 1
- 239000005782 Fluopicolide Substances 0.000 description 1
- 239000005783 Fluopyram Substances 0.000 description 1
- 239000005784 Fluoxastrobin Substances 0.000 description 1
- 239000005902 Flupyradifurone Substances 0.000 description 1
- VEVZCONIUDBCDC-UHFFFAOYSA-N Flurprimidol Chemical compound C=1N=CN=CC=1C(O)(C(C)C)C1=CC=C(OC(F)(F)F)C=C1 VEVZCONIUDBCDC-UHFFFAOYSA-N 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 239000005948 Formetanate Substances 0.000 description 1
- AIKKULXCBHRFOS-UHFFFAOYSA-N Formothion Chemical compound COP(=S)(OC)SCC(=O)N(C)C=O AIKKULXCBHRFOS-UHFFFAOYSA-N 0.000 description 1
- 239000005790 Fosetyl Substances 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 239000005791 Fuberidazole Substances 0.000 description 1
- 241001466042 Fulgoromorpha Species 0.000 description 1
- 241000221778 Fusarium fujikuroi Species 0.000 description 1
- 241000223195 Fusarium graminearum Species 0.000 description 1
- 239000005903 Gamma-cyhalothrin Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000221557 Gymnosporangium Species 0.000 description 1
- 241001194823 Gymnosporangium asiaticum Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 241000531392 Helicobasidium mompa Species 0.000 description 1
- 241001181532 Hemileia vastatrix Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- 108010072039 Histidine kinase Proteins 0.000 description 1
- 101000641031 Homo sapiens Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 229940127336 Hormone Receptor Agonists Drugs 0.000 description 1
- 241000549404 Hyaloperonospora parasitica Species 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 1
- 239000005796 Ipconazole Substances 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- VROYMKJUVCKXBU-UHFFFAOYSA-N Irumamycin Natural products CCC(=O)C1(C)OC1C(C)CC(C)C1C(C)C(O)C(C)C=CC(OC2OC(C)C(O)C(OC(N)=O)C2)CCCC=C(C)C(O2)C(C)=CCC2(O)CC(=O)O1 VROYMKJUVCKXBU-UHFFFAOYSA-N 0.000 description 1
- 239000005799 Isopyrazam Substances 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 241000228457 Leptosphaeria maculans Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000005912 Lufenuron Substances 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 239000005802 Mancozeb Substances 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241000330845 Marssonina coronariae Species 0.000 description 1
- 239000005805 Mepanipyrim Substances 0.000 description 1
- 239000005914 Metaflumizone Substances 0.000 description 1
- MIFOMMKAVSCNKQ-HWIUFGAZSA-N Metaflumizone Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)N\N=C(C=1C=C(C=CC=1)C(F)(F)F)\CC1=CC=C(C#N)C=C1 MIFOMMKAVSCNKQ-HWIUFGAZSA-N 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 239000005808 Metalaxyl-M Substances 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- 239000005917 Methoxyfenozide Substances 0.000 description 1
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 1
- 229940123379 Methyltransferase inhibitor Drugs 0.000 description 1
- 239000005810 Metrafenone Substances 0.000 description 1
- 239000005918 Milbemectin Substances 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 241000862466 Monilinia laxa Species 0.000 description 1
- 241001363493 Monilinia mali Species 0.000 description 1
- 241001459558 Monographella nivalis Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 241000285727 Mycosphaerella coffeicola Species 0.000 description 1
- 241000633856 Mycosphaerella pomi Species 0.000 description 1
- 241000899399 Mycovellosiella Species 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- XQJQCBDIXRIYRP-UHFFFAOYSA-N N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1C(C2CC2)C1 XQJQCBDIXRIYRP-UHFFFAOYSA-N 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241001329956 Nothopassalora personata Species 0.000 description 1
- NBHXEBUUNISYDA-UHFFFAOYSA-N O-[3-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxybutan-2-yl]hydroxylamine Chemical compound ClC=1C(=NC=C(C=1)C(F)(F)F)OC(C(C)ON)C NBHXEBUUNISYDA-UHFFFAOYSA-N 0.000 description 1
- 241001668536 Oculimacula yallundae Species 0.000 description 1
- 241000896238 Oidium Species 0.000 description 1
- 241001552243 Oidium neolycopersici Species 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- 239000005812 Oxathiapiprolin Substances 0.000 description 1
- 229940087098 Oxidase inhibitor Drugs 0.000 description 1
- 229940122272 Oxidoreductase inhibitor Drugs 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000845082 Panama Species 0.000 description 1
- 241000736122 Parastagonospora nodorum Species 0.000 description 1
- 241000222291 Passalora fulva Species 0.000 description 1
- 241001438726 Passalora janseana Species 0.000 description 1
- 241000588701 Pectobacterium carotovorum Species 0.000 description 1
- 239000005813 Penconazole Substances 0.000 description 1
- 239000005815 Penflufen Substances 0.000 description 1
- 241001507673 Penicillium digitatum Species 0.000 description 1
- 241000122123 Penicillium italicum Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 241001223281 Peronospora Species 0.000 description 1
- 241001670203 Peronospora manshurica Species 0.000 description 1
- 241000899392 Phaeoisariopsis griseola Species 0.000 description 1
- 244000309618 Phakopsora gossypii Species 0.000 description 1
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241001235318 Phomopsis fukushii Species 0.000 description 1
- 239000005921 Phosmet Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000309557 Phyllachora pomigena Species 0.000 description 1
- 241001609671 Phyllactinia kakicola Species 0.000 description 1
- 241001123457 Phyllactinia mali Species 0.000 description 1
- 241000210649 Phyllosticta ampelicida Species 0.000 description 1
- 241001270527 Phyllosticta citrullina Species 0.000 description 1
- 241001149949 Phytophthora cactorum Species 0.000 description 1
- 241000626604 Phytophthora porri Species 0.000 description 1
- 241000948155 Phytophthora sojae Species 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 239000005818 Picoxystrobin Substances 0.000 description 1
- 239000005924 Pirimiphos-methyl Substances 0.000 description 1
- 241001503436 Plasmodiophora brassicae Species 0.000 description 1
- 241000233610 Plasmopara halstedii Species 0.000 description 1
- 241001281803 Plasmopara viticola Species 0.000 description 1
- 241000500437 Plutella xylostella Species 0.000 description 1
- 241001337928 Podosphaera leucotricha Species 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 241000524949 Polystigma rubrum Species 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- DTAPQAJKAFRNJB-UHFFFAOYSA-N Promecarb Chemical compound CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 DTAPQAJKAFRNJB-UHFFFAOYSA-N 0.000 description 1
- MKIMSXGUTQTKJU-UHFFFAOYSA-N Propamocarb hydrochloride Chemical compound [Cl-].CCCOC(=O)NCCC[NH+](C)C MKIMSXGUTQTKJU-UHFFFAOYSA-N 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 239000005823 Propineb Substances 0.000 description 1
- 239000005825 Prothioconazole Substances 0.000 description 1
- 235000010401 Prunus avium Nutrition 0.000 description 1
- 244000007021 Prunus avium Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000087479 Pseudocercospora fijiensis Species 0.000 description 1
- 241001322464 Pseudocercospora fuligena Species 0.000 description 1
- 241000301598 Pseudocercospora kaki Species 0.000 description 1
- 241000184297 Pseudocercospora musae Species 0.000 description 1
- 241000386899 Pseudocercospora vitis Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241001281805 Pseudoperonospora cubensis Species 0.000 description 1
- 241001624808 Pseudopestalotiopsis theae Species 0.000 description 1
- 241000343500 Puccinia arachidis Species 0.000 description 1
- 241000928332 Puccinia melanocephala Species 0.000 description 1
- 241001304534 Puccinia polysora Species 0.000 description 1
- 241001123567 Puccinia sorghi Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- 241000228454 Pyrenophora graminea Species 0.000 description 1
- 241000520648 Pyrenophora teres Species 0.000 description 1
- VMORCWYWLVLMDG-YZGWKJHDSA-N Pyrethrin-II Natural products CC(=O)OC(=C[C@@H]1[C@H](C(=O)O[C@H]2CC(=O)C(=C2C)CC=CC=C)C1(C)C)C VMORCWYWLVLMDG-YZGWKJHDSA-N 0.000 description 1
- 241000231139 Pyricularia Species 0.000 description 1
- 241000619663 Pyricularia sp. Species 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 239000005926 Pyridalyl Substances 0.000 description 1
- 239000005927 Pyriproxyfen Substances 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000599030 Pythium debaryanum Species 0.000 description 1
- 241000202873 Pythium iwayamai Species 0.000 description 1
- 102000017143 RNA Polymerase I Human genes 0.000 description 1
- 108010013845 RNA Polymerase I Proteins 0.000 description 1
- 229940123752 RNA synthesis inhibitor Drugs 0.000 description 1
- 241000196686 Ramulariopsis gossypii Species 0.000 description 1
- 229940123934 Reductase inhibitor Drugs 0.000 description 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 1
- 241001515790 Rhynchosporium secalis Species 0.000 description 1
- 102000001424 Ryanodine receptors Human genes 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- OUNSASXJZHBGAI-UHFFFAOYSA-N Salithion Chemical compound C1=CC=C2OP(OC)(=S)OCC2=C1 OUNSASXJZHBGAI-UHFFFAOYSA-N 0.000 description 1
- 241000825108 Schizothyrium pomi Species 0.000 description 1
- 241000221662 Sclerotinia Species 0.000 description 1
- 241001518640 Sclerotinia homoeocarpa Species 0.000 description 1
- 239000005834 Sedaxane Substances 0.000 description 1
- 239000005835 Silthiofam Substances 0.000 description 1
- 108010052164 Sodium Channels Proteins 0.000 description 1
- 102000018674 Sodium Channels Human genes 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 239000005929 Spinetoram Substances 0.000 description 1
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 description 1
- 239000005930 Spinosad Substances 0.000 description 1
- 239000005664 Spirodiclofen Substances 0.000 description 1
- 239000005665 Spiromesifen Substances 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 102000005782 Squalene Monooxygenase Human genes 0.000 description 1
- 108020003891 Squalene monooxygenase Proteins 0.000 description 1
- 241000266365 Stemphylium vesicarium Species 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 239000005934 Sulfoxaflor Substances 0.000 description 1
- 239000005935 Sulfuryl fluoride Substances 0.000 description 1
- 241001104043 Syringa Species 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- 241001454295 Tetranychidae Species 0.000 description 1
- QUWSDLYBOVGOCW-UHFFFAOYSA-N Tetrasul Chemical compound C1=CC(Cl)=CC=C1SC1=CC(Cl)=C(Cl)C=C1Cl QUWSDLYBOVGOCW-UHFFFAOYSA-N 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- 239000005941 Thiamethoxam Substances 0.000 description 1
- 241000722093 Tilletia caries Species 0.000 description 1
- 101710110901 Trehalase inhibitor Proteins 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- 239000005857 Trifloxystrobin Substances 0.000 description 1
- 239000005858 Triflumizole Substances 0.000 description 1
- 239000005942 Triflumuron Substances 0.000 description 1
- ZKEKDTIKFVCKMW-UHFFFAOYSA-N Trifolin Natural products OCC1OC(Oc2cc(O)ccc2C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O ZKEKDTIKFVCKMW-UHFFFAOYSA-N 0.000 description 1
- 239000005859 Triticonazole Substances 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 229940122530 Tubulin polymerization inhibitor Drugs 0.000 description 1
- 241000722921 Tulipa gesneriana Species 0.000 description 1
- 241001593750 Turcica Species 0.000 description 1
- 241000333201 Typhula incarnata Species 0.000 description 1
- 235000015919 Ustilago maydis Nutrition 0.000 description 1
- 244000301083 Ustilago maydis Species 0.000 description 1
- 241000233791 Ustilago tritici Species 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- 241001512566 Valsa mali Species 0.000 description 1
- 241000228452 Venturia inaequalis Species 0.000 description 1
- 241001669638 Venturia nashicola Species 0.000 description 1
- 241001123669 Verticillium albo-atrum Species 0.000 description 1
- 101710175177 Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 241000282188 Wilsonomyces carpophilus Species 0.000 description 1
- 241000589634 Xanthomonas Species 0.000 description 1
- 241000985670 Xanthomonas arboricola pv. pruni Species 0.000 description 1
- 241000589655 Xanthomonas citri Species 0.000 description 1
- 241000589652 Xanthomonas oryzae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000006011 Zinc phosphide Substances 0.000 description 1
- 239000005870 Ziram Substances 0.000 description 1
- 239000005863 Zoxamide Substances 0.000 description 1
- 241001360088 Zymoseptoria tritici Species 0.000 description 1
- GBAWQJNHVWMTLU-RQJHMYQMSA-N [(1R,5S)-7-chloro-6-bicyclo[3.2.0]hepta-2,6-dienyl] dimethyl phosphate Chemical compound C1=CC[C@@H]2C(OP(=O)(OC)OC)=C(Cl)[C@@H]21 GBAWQJNHVWMTLU-RQJHMYQMSA-N 0.000 description 1
- QQODLKZGRKWIFG-RUTXASTPSA-N [(R)-cyano-(4-fluoro-3-phenoxyphenyl)methyl] (1S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-RUTXASTPSA-N 0.000 description 1
- FZSVSABTBYGOQH-XFFZJAGNSA-N [(e)-(3,3-dimethyl-1-methylsulfanylbutan-2-ylidene)amino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(C(C)(C)C)\CSC FZSVSABTBYGOQH-XFFZJAGNSA-N 0.000 description 1
- CTJBHIROCMPUKL-WEVVVXLNSA-N [(e)-3-methylsulfonylbutan-2-ylideneamino] n-methylcarbamate Chemical compound CNC(=O)O\N=C(/C)C(C)S(C)(=O)=O CTJBHIROCMPUKL-WEVVVXLNSA-N 0.000 description 1
- BZMIHNKNQJJVRO-LVZFUZTISA-N [(e)-c-(3-chloro-2,6-dimethoxyphenyl)-n-ethoxycarbonimidoyl] benzoate Chemical compound COC=1C=CC(Cl)=C(OC)C=1C(=N/OCC)\OC(=O)C1=CC=CC=C1 BZMIHNKNQJJVRO-LVZFUZTISA-N 0.000 description 1
- KAATUXNTWXVJKI-QPIRBTGLSA-N [(s)-cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-QPIRBTGLSA-N 0.000 description 1
- OOWCJRMYMAMSOH-UHFFFAOYSA-N [2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound FC1=C(F)C(COC)=C(F)C(F)=C1COC(=O)C1C(C)(C)C1C=C(C)C OOWCJRMYMAMSOH-UHFFFAOYSA-N 0.000 description 1
- CFGPESLNPCIKIX-UHFFFAOYSA-N [2-[ethoxy(propylsulfanyl)phosphoryl]oxyphenyl] n-methylcarbamate Chemical compound CCCSP(=O)(OCC)OC1=CC=CC=C1OC(=O)NC CFGPESLNPCIKIX-UHFFFAOYSA-N 0.000 description 1
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 1
- YXWCBRDRVXHABN-JCMHNJIXSA-N [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[(z)-2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate Chemical compound C=1C=C(F)C(OC=2C=CC=CC=2)=CC=1C(C#N)OC(=O)C1C(C)(C)C1\C=C(/Cl)C1=CC=C(Cl)C=C1 YXWCBRDRVXHABN-JCMHNJIXSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- YLJLLELGHSWIDU-OKZTUQRJSA-N acetic acid;(2s,6r)-4-cyclododecyl-2,6-dimethylmorpholine Chemical compound CC(O)=O.C1[C@@H](C)O[C@@H](C)CN1C1CCCCCCCCCCC1 YLJLLELGHSWIDU-OKZTUQRJSA-N 0.000 description 1
- 229940121373 acetyl-coa carboxylase inhibitor Drugs 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003670 adamantan-2-yl group Chemical group [H]C1([H])C(C2([H])[H])([H])C([H])([H])C3([H])C([*])([H])C1([H])C([H])([H])C2([H])C3([H])[H] 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002487 adenosine deaminase inhibitor Substances 0.000 description 1
- LRZWFURXIMFONG-HRSIRGMGSA-N afidopyropen Chemical compound C([C@@]1(C)[C@H]2[C@]([C@H]3[C@@H](O)C=4C(=O)OC(=CC=4O[C@]3(C)[C@@H](O)C2)C=2C=NC=CC=2)(C)CC[C@@H]1OC(=O)C1CC1)OC(=O)C1CC1 LRZWFURXIMFONG-HRSIRGMGSA-N 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 229940024113 allethrin Drugs 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- IMIDOCRTMDIQIJ-UHFFFAOYSA-N aminocarb Chemical compound CNC(=O)OC1=CC=C(N(C)C)C(C)=C1 IMIDOCRTMDIQIJ-UHFFFAOYSA-N 0.000 description 1
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- IMHBYKMAHXWHRP-UHFFFAOYSA-N anilazine Chemical compound ClC1=CC=CC=C1NC1=NC(Cl)=NC(Cl)=N1 IMHBYKMAHXWHRP-UHFFFAOYSA-N 0.000 description 1
- 208000020282 anthrax disease Diseases 0.000 description 1
- 230000001887 anti-feedant effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 description 1
- 229950000294 azaconazole Drugs 0.000 description 1
- VEHPJKVTJQSSKL-UHFFFAOYSA-N azadirachtin Natural products O1C2(C)C(C3(C=COC3O3)O)CC3C21C1(C)C(O)C(OCC2(OC(C)=O)C(CC3OC(=O)C(C)=CC)OC(C)=O)C2C32COC(C(=O)OC)(O)C12 VEHPJKVTJQSSKL-UHFFFAOYSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-IRYYUVNJSA-N azadirachtin A Natural products C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C/C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-IRYYUVNJSA-N 0.000 description 1
- FTNJWQUOZFUQQJ-NDAWSKJSSA-N azadirachtin A Chemical compound C([C@@H]([C@]1(C=CO[C@H]1O1)O)[C@]2(C)O3)[C@H]1[C@]23[C@]1(C)[C@H](O)[C@H](OC[C@@]2([C@@H](C[C@@H]3OC(=O)C(\C)=C\C)OC(C)=O)C(=O)OC)[C@@H]2[C@]32CO[C@@](C(=O)OC)(O)[C@@H]12 FTNJWQUOZFUQQJ-NDAWSKJSSA-N 0.000 description 1
- RQVGAIADHNPSME-UHFFFAOYSA-N azinphos-ethyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OCC)OCC)N=NC2=C1 RQVGAIADHNPSME-UHFFFAOYSA-N 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- ONHBDDJJTDTLIR-UHFFFAOYSA-N azocyclotin Chemical compound C1CCCCC1[Sn](N1N=CN=C1)(C1CCCCC1)C1CCCCC1 ONHBDDJJTDTLIR-UHFFFAOYSA-N 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- CJPQIRJHIZUAQP-MRXNPFEDSA-N benalaxyl-M Chemical compound CC=1C=CC=C(C)C=1N([C@H](C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-MRXNPFEDSA-N 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- YFXPPSKYMBTNAV-UHFFFAOYSA-N bensultap Chemical compound C=1C=CC=CC=1S(=O)(=O)SCC(N(C)C)CSS(=O)(=O)C1=CC=CC=C1 YFXPPSKYMBTNAV-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 208000036815 beta tubulin Diseases 0.000 description 1
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 229950002373 bioresmethrin Drugs 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- DSKJPMWIHSOYEA-UHFFFAOYSA-N bupirimate Chemical compound CCCCC1=C(C)N=C(NCC)N=C1OS(=O)(=O)N(C)C DSKJPMWIHSOYEA-UHFFFAOYSA-N 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- 125000005569 butenylene group Chemical group 0.000 description 1
- SFNPDDSJBGRXLW-UITAMQMPSA-N butocarboxim Chemical compound CNC(=O)O\N=C(\C)C(C)SC SFNPDDSJBGRXLW-UITAMQMPSA-N 0.000 description 1
- 125000005622 butynylene group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- JLQUFIHWVLZVTJ-UHFFFAOYSA-N carbosulfan Chemical compound CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 JLQUFIHWVLZVTJ-UHFFFAOYSA-N 0.000 description 1
- RXDMAYSSBPYBFW-PKFCDNJMSA-N carpropamide Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)[C@@]1(CC)[C@H](C)C1(Cl)Cl RXDMAYSSBPYBFW-PKFCDNJMSA-N 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 108090001110 cellulose synthase (GDP-forming) Proteins 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- XCJXQCUJXDUNDN-UHFFFAOYSA-N chlordene Chemical compound C12C=CCC2C2(Cl)C(Cl)=C(Cl)C1(Cl)C2(Cl)Cl XCJXQCUJXDUNDN-UHFFFAOYSA-N 0.000 description 1
- XFDJMIHUAHSGKG-UHFFFAOYSA-N chlorethoxyfos Chemical compound CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl XFDJMIHUAHSGKG-UHFFFAOYSA-N 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
- 239000003467 chloride channel stimulating agent Substances 0.000 description 1
- QGTYWWGEWOBMAK-UHFFFAOYSA-N chlormephos Chemical compound CCOP(=S)(OCC)SCCl QGTYWWGEWOBMAK-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- 125000004651 chloromethoxy group Chemical group ClCO* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
- HRBKVYFZANMGRE-UHFFFAOYSA-N chlorpyrifos-methyl Chemical group COP(=S)(OC)OC1=NC(Cl)=C(Cl)C=C1Cl HRBKVYFZANMGRE-UHFFFAOYSA-N 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- PZSIFLLRHQZAKV-UHFFFAOYSA-L copper;4-dodecylbenzenesulfonate;ethane-1,2-diamine Chemical compound [Cu+2].NCCN.NCCN.CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1.CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 PZSIFLLRHQZAKV-UHFFFAOYSA-L 0.000 description 1
- CAMXOLUXKJMDSB-UHFFFAOYSA-L copper;naphthalene-1-carboxylate Chemical compound [Cu+2].C1=CC=C2C(C(=O)[O-])=CC=CC2=C1.C1=CC=C2C(C(=O)[O-])=CC=CC2=C1 CAMXOLUXKJMDSB-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- BXNANOICGRISHX-UHFFFAOYSA-N coumaphos Chemical compound CC1=C(Cl)C(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 BXNANOICGRISHX-UHFFFAOYSA-N 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229910001610 cryolite Inorganic materials 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 150000001925 cycloalkenes Chemical class 0.000 description 1
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 description 1
- 125000006637 cyclobutyl carbonyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004976 cyclobutylene group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000062 cyclohexylmethoxy group Chemical group [H]C([H])(O*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 1
- 125000006638 cyclopentyl carbonyl group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 1
- 125000004980 cyclopropylene group Chemical group 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004859 cyclopropyloxymethyl group Chemical group C1(CC1)OC* 0.000 description 1
- LSFUGNKKPMBOMG-UHFFFAOYSA-N cycloprothrin Chemical compound ClC1(Cl)CC1(C=1C=CC=CC=1)C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 LSFUGNKKPMBOMG-UHFFFAOYSA-N 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-UNOMPAQXSA-N cyhalothrin Chemical compound CC1(C)C(\C=C(/Cl)C(F)(F)F)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-UNOMPAQXSA-N 0.000 description 1
- KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
- 229960005424 cypermethrin Drugs 0.000 description 1
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
- OAWUUPVZMNKZRY-UHFFFAOYSA-N cyprosulfamide Chemical compound COC1=CC=CC=C1C(=O)NS(=O)(=O)C1=CC=C(C(=O)NC2CC2)C=C1 OAWUUPVZMNKZRY-UHFFFAOYSA-N 0.000 description 1
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 1
- 229950000775 cyromazine Drugs 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 229940008203 d-transallethrin Drugs 0.000 description 1
- QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical compound CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- 229950003960 demiditraz Drugs 0.000 description 1
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- USLKCMBGQFYUFI-UHFFFAOYSA-N dichloromethane;tribromoborane Chemical compound ClCCl.BrB(Br)Br USLKCMBGQFYUFI-UHFFFAOYSA-N 0.000 description 1
- 125000004783 dichloromethoxy group Chemical group ClC(O*)Cl 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229950001327 dichlorvos Drugs 0.000 description 1
- VEENJGZXVHKXNB-VOTSOKGWSA-N dicrotophos Chemical compound COP(=O)(OC)O\C(C)=C\C(=O)N(C)C VEENJGZXVHKXNB-VOTSOKGWSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000005043 dihydropyranyl group Chemical group O1C(CCC=C1)* 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- YOTZYFSGUCFUKA-UHFFFAOYSA-N dimethylphosphine Chemical compound CPC YOTZYFSGUCFUKA-UHFFFAOYSA-N 0.000 description 1
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 description 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- PYZSVQVRHDXQSL-UHFFFAOYSA-N dithianon Chemical compound S1C(C#N)=C(C#N)SC2=C1C(=O)C1=CC=CC=C1C2=O PYZSVQVRHDXQSL-UHFFFAOYSA-N 0.000 description 1
- JMXKCYUTURMERF-UHFFFAOYSA-N dodemorph Chemical compound C1C(C)OC(C)CN1C1CCCCCCCCCCC1 JMXKCYUTURMERF-UHFFFAOYSA-N 0.000 description 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 1
- 229960003997 doramectin Drugs 0.000 description 1
- GCKZANITAMOIAR-XWVCPFKXSA-N dsstox_cid_14566 Chemical compound [O-]C(=O)C1=CC=CC=C1.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H]([NH2+]C)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 GCKZANITAMOIAR-XWVCPFKXSA-N 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 108010056417 emodepside Proteins 0.000 description 1
- ZMQMTKVVAMWKNY-YSXLEBCMSA-N emodepside Chemical compound C([C@@H]1C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@H](C(O[C@H](CC=2C=CC(=CC=2)N2CCOCC2)C(=O)N(C)[C@@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)O1)=O)CC(C)C)C(C=C1)=CC=C1N1CCOCC1 ZMQMTKVVAMWKNY-YSXLEBCMSA-N 0.000 description 1
- 229960001575 emodepside Drugs 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- 229960002125 enilconazole Drugs 0.000 description 1
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- WPNHOHPRXXCPRA-TVXIRPTOSA-N eprinomectin Chemical compound O1[C@@H](C)[C@@H](NC(C)=O)[C@H](OC)C[C@@H]1O[C@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C\C=C/[C@@H]2C)\C)O[C@H]1C WPNHOHPRXXCPRA-TVXIRPTOSA-N 0.000 description 1
- 229960002346 eprinomectin Drugs 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- DWRKFAJEBUWTQM-UHFFFAOYSA-N etaconazole Chemical compound O1C(CC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 DWRKFAJEBUWTQM-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 1
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000006627 ethoxycarbonylamino group Chemical group 0.000 description 1
- YPMPTULBFPFSEQ-PLNGDYQASA-N ethyl (z)-3-aminobut-2-enoate Chemical compound CCOC(=O)\C=C(\C)N YPMPTULBFPFSEQ-PLNGDYQASA-N 0.000 description 1
- FNENWZWNOPCZGK-UHFFFAOYSA-N ethyl 2-methyl-3-oxobutanoate Chemical compound CCOC(=O)C(C)C(C)=O FNENWZWNOPCZGK-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 1
- 229950005085 etofenprox Drugs 0.000 description 1
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- 229950006668 fenfluthrin Drugs 0.000 description 1
- JFSPBVWPKOEZCB-UHFFFAOYSA-N fenfuram Chemical compound O1C=CC(C(=O)NC=2C=CC=CC=2)=C1C JFSPBVWPKOEZCB-UHFFFAOYSA-N 0.000 description 1
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- UTOHZQYBSYOOGC-UHFFFAOYSA-N fenpyrazamine Chemical compound O=C1N(C(C)C)N(C(=O)SCC=C)C(N)=C1C1=CC=CC=C1C UTOHZQYBSYOOGC-UHFFFAOYSA-N 0.000 description 1
- WDQNIWFZKXZFAY-UHFFFAOYSA-M fentin acetate Chemical compound CC([O-])=O.C1=CC=CC=C1[Sn+](C=1C=CC=CC=1)C1=CC=CC=C1 WDQNIWFZKXZFAY-UHFFFAOYSA-M 0.000 description 1
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- UZCGKGPEKUCDTF-UHFFFAOYSA-N fluazinam Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=C(Cl)C([N+]([O-])=O)=C1NC1=NC=C(C(F)(F)F)C=C1Cl UZCGKGPEKUCDTF-UHFFFAOYSA-N 0.000 description 1
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 1
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 description 1
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 1
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- GNVDAZSPJWCIQZ-UHFFFAOYSA-N flusulfamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1NS(=O)(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 GNVDAZSPJWCIQZ-UHFFFAOYSA-N 0.000 description 1
- KGXUEPOHGFWQKF-ZCXUNETKSA-N flutianil Chemical compound COC1=CC=CC=C1N(CCS\1)C/1=C(C#N)/SC1=CC(C(F)(F)F)=CC=C1F KGXUEPOHGFWQKF-ZCXUNETKSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- RMFNNCGOSPBBAD-MDWZMJQESA-N formetanate Chemical compound CNC(=O)OC1=CC=CC(\N=C\N(C)C)=C1 RMFNNCGOSPBBAD-MDWZMJQESA-N 0.000 description 1
- VUERQRKTYBIULR-UHFFFAOYSA-N fosetyl Chemical compound CCOP(O)=O VUERQRKTYBIULR-UHFFFAOYSA-N 0.000 description 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 description 1
- ZXQYGBMAQZUVMI-GCMPRSNUSA-N gamma-cyhalothrin Chemical compound CC1(C)[C@@H](\C=C(/Cl)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-GCMPRSNUSA-N 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 description 1
- CNKHSLKYRMDDNQ-UHFFFAOYSA-N halofenozide Chemical compound C=1C=CC=CC=1C(=O)N(C(C)(C)C)NC(=O)C1=CC=C(Cl)C=C1 CNKHSLKYRMDDNQ-UHFFFAOYSA-N 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 125000005368 heteroarylthio group Chemical group 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000004095 hydrolyase inhibitor Substances 0.000 description 1
- FYQGBXGJFWXIPP-UHFFFAOYSA-N hydroprene Chemical compound CCOC(=O)C=C(C)C=CCC(C)CCCC(C)C FYQGBXGJFWXIPP-UHFFFAOYSA-N 0.000 description 1
- 229930000073 hydroprene Natural products 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- KGVPNLBXJKTABS-UHFFFAOYSA-N hymexazol Chemical compound CC1=CC(O)=NO1 KGVPNLBXJKTABS-UHFFFAOYSA-N 0.000 description 1
- HICUREFSAIZXFQ-JOWPUVSESA-N i9z29i000j Chemical compound C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\[C@H](OC(=O)C(=N/OC)\C=1C=CC=CC=1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 HICUREFSAIZXFQ-JOWPUVSESA-N 0.000 description 1
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002428 insect molting hormone Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- VROYMKJUVCKXBU-YACXGCCLSA-N irumamycin Chemical compound CCC(=O)[C@@]1(C)OC1[C@H](C)C[C@@H](C)[C@@H]1[C@H](C)C(O)[C@@H](C)/C=C/[C@H](OC2O[C@H](C)[C@@H](O)[C@H](OC(N)=O)C2)CCC/C=C(C)/[C@@H](O2)C(C)=CC[C@]2(O)CC(=O)O1 VROYMKJUVCKXBU-YACXGCCLSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- YFVOXLJXJBQDEF-UHFFFAOYSA-N isocarbophos Chemical compound COP(N)(=S)OC1=CC=CC=C1C(=O)OC(C)C YFVOXLJXJBQDEF-UHFFFAOYSA-N 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- WLPCAERCXQSYLQ-UHFFFAOYSA-N isotianil Chemical compound ClC1=NSC(C(=O)NC=2C(=CC=CC=2)C#N)=C1Cl WLPCAERCXQSYLQ-UHFFFAOYSA-N 0.000 description 1
- SDMSCIWHRZJSRN-UHFFFAOYSA-N isoxathion Chemical compound O1N=C(OP(=S)(OCC)OCC)C=C1C1=CC=CC=C1 SDMSCIWHRZJSRN-UHFFFAOYSA-N 0.000 description 1
- 125000003971 isoxazolinyl group Chemical group 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- JPUKWEQWGBDDQB-DTGCRPNFSA-N kaempferol 3-O-beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-DTGCRPNFSA-N 0.000 description 1
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000005910 lambda-Cyhalothrin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229960000521 lufenuron Drugs 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-GFCCVEGCSA-N metalaxyl-M Chemical compound COCC(=O)N([C@H](C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-GFCCVEGCSA-N 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- NKSXDMWAVIOSTD-PLNGDYQASA-N methyl (z)-3-aminopent-2-enoate Chemical compound CC\C(N)=C\C(=O)OC NKSXDMWAVIOSTD-PLNGDYQASA-N 0.000 description 1
- KBHDSWIXRODKSZ-UHFFFAOYSA-N methyl 5-chloro-2-(trifluoromethylsulfonylamino)benzoate Chemical compound COC(=O)C1=CC(Cl)=CC=C1NS(=O)(=O)C(F)(F)F KBHDSWIXRODKSZ-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 125000006216 methylsulfinyl group Chemical group [H]C([H])([H])S(*)=O 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000003697 methyltransferase inhibitor Substances 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- HIIRDDUVRXCDBN-OBGWFSINSA-N metominostrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1OC1=CC=CC=C1 HIIRDDUVRXCDBN-OBGWFSINSA-N 0.000 description 1
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 description 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 1
- CKVMAPHTVCTEMM-ALPQRHTBSA-N milbemycin oxime Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\2)O)C[C@H]4C1.C1C[C@H](C)[C@@H](CC)O[C@@]21O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)C(=N/O)/[C@H]3OC\1)O)C[C@H]4C2 CKVMAPHTVCTEMM-ALPQRHTBSA-N 0.000 description 1
- 229940099245 milbemycin oxime Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 description 1
- 229960004816 moxidectin Drugs 0.000 description 1
- YNKFZRGTXAPYFD-UHFFFAOYSA-N n-[[2-chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl]-2,6-difluorobenzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1Cl YNKFZRGTXAPYFD-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004708 n-butylthio group Chemical group C(CCC)S* 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004718 n-hexylthio group Chemical group C(CCCCC)S* 0.000 description 1
- 125000003935 n-pentoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004712 n-pentylthio group Chemical group C(CCCC)S* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004706 n-propylthio group Chemical group C(CC)S* 0.000 description 1
- 125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- 108010003516 norsynephrine receptor Proteins 0.000 description 1
- YTYGAJLZOJPJGH-UHFFFAOYSA-N noviflumuron Chemical compound FC1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F YTYGAJLZOJPJGH-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- JHIPUJPTQJYEQK-ZLHHXESBSA-N orysastrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1CO\N=C(/C)\C(=N\OC)\C(\C)=N\OC JHIPUJPTQJYEQK-ZLHHXESBSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- 125000005968 oxazolinyl group Chemical group 0.000 description 1
- 125000005564 oxazolylene group Chemical group 0.000 description 1
- 239000002457 oxidoreductase inhibitor Substances 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000005005 perfluorohexyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- HOKBIQDJCNTWST-UHFFFAOYSA-N phosphanylidenezinc;zinc Chemical compound [Zn].[Zn]=P.[Zn]=P HOKBIQDJCNTWST-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229940096992 potassium oleate Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- MLICVSDCCDDWMD-KVVVOXFISA-M potassium;(z)-octadec-9-enoate Chemical compound [K+].CCCCCCCC\C=C/CCCCCCCC([O-])=O MLICVSDCCDDWMD-KVVVOXFISA-M 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- WTFXJFJYEJZMFO-UHFFFAOYSA-N propamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCOC1=CC=C(C(N)=N)C=C1 WTFXJFJYEJZMFO-UHFFFAOYSA-N 0.000 description 1
- 229960003761 propamidine Drugs 0.000 description 1
- PWYIUEFFPNVCMW-UHFFFAOYSA-N propaphos Chemical compound CCCOP(=O)(OCCC)OC1=CC=C(SC)C=C1 PWYIUEFFPNVCMW-UHFFFAOYSA-N 0.000 description 1
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- BZNDWPRGXNILMS-VQHVLOKHSA-N propetamphos Chemical compound CCNP(=S)(OC)O\C(C)=C\C(=O)OC(C)C BZNDWPRGXNILMS-VQHVLOKHSA-N 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- KKMLIVYBGSAJPM-UHFFFAOYSA-L propineb Chemical compound [Zn+2].[S-]C(=S)NC(C)CNC([S-])=S KKMLIVYBGSAJPM-UHFFFAOYSA-L 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- YRRBXJLFCBCKNW-UHFFFAOYSA-N prothiocarb Chemical compound CCSC(=O)NCCCN(C)C YRRBXJLFCBCKNW-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 1
- ROVGZAWFACYCSP-VUMXUWRFSA-N pyrethrin I Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-VUMXUWRFSA-N 0.000 description 1
- 229940015367 pyrethrum Drugs 0.000 description 1
- CRFYLQMIDWBKRT-LPYMAVHISA-N pyribencarb Chemical compound C1=C(Cl)C(CNC(=O)OC)=CC(C(\C)=N\OCC=2N=C(C)C=CC=2)=C1 CRFYLQMIDWBKRT-LPYMAVHISA-N 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 description 1
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 229960002132 pyrrolnitrin Drugs 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229940108410 resmethrin Drugs 0.000 description 1
- VEMKTZHHVJILDY-FIWHBWSRSA-N resmethrin Chemical compound CC1(C)[C@H](C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-FIWHBWSRSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- 108091052345 ryanodine receptor (TC 1.A.3.1) family Proteins 0.000 description 1
- MSHXTAQSSIEBQS-UHFFFAOYSA-N s-[3-carbamoylsulfanyl-2-(dimethylamino)propyl] carbamothioate;hydron;chloride Chemical compound [Cl-].NC(=O)SCC([NH+](C)C)CSC(N)=O MSHXTAQSSIEBQS-UHFFFAOYSA-N 0.000 description 1
- YGBMMMOLNODPBP-GWGZPXPZSA-N s-ethyl (2e,4e)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienethioate Chemical compound CCSC(=O)\C=C(/C)\C=C\CC(C)CCCC(C)(C)OC YGBMMMOLNODPBP-GWGZPXPZSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- AFJYYKSVHJGXSN-KAJWKRCWSA-N selamectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C(/C)=C/C[C@@H](O[C@]2(O[C@@H]([C@@H](C)CC2)C2CCCCC2)C2)C[C@@H]2OC(=O)[C@@H]([C@]23O)C=C(C)C(=N\O)/[C@H]3OC\C2=C/C=C/[C@@H]1C AFJYYKSVHJGXSN-KAJWKRCWSA-N 0.000 description 1
- 229960002245 selamectin Drugs 0.000 description 1
- HPYNBECUCCGGPA-UHFFFAOYSA-N silafluofen Chemical compound C1=CC(OCC)=CC=C1[Si](C)(C)CCCC1=CC=C(F)C(OC=2C=CC=CC=2)=C1 HPYNBECUCCGGPA-UHFFFAOYSA-N 0.000 description 1
- MXMXHPPIGKYTAR-UHFFFAOYSA-N silthiofam Chemical compound CC=1SC([Si](C)(C)C)=C(C(=O)NCC=C)C=1C MXMXHPPIGKYTAR-UHFFFAOYSA-N 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- IYYIUOWKEMQYNV-UHFFFAOYSA-N sodium;ethoxy-oxido-oxophosphanium Chemical compound [Na+].CCO[P+]([O-])=O IYYIUOWKEMQYNV-UHFFFAOYSA-N 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 108010025009 spectrin-like proteins Proteins 0.000 description 1
- 229940014213 spinosad Drugs 0.000 description 1
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- XIUROWKZWPIAIB-UHFFFAOYSA-N sulfotep Chemical compound CCOP(=S)(OCC)OP(=S)(OCC)OCC XIUROWKZWPIAIB-UHFFFAOYSA-N 0.000 description 1
- OBTWBSRJZRCYQV-UHFFFAOYSA-N sulfuryl difluoride Chemical compound FS(F)(=O)=O OBTWBSRJZRCYQV-UHFFFAOYSA-N 0.000 description 1
- JXHJNEJVUNHLKO-UHFFFAOYSA-N sulprofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1 JXHJNEJVUNHLKO-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000005936 tau-Fluvalinate Substances 0.000 description 1
- INISTDXBRIBGOC-XMMISQBUSA-N tau-fluvalinate Chemical compound N([C@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-XMMISQBUSA-N 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- UOORRWUZONOOLO-UHFFFAOYSA-N telone II Natural products ClCC=CCl UOORRWUZONOOLO-UHFFFAOYSA-N 0.000 description 1
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 125000006223 tetrahydrofuranylmethyl group Chemical group 0.000 description 1
- 125000005710 tetrahydropyranylene group Chemical group 0.000 description 1
- 125000006173 tetrahydropyranylmethyl group Chemical group 0.000 description 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- KNDVJPKNBVIKML-UHFFFAOYSA-N tetraniliprole Chemical compound CNC(=O)C1=CC(C#N)=CC(C)=C1NC(=O)C1=CC(CN2N=C(N=N2)C(F)(F)F)=NN1C1=NC=CC=C1Cl KNDVJPKNBVIKML-UHFFFAOYSA-N 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
- 125000005557 thiazolylene group Chemical group 0.000 description 1
- DNVLJEWNNDHELH-UHFFFAOYSA-N thiocyclam Chemical compound CN(C)C1CSSSC1 DNVLJEWNNDHELH-UHFFFAOYSA-N 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 1
- MBNMHBAJUNHZRE-UHFFFAOYSA-M thiosultap monosodium Chemical class [Na+].OS(=O)(=O)SCC(N(C)C)CSS([O-])(=O)=O MBNMHBAJUNHZRE-UHFFFAOYSA-M 0.000 description 1
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical group COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 1
- WPALTCMYPARVNV-UHFFFAOYSA-N tolfenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(OC=3C=CC(C)=CC=3)=CC=2)=C1Cl WPALTCMYPARVNV-UHFFFAOYSA-N 0.000 description 1
- RSOBJVBYZCMJOS-CYBMUJFWSA-N tolprocarb Chemical compound FC(F)(F)COC(=O)N[C@@H](C(C)C)CNC(=O)C1=CC=C(C)C=C1 RSOBJVBYZCMJOS-CYBMUJFWSA-N 0.000 description 1
- HYVWIQDYBVKITD-UHFFFAOYSA-N tolylfluanid Chemical compound CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)C1=CC=C(C)C=C1 HYVWIQDYBVKITD-UHFFFAOYSA-N 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- XNFIRYXKTXAHAC-UHFFFAOYSA-N tralopyril Chemical compound BrC1=C(C(F)(F)F)NC(C=2C=CC(Cl)=CC=2)=C1C#N XNFIRYXKTXAHAC-UHFFFAOYSA-N 0.000 description 1
- DDVNRFNDOPPVQJ-HQJQHLMTSA-N transfluthrin Chemical compound CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCC1=C(F)C(F)=CC(F)=C1F DDVNRFNDOPPVQJ-HQJQHLMTSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- NKNFWVNSBIXGLL-UHFFFAOYSA-N triazamate Chemical compound CCOC(=O)CSC1=NC(C(C)(C)C)=NN1C(=O)N(C)C NKNFWVNSBIXGLL-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- UGCNRZFAUBJVPT-UHFFFAOYSA-N tricyclohexyltin;hydrate Chemical compound O.C1CCCCC1[Sn](C1CCCCC1)C1CCCCC1 UGCNRZFAUBJVPT-UHFFFAOYSA-N 0.000 description 1
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 1
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 description 1
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- 108010013280 ubiquinol oxidase Proteins 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000000664 voltage gated sodium channel blocking agent Substances 0.000 description 1
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 1
- 229960004740 voriconazole Drugs 0.000 description 1
- 239000004562 water dispersible granule Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000005943 zeta-Cypermethrin Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229940048462 zinc phosphide Drugs 0.000 description 1
- DUBNHZYBDBBJHD-UHFFFAOYSA-L ziram Chemical compound [Zn+2].CN(C)C([S-])=S.CN(C)C([S-])=S DUBNHZYBDBBJHD-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
- A01N47/06—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom containing —O—CO—O— groups; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
Description
本発明は、ピリジン化合物、並びに農園芸用殺菌剤、有害生物防除剤、および殺虫または殺ダニ剤などの用途に関する。 The present invention relates to pyridine compounds and uses such as agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents.
農園芸作物の栽培に当り、作物の病害に対して多数の防除薬剤が提案されているが、それらは、その防除効力が不十分であったり、薬剤耐性の病原菌の出現によりその使用が制限されたり、植物体に薬害や汚染を生じさせたり、若しくは人畜魚類に対する毒性や環境への影響が大きかったりなどで、十分に満足できる防除薬剤とは言い難いものが少なくない。そのため、かかる欠点の少ない安全に使用できる薬剤の出現が強く要望されている。 In the cultivation of agricultural and horticultural crops, a large number of control agents have been proposed against crop diseases, but their use is limited by their inadequate control efficacy and the emergence of drug resistant pathogens. There are many cases where it is difficult to say that it is a sufficiently satisfactory control drug because it causes phytotoxicity and pollution to plants, or the toxicity to animals and fish and its environmental impact is large. Therefore, there is a strong demand for the emergence of drugs that can be used safely with few such drawbacks.
ところで、特許文献1には、式(A)若しくは式(B)で表されるピリジン化合物が開示されている。特許文献1によれば、このピリジン化合物は電子伝達系の複合体II阻害剤として有用であるらしい。 Patent Document 1 discloses a pyridine compound represented by Formula (A) or Formula (B). According to Patent Document 1, this pyridine compound seems to be useful as a complex II inhibitor of the electron transfer system.
本発明の課題は、新規なピリジン化合物、ならびに農園芸用殺菌剤、有害生物防除剤、および殺虫または殺ダニ剤を提供することである。 The object of the present invention is to provide novel pyridine compounds, as well as agricultural and horticultural fungicides, pest control agents and insecticides or acaricides.
上記課題を解決するために検討した結果、以下の態様を包含する本発明を完成するに至った。 As a result of studying in order to solve the above-mentioned subject, it came to complete the present invention including the following modes.
〔1〕式(I)で表される化合物またはその塩。 [1] A compound represented by the formula (I) or a salt thereof.
〔式(I)中、
R1は、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基、無置換の若しくはG2で置換されたC6〜10アリール基、無置換の若しくはG2で置換された3〜6員ヘテロシクリル基、シアノ基またはハロゲノ基を示す。
R2およびR3は、それぞれ独立に、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基、ホルミル基、ホルミルオキシ基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニルオキシ基、無置換の若しくはG2で置換されたC6〜10アリール基、(無置換の若しくはG1で置換されたC1〜6アルコキシイミノ)−C1〜6アルキル基、シアノ基、またはハロゲノ基を示す。
ここで、R1とR2は一緒になってR1およびR2のそれぞれが結合する炭素原子と共に5〜6員環を形成してもよい。
R4は、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC2〜6アルケニル基、無置換の若しくはG1で置換されたC2〜6アルキニル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、無置換の若しくはG2で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG2で置換された3〜6員ヘテロシクリル基、無置換の若しくはG2で置換された3〜6員ヘテロシクリル基C1〜6アルキル基、ホルミル基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニル基、無置換の若しくはG1で置換されたC3〜8シクロアルキルカルボニル基、無置換の若しくはG1で置換されたC1〜6アルケニルカルボニル基、無置換の若しくはG2で置換されたC6〜10アリールカルボニル基、無置換の若しくはG1で置換されたC1〜6アルコキシカルボニル基、無置換の若しくはG1で置換されたC2〜6アルケニルオキシカルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルスルホニル基、無置換の若しくはG1で置換されたC1〜6アルキルアミノカルボニル基、無置換の若しくはG1で置換された(C1〜6アルキルチオ)カルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルアミノ(チオカルボニル)基、または式(IV)で表される基を示す。[In the formula (I),
R 1 is hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C1~6 alkoxy group substituted with G 1, which is substituted by unsubstituted or G 2 C6 And an aryl group of 10 to 10, a 3 to 6 membered heterocyclyl group which is unsubstituted or substituted by G 2 , a cyano group or a halogeno group.
R 2 and R 3 are each independently a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C3~8 cycloalkyl group substituted by G 1, the unsubstituted Or a G 1 substituted C1-6 alkoxy group, a formyl group, a formyloxy group, an unsubstituted or G 1 substituted C1-6 alkylcarbonyl group, an unsubstituted or G 1 substituted C1-6 alkylcarbonyloxy group, an unsubstituted or C6~10 aryl groups substituted with G 2, (unsubstituted or substituted with G 1 a C1~6 alkoxyimino)-C1-6 alkyl group, a cyano group or a halogeno, Indicates a group.
Here, R 1 and R 2 may be combined to form a 5- to 6-membered ring together with the carbon atom to which each of R 1 and R 2 is bonded.
R 4 is a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, which is substituted by unsubstituted or G 1 C2ア ル キ ニ 6 alkynyl group, unsubstituted or G 1 substituted C 3-8 cycloalkyl group, unsubstituted or G 2 substituted C 6 to 10 aryl C 1 6 alkyl group, unsubstituted or substituted G 2 3 to 6 membered heterocyclyl group, unsubstituted or G 2 substituted 3 to 6 membered heterocyclyl group C1-6 alkyl group, formyl group, unsubstituted or G 1 substituted C1-6 alkyl carbonyl group , unsubstituted or C3~8 cycloalkylcarbonyl group substituted with G 1, unsubstituted or C1~6 alkenylcarbonyl group substituted with G 1, unsubstituted or with G 2 is substituted And C6~10 aryl carbonyl group, an unsubstituted or C1~6 alkoxycarbonyl group substituted with G 1, unsubstituted or C2~6 alkenyloxycarbonyl group substituted with G 1, unsubstituted or with G 1 substituted Cl to 6 alkylsulfonyl group, unsubstituted or Cl to 6 alkylaminocarbonyl group substituted with G 1, unsubstituted or substituted with G 1 a (Cl to 6 alkylthio) carbonyl group, the unsubstituted Or a C1-6 alkylamino (thiocarbonyl) group substituted by G 1 or a group represented by formula (IV).
式(IV)中、Gaは、それぞれ独立に、水素原子、無置換のもしくはG1で置換されたC1〜6アルキル基、無置換のもしくはG1で置換されたC2〜6アルケニル基、無置換のもしくはG1で置換されたC2〜6アルキニル基、無置換のもしくはG1で置換されたC3〜8シクロアルキル基、または無置換のもしくはG2で置換されたC6〜10アリール基を示す。Wherein (IV), G a are independently a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, no showing a substituted by a substituted or G 1 a C2~6 alkynyl group, an unsubstituted or C3~8 cycloalkyl group substituted by G 1 or unsubstituted or C6~10 aryl groups substituted with G 2, .
式(IV)中、Gbは、水素原子、無置換のもしくはG1で置換されたC1〜6アルキル基、無置換のもしくはG1で置換されたC2〜6アルケニル基、無置換のもしくはG1で置換されたC2〜6アルキニル基、無置換のもしくはG1で置換されたC3〜8シクロアルキル基、無置換のもしくはG2で置換されたC6〜10アリール基、または無置換のもしくはG2で置換された3〜6員ヘテロシクリル基を示す。Wherein (IV), G b represents a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, unsubstituted or G C2~6 alkynyl group substituted with 1, unsubstituted or C3~8 cycloalkyl group substituted with G 1, unsubstituted or C6~10 aryl groups substituted with G 2 or unsubstituted or G, The 3- to 6-membered heterocyclyl group substituted by 2 is shown.
式(IV)中、Tは、酸素原子、オキシカルボニル基、カルボニルオキシ基、オキシカルボニルオキシ基、硫黄原子、(チオ)カルボニル基、カルボニル(チオ)基、(チオ)カルボニルオキシ基、オキシカルボニル(チオ)基、または−O−C(=O)−N(Gb)−で表される二価の基を示す。
*は式(IV)で表される基の結合位置を示す。In the formula (IV), T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio) carbonyl group, a carbonyl (thio) group, a (thio) carbonyloxy group, an oxycarbonyl ( It represents a divalent group represented by a thio) group or -O-C (= O) -N ( Gb )-.
* Indicates the bonding position of the group represented by formula (IV).
Qは、式(II)または式(III)で表される有機基のいずれかを示す。 Q represents any one of the organic groups represented by Formula (II) or Formula (III).
[式(II)および式(III)中、
Ar1は、無置換の若しくはG2で置換されたC6〜10アリール基、または無置換の若しくはG2で置換された3〜10員ヘテロシクリル基を示す。
Ar2は、無置換の若しくはG2で置換されたC6〜10アリール基、無置換の若しくはG2で置換されたC6〜10アリールオキシ基、無置換の若しくはG2で置換されたC6〜10アリールチオ基、無置換の若しくはG2で置換されたC6〜10アリールスルフィニル基、無置換の若しくはG2で置換されたC6〜10アリールスルホニル基、無置換の若しくはG2で置換された3〜10員ヘテロシクリル基、無置換の若しくはG2で置換された3〜10員ヘテロシクリルオキシ基、無置換の若しくはG2で置換された3〜10員ヘテロシクリルチオ基またはフェロセニル基を示す。
Raは、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、アミノ基、C1〜6アルキルカルボニルアミノ基、または無置換の若しくはG2で置換されたC6〜10アリール基を示す。
Baは、無置換の若しくはG4で置換されたC1〜C6アルキレン基、無置換の若しくはG4で置換されたC2〜C6アルケニレン基、無置換の若しくはG4で置換されたC2〜C6アルキニレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンオキシC1〜6アルキレン基、無置換の若しくはG4で置換されたC3〜C6シクロアルキレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンC3〜6シクロアルキレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンオキシC3〜6シクロアルキレン基、無置換の若しくはG4で置換されたC4〜C6シクロアルケニレン基、または無置換の若しくはG4で置換された3〜6員ヘテロシクリレン基を示す。
また、Baの炭素原子またはBa上の置換基G4の一部が、Ar2上の炭素原子と結合して5〜6員環を形成してもよい。
*は、式(II)または式(III)で表される有機基の結合位置を示す。][In the formula (II) and the formula (III),
Ar 1 represents an unsubstituted or C6~10 aryl groups substituted with G 2 or unsubstituted or 3-10 membered heterocyclyl group which is substituted by G 2,.
Ar 2 is an unsubstituted or G 2 substituted C 6 to 10 aryl group, an unsubstituted or G 2 substituted C 6 to 10 aryloxy group, an unsubstituted or G 2 substituted C 6 to 10 arylthio group, an unsubstituted or C6~10 arylsulfinyl group substituted by G 2, unsubstituted or C6~10 arylsulfonyl group substituted with G 2, substituted with unsubstituted or G 2 3 to 10 membered heterocyclyl group, an unsubstituted or 3-10 membered heterocyclyloxy group which is substituted by G 2, unsubstituted or 3-10 membered heterocyclylthio group or a ferrocenyl group substituted with G 2.
R a is a hydrogen atom, an unsubstituted or Cl to 6 alkyl group substituted with G 1, unsubstituted or C3~8 cycloalkyl group substituted with G 1, amino group, Cl to 6 alkylcarbonylamino group , or unsubstituted or showing a C6~10 aryl group substituted by G 2.
B a is an unsubstituted or G 4 substituted C 1 to C 6 alkylene group, an unsubstituted or G 4 substituted C 2 to C 6 alkenylene group, an unsubstituted or G 4 substituted C 2 to C 6 alkynylene group, an unsubstituted or C1~C6 alkyleneoxy C1~6 alkylene group substituted with G 4, unsubstituted or C3~C6 cycloalkylene group substituted by G 4, which is substituted unsubstituted or at G 4 C1~C6 alkylene C3~6 cycloalkylene group, an unsubstituted or substituted by G 4 a C1~C6 alkyleneoxy C3~6 cycloalkylene group, an unsubstituted or C4~C6 cycloalkenylene group substituted with G 4, Or 3 to 6 membered heterocyclylene group which is unsubstituted or substituted by G 4 .
In addition, a carbon atom of B a or a part of the substituent G 4 on B a may be bonded to a carbon atom on Ar 2 to form a 5- to 6-membered ring.
* Represents the bonding position of the organic group represented by Formula (II) or Formula (III). ]
G1は、水酸基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6アルコキシカルボニル基、ホルミルオキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、シアノ基、またはハロゲノ基を示す。R1、R2、R3、R4またはRaのうちの2つ以上がG1で置換された前記の基である場合、係るG1は、相互に同じであっても異なってもよい。G 1 represents a hydroxyl group, a C1-6 alkoxy group, a C1-6 alkoxy C1-6 alkoxy group, a C1-6 alkoxycarbonyl group, a formyloxy group, a C1-6 alkylcarbonyloxy group, a C1-6 alkoxycarbonyloxy group, a cyano Group or a halogeno group is shown. R 1, R 2, R 3, when two or more of R 4 or R a is the radical which is substituted by G 1, G 1 according may be the same or different from each other .
G2は、C1〜6アルキル基、ヒドロキシC1〜6アルキル基、C2〜6アルケニル基、C2〜6アルキニル基、C3〜8シクロアルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C1〜6アルコキシC1〜6ハロアルキル基、C2〜6ハロアルケニル基、C2〜6ハロアルキニル基、水酸基、C1〜6アルコキシ基、C3〜8シクロアルキルC1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6ハロアルコキシ基、C1〜6ハロアルコキシC1〜6ハロアルコキシ基、ホルミル基、C1〜6アルキルカルボニル基、C1〜6アルコキシカルボニル基、ホルミルオキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、C1〜6アルコキシカルボニルアミノ基、無置換の若しくはG21で置換されたC6〜10アリール基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールオキシ基、無置換の若しくはG21で置換された3〜6員ヘテロシクリル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルオキシ基、C1〜6アルキルチオ基、C1〜6アルキルスルフィニル基、C1〜6アルキルスルホニル基、C1〜6ハロアルキルチオ基、C1〜6ハロアルキルスルフィニル基、C1〜6ハロアルキルスルホニル基、ペンタフルオロスルファニル基、無置換の若しくはG21で置換されたC6〜10アリールチオ基、無置換の若しくはG21で置換されたC6〜10アリールスルフィニル基、無置換の若しくはG21で置換されたC6〜10アリールスルホニル基、ニトロ基、シアノ基、ハロゲノ基、C1〜6アルキレン基、C1〜6アルキレンジオキシ基、またはC1〜6ハロアルキレンジオキシ基を示す。R1、R2、R3、R4、Ra、G4、Ar1またはAr2のうちの2つ以上がG2で置換された前記の基である場合、係るG2は、相互に同じであっても異なってもよい。G 2 is, Cl to 6 alkyl group, hydroxyalkyl Cl to 6 alkyl groups, C2-6 alkenyl groups, C2-6 alkynyl groups, C3-8 cycloalkyl groups, Cl to 6 haloalkyl, Cl to 6 alkoxy Cl to 6 alkyl Group, C1-6 alkoxy C1-6 haloalkyl group, C2-6 haloalkenyl group, C2-6 haloalkynyl group, hydroxyl group, C1-6 alkoxy group, C3-8 cycloalkyl C1-6 alkoxy group, C1-6 alkoxy C1 -6 alkoxy group, C1-6 haloalkoxy group, C1-6 haloalkoxy C1-6 haloalkoxy group, formyl group, C1-6 alkylcarbonyl group, C1-6 alkoxycarbonyl group, formyloxy group, C1-6 alkylcarbonyl Oxy group, C1-6 alkoxy carbonyloxy group, C1-6 alkoxy carbonyl Amino group, an unsubstituted or C6~10 aryl groups substituted with G 21, unsubstituted or C6~10 aryl C1~6 alkyl group substituted with G 21, which is substituted by unsubstituted or G 21 C6 To 10 aryloxy group, an unsubstituted or G 21 -substituted 3- to 6-membered heterocyclyl group, an unsubstituted or G 21 -substituted 3- to 6-membered heterocyclyloxy group, a C 1-6 alkylthio group, C 1 to 6 Alkylsulfinyl group, C1-6 alkylsulfonyl group, C1-6 haloalkylthio group, C1-6 haloalkylsulfinyl group, C1-6 haloalkylsulfonyl group, pentafluorosulfanyl group, unsubstituted or C6-10 substituted with G 21 Arylthio group, unsubstituted or G 21 substituted C 6-10 arylsulfinyl group, unsubstituted or Shows C6~10 arylsulfonyl group substituted with G 21, a nitro group, a cyano group, a halogeno group, Cl to 6 alkylene group, a Cl to 6 alkylenedioxy group or a Cl to 6 halo alkylenedioxy group. R 1, R 2, R 3 , R 4, R a, if two or more of G 4, Ar 1 or Ar 2 is said group substituted with G 2, G 2 according are mutually It may be the same or different.
G21は、C1〜6アルキル基、C1〜6ハロアルキル基、C1〜6アルコキシ基、C1〜6ハロアルコキシ基、またはハロゲノ基を示す。G2またはG4のうちの2つ以上がG21で置換された前記の基である場合、係るG21は、相互に同じであっても異なってもよい。G 21 represents a C1-6 alkyl group, a C1-6 haloalkyl group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, or a halogeno group. If more than one of G 2 or G 4 is a said group substituted with G 21, G 21 according may be the same or different from each other.
G4は、C1〜6アルキル基、C3〜8シクロアルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C2〜6アルケニルオキシC1〜6アルキル基、水酸基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C2〜6アルケニルオキシ基、C1〜6アルコキシカルボニル基、無置換の若しくはG21で置換されたC6〜10アリール基、無置換の若しくはG21で置換された3〜6員ヘテロシクリル基、シアノ基、ハロゲノ基、C1〜6アルキレン基、C1〜6アルキレンジオキシ基、オキソ基、C3〜8シクロアルキルC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルC1〜6アルキル基、C3〜8シクロアルキルオキシC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールオキシC1〜6アルキル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルオキシC1〜6アルキル基、C1〜6アルキリデン基、C1〜6アルコキシイミノ基、無置換の若しくはG21 で置換されたC6〜10アリールC1〜6アルコキシイミノ基、またはC1〜6アルキルヒドラジノ基を示す。〕G 4 are, Cl to 6 alkyl, C3-8 cycloalkyl, Cl to 6 haloalkyl, Cl to 6 alkoxy Cl to 6 alkyl groups, C2-6 alkenyloxy Cl to 6 alkyl groups, hydroxyl, Cl to 6 alkoxy group, Cl to 6 alkoxy Cl to 6 alkoxy, C2-6 alkenyloxy group, substituted with Cl to 6 alkoxy carbonyl group, an unsubstituted or C6~10 aryl groups substituted with G 21, unsubstituted or G 21 3 to 6 membered heterocyclyl group, cyano group, halogeno group, C1-6 alkylene group, C1-6 alkylenedioxy group, oxo group, C3-8 cycloalkyl C1-6 alkyl group, unsubstituted or G 21 substituted C6~10 aryl C1~6 alkyl, 3-6 membered heterocyclyl C1~6 alkyl substituted with unsubstituted or G 21 Group, C3-8 cycloalkyloxy C1~6 alkyl group, an unsubstituted or C6~10 aryloxy C1~6 alkyl group substituted with G 21, unsubstituted or 3-6 membered heterocyclyl optionally substituted with G 21 Oxy C1-6 alkyl group, C1-6 alkylidene group, C1-6 alkoxy imino group, C6-10 aryl C1-6 alkoxy imino group which is unsubstituted or substituted by G2 1 , or C1-6 alkyl hydrazino group Indicates ]
〔2〕前記〔1〕に記載の化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する農園芸用殺菌剤。
〔3〕前記〔1〕に記載の化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する有害生物防除剤。
〔4〕前記〔1〕に記載の化合物およびその塩からなる群から選ばれる少なくとも1つを有効成分として含有する殺虫または殺ダニ剤。[2] An agricultural and horticultural germicidal agent comprising, as an active ingredient, at least one selected from the group consisting of the compound according to the above [1] and a salt thereof.
[3] A pest control agent containing, as an active ingredient, at least one selected from the group consisting of the compound according to the above [1] and a salt thereof.
[4] An insecticidal or acaricidal agent comprising, as an active ingredient, at least one selected from the group consisting of the compounds according to the above [1] and salts thereof.
本発明に係るピリジン化合物は、有害生物防除、殺菌、殺ダニ、殺虫などの効果を有し、植物体に薬害を生じることがなく、人畜魚類に対する毒性や環境への影響が少ない新規化合物である。特に、ムギ病害に対して優れた防除効果を示す。本発明に係るピリジン化合物は、農園芸用殺菌剤、有害生物防除剤、および殺虫または殺ダニ剤の有効成分として有用である。 The pyridine compound according to the present invention is a novel compound having the effects of pest control, sterilization, acaricide, insecticidal and the like, causing no adverse effects on plants, and having little toxicity to human and fish and environmental impact. . In particular, it exhibits excellent control effects against wheat diseases. The pyridine compound according to the present invention is useful as an active ingredient of agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents.
本発明に係るピリジン化合物は、式(I)で表される化合物(以下、化合物(I)と表記することがある。)およびその塩である。 The pyridine compound according to the present invention is a compound represented by the formula (I) (hereinafter sometimes referred to as a compound (I)) and a salt thereof.
〔R1〕
R1は、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基、無置換の若しくはG2で置換されたC6〜10アリール基、3〜6員ヘテロシクリル基、シアノ基またはハロゲノ基を示す。
C1〜6アルキル基は、直鎖であってもよいし、炭素数が3以上であれば分岐鎖であってもよい。C1〜6アルキル基としては、メチル基、エチル基、n−プロピル基、i−プロピル基、n−ブチル基、s−ブチル基、i−ブチル基、t−ブチル基、n−ペンチル基、n−ヘキシル基、i−ペンチル基、ネオペンチル基、2−メチルブチル基、2,2−ジメチルプロピル基、i−ヘキシル基などを挙げることができる。
C1〜6アルコキシ基としては、メトキシ基、エトキシ基、n−プロポキシ基、n−ブトキシ基、n−ペンチルオキシ基、n−ヘキシルオキシ基、i−プロポキシ基、i−ブトキシ基、s−ブトキシ基、t−ブトキシ基、i−ヘキシルオキシ基などを挙げることができる。[R 1 ]
R 1 is hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C1~6 alkoxy group substituted with G 1, which is substituted by unsubstituted or G 2 C6 And -10 aryl group, 3- to 6-membered heterocyclyl group, cyano group or halogeno group is shown.
The C1-6 alkyl group may be linear, or may be branched as long as the carbon number is 3 or more. As a C1-6 alkyl group, a methyl group, an ethyl group, n-propyl group, i-propyl group, n-butyl group, s-butyl group, i-butyl group, t-butyl group, n-pentyl group, n And -hexyl, i-pentyl, neopentyl, 2-methylbutyl, 2,2-dimethylpropyl and i-hexyl can be mentioned.
As a C1-6 alkoxy group, a methoxy group, an ethoxy group, n-propoxy group, n-butoxy group, n-pentyloxy group, n-hexyloxy group, i-propoxy group, i-butoxy group, s-butoxy group , T-butoxy group, i-hexyloxy group and the like can be mentioned.
C6〜10アリール基としては、フェニル基、ナフチル基、アズレニル基、インデニル基、インダニル基、テトラリニル基などを挙げることができる。 As a C6-10 aryl group, a phenyl group, a naphthyl group, an azulenyl group, an indenyl group, an indanyl group, a tetralinyl group etc. can be mentioned.
3〜6員ヘテロシクリル基は、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1〜4個のヘテロ原子を環の構成原子として含むものである。ヘテロシクリル基は、単環および多環のいずれであってもよい。多環ヘテロシクリル基は、少なくとも一つの環がヘテロシクリルであれば、残りの環が飽和脂環、不飽和脂環または芳香環のいずれであってもよい。3〜6員ヘテロシクリル基としては、3〜6員飽和へテロシクリル基、5〜6員ヘテロアリール基、5〜6員部分不飽和へテロシクリル基などを挙げることができる。 The 3- to 6-membered heterocyclyl group contains, as a constituent atom of the ring, 1 to 4 heteroatoms selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom. The heterocyclyl group may be monocyclic or polycyclic. In the polycyclic heterocyclyl group, when at least one ring is heterocyclyl, the remaining rings may be either saturated alicyclic, unsaturated alicyclic or aromatic rings. As a 3- to 6-membered heterocyclyl group, a 3- to 6-membered saturated heterocyclyl group, a 5- to 6-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group and the like can be mentioned.
3〜6員飽和ヘテロシクリル基としては、アジリジニル基、オキシラニル基、アゼチジニル基、オキセタニル基、ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、ピペリジル基、ピペラジニル基、モルホリニル基、テトラヒドロピラニル基、ジオキソラニル基、ジオキサニル基などを挙げることができる。 As a 3- to 6-membered saturated heterocyclyl group, aziridinyl group, oxiranyl group, azetidinyl group, oxetanyl group, pyrrolidinyl group, tetrahydrofuranyl group, thiazolidinyl group, piperidyl group, piperazinyl group, morpholinyl group, tetrahydropyranyl group, dioxolanyl group, dioxanyl group Groups can be mentioned.
5員ヘテロアリール基としては、ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などを挙げることができる。
6員ヘテロアリール基としては、ピリジル基、ピラジニル基、ピリミジニル基、ピリダニジル基、トリアジニル基などを挙げることができる。
ハロゲノ基としては、フルオロ基、クロロ基、ブロモ基、イオド基を挙げることができる。Examples of 5-membered heteroaryl groups include pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group and the like. Can.
Examples of the 6-membered heteroaryl group include pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group and triazinyl group.
Examples of halogeno groups include fluoro, chloro, bromo and iodo groups.
置換基G1は、水酸基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6アルコキシカルボニル基、ホルミルオキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、シアノ基、またはハロゲノ基を示す。なお、R1、R2、R3、R4またはRaのうちの2つ以上がG1で置換された基である場合、係るG1は、相互に同じであっても異なってもよい。The substituent G 1 is a hydroxyl group, a C1-6 alkoxy group, a C1-6 alkoxy C1-6 alkoxy group, a C1-6 alkoxycarbonyl group, a formyloxy group, a C1-6 alkylcarbonyloxy group, a C1-6 alkoxycarbonyloxy group , A cyano group, or a halogeno group. In the case two or more of R 1, R 2, R 3 , R 4 or R a is been substituted with G 1, according G 1 may be the same or different from each other .
置換基G1における、C1〜6アルコキシ基、ハロゲノ基は既に述べたとおりのものである。
C1〜6アルコキシC1〜6アルコキシ基としては、メトキシメトキシ基、メトキシエトキシ基などを挙げることができる。
C1〜6アルコキシカルボニル基としては、メトキシカルボニル基、エトキシカルボニル基、n−プロポキシカルボニル基、i−プロポキシカルボニル基、t−ブトキシカルボニル基などを挙げることができる。
C1〜6アルキルカルボニルオキシ基としては、アセチルオキシ基、プロピオニルオキシ基、ブチリルオキシ基などを挙げることができる。
C1〜6アルコキシカルボニルオキシ基としては、メトキシカルボニルオキシ基、エトキシカルボニルオキシ基、n−プロポキシカルボニルオキシ基、i−プロポキシカルボニルオキシ基、n−ブトキシカルボニルオキシ基、t−ブトキシカルボニルオキシ基などを挙げることができる。The C1-6 alkoxy group and the halogeno group in the substituent G 1 are as described above.
As a C1-6 alkoxy C1-6 alkoxy group, a methoxy methoxy group, a methoxy ethoxy group, etc. can be mentioned.
Examples of the C1-6 alkoxycarbonyl group include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, a t-butoxycarbonyl group and the like.
As a C1-6 alkyl carbonyloxy group, an acetyloxy group, a propionyloxy group, a butyryloxy group etc. can be mentioned.
Examples of the C1-6 alkoxycarbonyloxy group include methoxycarbonyloxy group, ethoxycarbonyloxy group, n-propoxycarbonyloxy group, i-propoxycarbonyloxy group, n-butoxycarbonyloxy group, t-butoxycarbonyloxy group and the like. be able to.
置換基G2は、C1〜6アルキル基、ヒドロキシC1〜6アルキル基、C2〜6アルケニル基、C2〜6アルキニル基、C3〜8シクロアルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C1〜6アルコキシC1〜6ハロアルキル基、C2〜6ハロアルケニル基、C2〜6ハロアルキニル基、水酸基、C1〜6アルコキシ基、C3〜8シクロアルキルC1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6ハロアルコキシ基、C1〜6ハロアルコキシC1〜6ハロアルコキシ基、ホルミル基、C1〜6アルキルカルボニル基、C1〜6アルコキシカルボニル基、ホルミルオキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、C1〜6アルコキシカルボニルアミノ基、無置換の若しくはG21で置換されたC6〜10アリール基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールオキシ基、無置換の若しくはG21で置換された3〜6員ヘテロシクリル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルオキシ基、C1〜6アルキルチオ基、C1〜6アルキルスルフィニル基、C1〜6アルキルスルホニル基、C1〜6ハロアルキルチオ基、C1〜6ハロアルキルスルフィニル基、C1〜6ハロアルキルスルホニル基、ペンタフルオロスルファニル基、無置換の若しくはG21で置換されたC6〜10アリールチオ基、無置換の若しくはG21で置換されたC6〜10アリールスルフィニル基、無置換の若しくはG21で置換されたC6〜10アリールスルホニル基、ニトロ基、シアノ基、ハロゲノ基、C1〜6アルキレン基、C1〜6アルキレンジオキシ基、またはC1〜6ハロアルキレンジオキシ基を示す。Substituents G 2 is, Cl to 6 alkyl group, hydroxyalkyl Cl to 6 alkyl groups, C2-6 alkenyl groups, C2-6 alkynyl groups, C3-8 cycloalkyl groups, Cl to 6 haloalkyl, Cl to 6 alkoxy C1~ 6 alkyl group, C1-6 alkoxy C1-6 haloalkyl group, C2-6 haloalkenyl group, C2-6 haloalkynyl group, hydroxyl group, C1-6 alkoxy group, C3-8 cycloalkyl C1-6 alkoxy group, C1-6 Alkoxy C1-6 alkoxy group, C1-6 haloalkoxy group, C1-6 haloalkoxy C1-6 haloalkoxy group, formyl group, C1-6 alkylcarbonyl group, C1-6 alkoxycarbonyl group, formyloxy group, C1-6 Alkyl carbonyloxy group, C1-6 alkoxy carbonyloxy group, C1-6 alkoxy carbon Niruamino group, an unsubstituted or C6~10 aryl groups substituted with G 21, unsubstituted or C6~10 aryl C1~6 alkyl group substituted with G 21, C6 substituted with unsubstituted or G 21 To 10 aryloxy group, an unsubstituted or G 21 -substituted 3- to 6-membered heterocyclyl group, an unsubstituted or G 21 -substituted 3- to 6-membered heterocyclyloxy group, a C 1-6 alkylthio group, C 1 to 6 Alkylsulfinyl group, C1-6 alkylsulfonyl group, C1-6 haloalkylthio group, C1-6 haloalkylsulfinyl group, C1-6 haloalkylsulfonyl group, pentafluorosulfanyl group, unsubstituted or C6-10 substituted with G 21 Arylthio group, unsubstituted or G 21 substituted C 6-10 arylsulfinyl group, unsubstituted Or a C6-10 arylsulfonyl group substituted by G 21 , a nitro group, a cyano group, a halogeno group, a C1-6 alkylene group, a C1-6 alkylenedioxy group, or a C1-6 haloalkylenedioxy group.
置換基G2における、C1〜6アルキル基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6アルコキシカルボニル基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、C6〜10アリール基、3〜6員ヘテロシクリル基およびハロゲノ基は既に述べたとおりのものである。In the substituents G 2, Cl to 6 alkyl, Cl to 6 alkoxy, Cl to 6 alkoxy Cl to 6 alkoxy, Cl to 6 alkoxycarbonyl, Cl to 6 alkylcarbonyloxy group, Cl to 6 alkoxycarbonyloxy group , A C 6-10 aryl group, a 3 to 6 membered heterocyclyl group and a halogeno group are as described above.
ヒドロキシC1〜C6アルキル基としては、ヒドロキシメチル基、ヒドロキシエチル基、ヒドロキシプロピル基などを挙げることができる。
C2〜6アルケニル基としては、ビニル基、1−プロペニル基、2−プロペニル基(アリル基)、1−ブテニル基、2−ブテニル基、3−ブテニル基、1−メチル−2−プロペニル基、2−メチル−2−プロペニル基、1−ペンテニル基、2−ペンテニル基、3−ペンテニル基、4−ペンテニル基、1−メチル−2−ブテニル基、2−メチル−2−ブテニル基、1−ヘキセニル基、2−ヘキセニル基、3−ヘキセニル基、4−ヘキセニル基、5−ヘキセニル基などを挙げることができる。
C2〜6アルキニル基としては、エチニル基、1−プロピニル基、2−プロピニル基、1−ブチニル基、2−ブチニル基、3−ブチニル基、1−メチル−2−プロピニル基、2−メチル−3−ブチニル基、1−ペンチニル基、2−ペンチニル基、3−ペンチニル基、4−ペンチニル基、1−メチル−2−ブチニル基、2−メチル−3−ペンチニル基、1−ヘキシニル基、1,1−ジメチル−2−ブチニル基などを挙げることができる。
C3〜8シクロアルキル基としては、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロヘプチル基、2−アダマンチル基などを挙げることができる。As a hydroxy C1-C6 alkyl group, a hydroxymethyl group, a hydroxyethyl group, a hydroxypropyl group etc. can be mentioned.
As a C2-6 alkenyl group, a vinyl group, 1-propenyl group, 2-propenyl group (allyl group), 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2 -Methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group And 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group and the like.
As a C2-6 alkynyl group, ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3 -Butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, 1,1 -A dimethyl -2- butynyl group etc. can be mentioned.
As C3-8 cycloalkyl group, a cyclopropyl group, cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, 2-adamantyl group etc. can be mentioned.
C1〜6アルコキシC1〜6アルキル基は、既に述べたC1〜6アルキル基に、上述のC1〜6アルコキシ基が置換したものである。C1〜6アルコキシC1〜6アルキル基としては、メトキシメチル基、エトキシメチル基、メトキシエチル基、エトキシエチル基、メトキシ−n−プロピル基、エトキシメチル基、エトキシエチル基、n−プロポキシメチル基、i−プロポキシエチル基、s−ブトキシメチル基、t−ブトキシエチル基などを挙げることできる。
C3〜8シクロアルキルC1〜6アルコキシ基は、既に述べたC1〜6アルコキシ基に、上述のC3〜8シクロアルキル基が置換したものである。C3〜8シクロアルキルC1〜6アルコキシ基としては、シクロプロピルメトキシ基、シクロブチルメトキシ基、シクロペンチルメトキシ基、シクロヘキシルメトキシ基、2−(シクロプロピル)−エトキシ基などを挙げることができる。The C1-6 alkoxy C1-6 alkyl group is obtained by substituting the above-mentioned C1-6 alkoxy group for the C1-6 alkyl group described above. As a C1-6 alkoxy C1-6 alkyl group, methoxymethyl group, ethoxymethyl group, methoxyethyl group, ethoxyethyl group, methoxy-n-propyl group, ethoxymethyl group, ethoxyethyl group, n-propoxymethyl group, i And-propoxyethyl group, s-butoxymethyl group, t-butoxyethyl group and the like can be mentioned.
The C3-8 cycloalkyl C1-6 alkoxy group is a group in which the above-mentioned C3-8 cycloalkyl group is substituted for the already mentioned C1-6 alkoxy group. Examples of the C3-8 cycloalkyl C1-6 alkoxy group include a cyclopropyl methoxy group, a cyclobutyl methoxy group, a cyclopentyl methoxy group, a cyclohexyl methoxy group, a 2- (cyclopropyl) -ethoxy group and the like.
C1〜6アルキルカルボニル基は、カルボニル基に、上述のC1〜6アルキル基が結合したものである。C1〜6アルキルカルボニル基としては、アセチル基、プロピオニル基、ブチリル基、イソブチリル基、ピバロイル基などを挙げることができる。 The C1-6 alkylcarbonyl group is a carbonyl group to which the above-mentioned C1-6 alkyl group is bonded. As a C1-6 alkyl carbonyl group, an acetyl group, a propionyl group, a butyryl group, an isobutyryl group, a pivaloyl group etc. can be mentioned.
C1〜6アルコキシカルボニルアミノ基は、アミノ基に、既に述べたC1〜6アルコキシカルボニル基が置換したものである。C1〜6アルコキシカルボニルアミノ基としては、メトキシカルボニルアミノ基、エトキシカルボニルアミノ基、n−プロポキシカルボニルアミノ基、i−プロポキシカルボニルアミノ基、n−ブトキシカルボニルアミノ基、t−ブトキシカルボニルアミノ基などを挙げることができる。
C6〜10アリールC1〜6アルキル基は、既に述べたC1〜6アルキル基に、上述のC6〜10アリール基が置換したものである。C6〜10アリールC1〜6アルキル基としては、ベンジル基、フェネチル基などを挙げることができる。The C1-6 alkoxycarbonylamino group is an amino group substituted with the already mentioned C1-6 alkoxycarbonyl group. Examples of the C1-6 alkoxycarbonylamino group include methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, i-propoxycarbonylamino group, n-butoxycarbonylamino group, t-butoxycarbonylamino group and the like. be able to.
The C6-10 aryl C1-6 alkyl group is obtained by substituting the above-mentioned C6-10 aryl group for the C1-6 alkyl group described above. Examples of the C6-10 aryl C1-6 alkyl group include a benzyl group and a phenethyl group.
C6〜10アリールオキシ基は、水酸基に、既に述べたC6〜10アリール基が置換したものである。C6〜10アリールオキシ基としては、フェノキシ基、ナフトキシ基などを挙げることができる。 The C6-10 aryloxy group is a hydroxyl group substituted with the already mentioned C6-10 aryl group. As a C6-10 aryloxy group, a phenoxy group, a naphthoxy group, etc. can be mentioned.
3〜6員ヘテロシクリルオキシ基は、水酸基に、3〜6員ヘテロシクリル基が置換したものである。3〜6員ヘテロシクリルオキシ基としては、ピラゾリルオキシ基、ピリジルオキシ基などを挙げることができる。3〜6員ヘテロシクリルオキシ基は、5〜6員ヘテロシクリルオキシ基が好ましい。
C1〜6アルキルチオ基は、SH基に、C1〜6アルキル基が置換したものである。C1〜6アルキルチオ基としては、メチルチオ基、エチルチオ基、n−プロピルチオ基、n−ブチルチオ基、n−ペンチルチオ基、n−ヘキシルチオ基、i−プロピルチオ基、i−ブチルチオ基などを挙げることができる。
C1〜6アルキルスルフィニル基は、スルフィニル基に、C1〜6アルキル基が結合したものである。C1〜6アルキルスルフィニル基としては、メチルスルフィニル基、エチルスルフィニル基、t−ブチルスルフィニル基などを挙げることができる。
C1〜6アルキルスルホニル基は、スルホニル基に、C1〜6アルキル基が結合したものである。C1〜6アルキルスルホニル基としては、メチルスルホニル基、エチルスルホニル基、t−ブチルスルホニル基などを挙げることができる。
C6〜10アリールチオ基は、SH基に、C6〜10アリール基が置換したものである。C6〜10アリールチオ基としては、フェニルチオ基、ナフチルチオ基などを挙げることができる。
C6〜10アリールチオ基は、スルファニル基に、C6〜10アリール基が置換したものである。C6〜10アリールチオ基としては、フェニルチオ基、ナフチルチオ基などを挙げることができる。
C6〜10アリールスルフィニル基は、スルフィニル基に、C6〜10アリール基が置換したものである。C6〜10アリールスルフィニル基としては、フェニルスルフィニル基、ナフチルスルフィニル基などを挙げることができる。
C6〜10アリールスルホニル基は、スルホニル基に、C6〜10アリール基が置換したものである。C6〜10アリールスルホニル基としては、フェニルスルホニル基、ナフチルスルホニル基などを挙げることができる。The 3- to 6-membered heterocyclyloxy group is a hydroxyl group substituted with a 3- to 6-membered heterocyclyl group. As a 3- to 6-membered heterocyclyloxy group, a pyrazolyloxy group, a pyridyloxy group and the like can be mentioned. The 3- to 6-membered heterocyclyloxy group is preferably a 5- to 6-membered heterocyclyloxy group.
The C1-6 alkylthio group is a SH group substituted with a C1-6 alkyl group. Examples of the C1-6 alkylthio group include methylthio group, ethylthio group, n-propylthio group, n-butylthio group, n-pentylthio group, n-hexylthio group, i-propylthio group, i-butylthio group and the like.
The C1-6 alkylsulfinyl group is a sulfinyl group to which a C1-6 alkyl group is bonded. As a C1-6 alkyl sulfinyl group, a methyl sulfinyl group, an ethyl sulfinyl group, t-butyl sulfinyl group etc. can be mentioned.
The C1-6 alkylsulfonyl group is a sulfonyl group in which a C1-6 alkyl group is bonded. As a C1-6 alkyl sulfonyl group, a methyl sulfonyl group, an ethyl sulfonyl group, t-butyl sulfonyl group etc. can be mentioned.
The C6-10 arylthio group is a SH group substituted with a C6-10 aryl group. As a C6-10 arylthio group, a phenylthio group, a naphthylthio group, etc. can be mentioned.
The C6-10 arylthio group is a sulfanyl group substituted with a C6-10 aryl group. As a C6-10 arylthio group, a phenylthio group, a naphthylthio group, etc. can be mentioned.
The C6-10 arylsulfinyl group is a sulfinyl group substituted with a C6-10 aryl group. Examples of the C6-10 arylsulfinyl group include phenylsulfinyl group and naphthylsulfinyl group.
The C.sub.6-10 arylsulfonyl group is a sulfonyl group substituted with a C.sub.6-10 aryl group. As C6-10 arylsulfonyl group, a phenylsulfonyl group, a naphthyl sulfonyl group, etc. can be mentioned.
C1〜6アルキレン基としては、C1〜6アルカン中の水素原子2個が外れてなる2価の基である。C1〜6アルキレン基としては、メチレン基、エチレン基(ジメチレン基)、トリメチレン基、テトラメチレン基、プロパン−1,2−ジイル基(すなわち、プロピレン基)などを挙げることができる。
C1〜6アルキレンジオキシ基は、C1〜6アルカン中の水素原子2個がオキシ基で置換されてなる2価の基である。C1〜6アルキレンジオキシ基としては、メチレンジオキシ基(-OCH2O-)、エチレンジオキシ基(-OCH2CH2O-)、トリメチレンジオキシ基などを挙げることができる。G2であるC1〜6アルキレンジオキシ基で置換されたC6〜10アリール基としては、2,3−ジヒドロ−ベンゾ[1,4]ジオキシル基、ベンゾ[1,3]ジオキソリル基などを挙げることができる。As a C1-6 alkylene group, it is a bivalent group which two hydrogen atoms in C1-6 alkane remove | deviate. As a C1-6 alkylene group, a methylene group, ethylene group (dimethylene group), trimethylene group, tetramethylene group, propane-1, 2-diyl group (namely, propylene group) etc. can be mentioned.
The C1-6 alkylenedioxy group is a divalent group formed by replacing two hydrogen atoms in a C1-6 alkane with an oxy group. The C1~6 alkylenedioxy group, methylenedioxy group (-OCH 2 O-), ethylenedioxy group (-OCH 2 CH 2 O-), and the like trimethylenedioxy group. The C6~10 aryl groups substituted with C1~6 alkylenedioxy group is G 2, 2,3-dihydro - benzo [1,4] Jiokishiru group, benzo [1,3] such that exemplified dioxolyl group Can.
C1〜6ハロアルキル基、C2〜6ハロアルケニル基、C2〜6ハロアルキニル基、C1〜6ハロアルコキシ基、およびC1〜6ハロアルキレンジオキシ基は、すでに述べた、C1〜6アルキル基、C2〜6アルケニル基、C2〜6アルキニル基、C1〜6アルコキシ基、およびC1〜6アルキレンジオキシ基に、ハロゲノ基が置換したものである。
C1〜6ハロアルキル基としては、フルオロメチル基、クロロメチル基、ブロモメチル基、ジフルオロメチル基、ジクロロメチル基、ジブロモメチル基、トリフルオロメチル基、トリクロロメチル基、トリブロモメチル基、1−クロロエチル基、2,2,2−トリフルオロエチル基、2,2,2−トリクロロエチル基、ペンタフルオロエチル基、4−フルオロブチル基、4−クロロブチル基、3,3,3−トリフルオロプロピル基、2,2,2−トリフルオロ−1−トリフルオロメチルエチル基、パーフロロヘキシル基、パークロロヘキシル基、2,4,6−トリクロロヘキシル基などを挙げることができる。The C1-6 haloalkyl group, the C2-6 haloalkenyl group, the C2-6 haloalkynyl group, the C1-6 haloalkoxy group, and the C1-6 haloalkylenedioxy group are the same as the C1-6 alkyl group, the C2-6 alkyl group described above. 6 alkenyl group, C2-6 alkynyl group, C1-6 alkoxy group, and C1-6 alkylenedioxy group substituted by a halogeno group.
As C1-6 haloalkyl group, fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, dichloromethyl group, dibromomethyl group, trifluoromethyl group, trichloromethyl group, tribromomethyl group, 1-chloroethyl group, 2,2,2-trifluoroethyl group, 2,2,2-trichloroethyl group, pentafluoroethyl group, 4-fluorobutyl group, 4-chlorobutyl group, 3,3,3-trifluoropropyl group, 2, Examples thereof include 2,2-trifluoro-1-trifluoromethylethyl group, perfluorohexyl group, perchlorohexyl group, and 2,4,6-trichlorohexyl group.
C2〜6ハロアルケニル基としては、2−クロロ−1−プロペニル基、2−フルオロ−1−ブテニル基などを挙げることができる。
C2〜6ハロアルキニル基としては、4,4−ジクロロ−1−ブチニル基、4−フルオロ−1−ペンチニル基、5−ブロモ−2−ペンチニル基などを挙げることができる。
C1〜6ハロアルコキシ基としては、クロロメトキシ基、ジクロロメトキシ基、ジフルオロメトキシ基、トリクロロメトキシ基、トリフルオロメトキシ基、1−フルオロエトキシ基、1,1−ジフルオロエトキシ基、2,2,2−トリフルオロエトキシ基、1,1,2,2−テトラフルオロエトキシ基、ペンタフルオロエトキシ基、2,2,3,4,4,4−ヘキサフルオロ−ブトキシ基、1−ブロモ−1,1,2,2−テトラフルオロエトキシ基などを挙げることができる。
C1〜6ハロアルキレンジオキシ基としては、ジフルオロメチレンジオキシ基(-OCF2O-)、テトラフルオロエチレンジオキシ基(-OCF2CF2O-)などを挙げることができる。G2であるC1〜6ハロアルキレンジオキシ基で置換されたC6〜10アリール基としては、2,2,3,3−テトラフルオロ−2,3−ジヒドロ−ベンゾ[1,4]ジオキシル基、2,2−ジフルオロ−ベンゾ[1,3]ジオキソリル基などを挙げることができる。Examples of the C 2-6 haloalkenyl group include a 2-chloro-1-propenyl group and a 2-fluoro-1-butenyl group.
Examples of the C2-6 haloalkynyl group include a 4,4-dichloro-1-butynyl group, a 4-fluoro-1-pentynyl group, a 5-bromo-2-pentynyl group and the like.
As C1-6 haloalkoxy group, chloromethoxy group, dichloromethoxy group, difluoromethoxy group, trichloromethoxy group, trifluoromethoxy group, 1-fluoroethoxy group, 1,1-difluoroethoxy group, 2,2,2- Trifluoroethoxy group, 1,1,2,2-tetrafluoroethoxy group, pentafluoroethoxy group, 2,2,3,4,4-hexafluoro-butoxy group, 1-bromo-1,1,2 And 2-tetrafluoroethoxy group.
The C1~6 halo alkylenedioxy group, difluoromethylene dioxy group (-OCF 2 O-), tetrafluoroethylene dioxy group (-OCF 2 CF 2 O-) and the like. The C6~10 aryl groups substituted with C1~6 halo alkylenedioxy group is G 2, 2,2,3,3-tetrafluoro-2,3-dihydro - benzo [1,4] Jiokishiru group, A 2, 2- difluoro- benzo [1, 3] dioxolyl group etc. can be mentioned.
C1〜6アルコキシC1〜6ハロアルキル基、C1〜6ハロアルコキシC1〜6ハロアルコキシ基、C1〜6ハロアルキルチオ基、C1〜6ハロアルキルスルフィニル基、およびC1〜6ハロアルキルスルホニル基は、すでに述べた、C1〜6アルコキシC1〜6アルキル基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6アルキルチオ基、C1〜6アルキルスルフィニル基、およびC1〜6アルキルスルホニル基に、ハロゲノ基が置換したものである。
C1〜6アルコキシC1〜6ハロアルキル基としては、ジフルオロ(メトキシ)メチル基、1,1,1,3,3,3−ヘキサフルオロ−2−メトキシプロパン−2−イル基などを挙げることができる。
C1〜6ハロアルコキシC1〜6ハロアルコキシ基としては、ジフルオロ(メトキシ)メトキシ基、1,2,2−トリフルオロ−2−(トリフルオロメトキシ)エトキシ基などを挙げることができる。
C1〜6ハロアルキルチオ基としては、トリフルオロメチルチオ基、2,2,2-トリフルオロエチルチオ基などを挙げることができる。
C1〜6ハロアルキルスルフィニル基としては、トリフルオロメチルスルフィニル基、2,2,2−トリフルオロエチルスルフィニル基などを挙げることができる。
C1〜6ハロアルキルスルホニル基としては、トリフルオロメチルスルホニル基、2,2,2−トリフルオロエチルスルホニル基などを挙げることができる。The C1-6 alkoxy C1-6 haloalkyl group, the C1-6 haloalkoxy C1-6 haloalkoxy group, the C1-6 haloalkylthio group, the C1-6 haloalkylsulfinyl group, and the C1-6 haloalkyl sulfonyl group are as described above, C1 A halogeno group is substituted by -6 alkoxy C1-6 alkyl group, C1-6 alkoxy C1-6 alkoxy group, C1-6 alkylthio group, C1-6 alkylsulfinyl group, and C1-6 alkylsulfonyl group.
Examples of the C1-6 alkoxy C1-6 haloalkyl group include difluoro (methoxy) methyl group, 1,1,1,3,3,3-hexafluoro-2-methoxypropan-2-yl group and the like.
Examples of the C1-6 haloalkoxy C1-6 haloalkoxy group include a difluoro (methoxy) methoxy group and a 1,2,2-trifluoro-2- (trifluoromethoxy) ethoxy group.
A trifluoromethylthio group, a 2,2,2- trifluoroethylthio group etc. can be mentioned as a C1-6 haloalkylthio group.
As C1-6 haloalkyl sulfinyl group, a trifluoromethyl sulfinyl group, a 2,2,2- trifluoroethyl sulfinyl group etc. can be mentioned.
A trifluoromethyl sulfonyl group, a 2,2,2- trifluoroethyl sulfonyl group etc. can be mentioned as a C1-6 haloalkyl sulfonyl group.
置換基G21は、C1〜6アルキル基、C1〜6ハロアルキル基、C1〜6アルコキシ基、C1〜6ハロアルコキシ基、またはハロゲノ基を示す。これらは既に述べたとおりのものである。
G2またはG4のうちの2つ以上がG21で置換された前記の基である場合、係るG21は、相互に同じであっても異なってもよい。The substituent G 21 represents a C1-6 alkyl group, a C1-6 haloalkyl group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, or a halogeno group. These are as already mentioned.
If more than one of G 2 or G 4 is a said group substituted with G 21, G 21 according may be the same or different from each other.
本発明においては、R1としては、水素原子、無置換のもしくはG1で置換されたC1〜6アルキル基(好ましくは無置換)、無置換のもしくはG1で置換されたアルコキシ基(好ましくは無置換)、無置換のもしくはG2(好ましくはC1〜6アルコキシ基、C1〜6アルコキシカルボニルオキシ基)で置換されたC6〜10アリール基(好ましくはフェニル基)、無置換のもしくはG2で置換された6員環のヘテロアリール基(好ましくは無置換のピリジル基)、シアノ基またはハロゲノ基が好ましく、無置換のC1〜6アルキル基またはハロゲノ基がより好ましい。 In the present invention, R 1 is a hydrogen atom, a C 1-6 alkyl group which is unsubstituted or substituted by G 1 (preferably unsubstituted), an alkoxy group which is unsubstituted or substituted by G 1 (preferably unsubstituted). , C6-10 aryl group (preferably phenyl group) substituted by unsubstituted or G2 (preferably C1-6 alkoxy group, C1-6 alkoxycarbonyloxy group), 6-membered unsubstituted or G2 substituted The ring is preferably a heteroaryl group (preferably an unsubstituted pyridyl group), a cyano group or a halogeno group, and more preferably an unsubstituted C1-6 alkyl group or a halogeno group.
〔R2およびR3〕
R2およびR3は、それぞれ独立に、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基、ホルミル基、ホルミルオキシ基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニルオキシ基、無置換の若しくはG2で置換されたC6〜10アリール基、(無置換の若しくはG1で置換されたC1〜6アルコキシイミノ)−C1〜6アルキル基、シアノ基、またはハロゲノ基を示す。
R2およびR3における、C1〜6アルキル基、C3〜8シクロアルキル基、C1〜6アルコキシ基、C1〜6アルキルカルボニル基、C1〜6アルキルカルボニルオキシ基、C6〜10アリール基、ハロゲノ基、および置換基G1、G2は、すでに述べたとおりのものである。
(C1〜6アルコキシイミノ)−C1〜6アルキル基としては、メトキシイミノ−メチル基、1−(エトキシイミノ)−エチル基などを挙げることができる。[R 2 and R 3 ]
R 2 and R 3 are each independently a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C3~8 cycloalkyl group substituted by G 1, the unsubstituted Or a G 1 substituted C1-6 alkoxy group, a formyl group, a formyloxy group, an unsubstituted or G 1 substituted C1-6 alkylcarbonyl group, an unsubstituted or G 1 substituted C1-6 alkylcarbonyloxy group, an unsubstituted or C6~10 aryl groups substituted with G 2, (unsubstituted or substituted with G 1 a C1~6 alkoxyimino)-C1-6 alkyl group, a cyano group or a halogeno, Indicates a group.
C1-6 alkyl group, C3-8 cycloalkyl group, C1-6 alkoxy group, C1-6 alkyl carbonyl group, C1-6 alkyl carbonyloxy group, C6-10 aryl group, halogeno group in R 2 and R 3 And the substituents G 1 , G 2 are as already mentioned.
Examples of the (C1-6 alkoxyimino) -C1-6 alkyl group include a methoxyimino-methyl group and a 1- (ethoxyimino) -ethyl group.
R1とR2は、一緒になってR1およびR2のそれぞれが結合する炭素原子と共に、5〜6員環を形成してもよい。係る5〜6員環としては、シクロペンテン環、シクロヘキセン環などを挙げることができる。R 1 and R 2 may together form a 5- to 6-membered ring with the carbon atom to which each of R 1 and R 2 is attached. Examples of the 5- to 6-membered ring include cyclopentene ring and cyclohexene ring.
本発明のおいては、R2としては、水素原子、無置換の若しくはG1(好ましくは水酸基、ハロゲノ基、C1〜6アルコキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基)で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基(好ましくは無置換)、無置換の若しくはG2(好ましくはC1〜6アルコキシ基)で置換されたC6〜10アリール基(好ましくはフェニル基)、無置換の若しくはG1で置換されたC1〜6アルキルカルボニル基(好ましくは無置換)、(無置換の若しくはG1で置換されたC1〜6アルコキシイミノ)−C1〜6アルキル基(好ましくは無置換)、ハロゲノ基、シアノ基、ホルミル基が好ましく、無置換のC1〜6アルキル基がより好ましい。
本発明のおいては、R3としては、無置換の若しくはG1(好ましくは水酸基、ハロゲノ基、C1〜6アルコキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基)で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基(好ましくは無置換)、無置換のC3〜8シクロアルキル基(好ましくは3〜4シクロアルキル基)、無置換の若しくはG1で置換されたC1〜6アルキルカルボニルオキシ基(好ましくは無置換)、無置換の若しくはG2で置換されたC6〜10アリール基(好ましくは無置換のフェニル基)、(無置換の若しくはG1で置換されたC1〜6アルコキシイミノ)−C1〜6アルキル基(好ましくは無置換)、ハロゲノ基、シアノ基またはホルミル基が好ましく、無置換の若しくはG1(好ましくは水酸基、ハロゲノ基、C1〜6アルコキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基)で置換されたC1〜6アルキル基またはハロゲノ基がより好ましい。In the present invention, R 2 is a hydrogen atom, unsubstituted or G 1 (preferably a hydroxyl group, a halogeno group, a C1-6 alkoxy group, a C1-6 alkylcarbonyloxy group, a C1-6 alkoxycarbonyloxy group C1~6 alkyl group substituted with), substituted with unsubstituted or C1~6 alkoxy group substituted with G 1 (preferably unsubstituted), unsubstituted or G 2 (preferably C1~6 alkoxy group) been C6~10 aryl groups (preferably phenyl group), an unsubstituted or C1~6 alkylcarbonyl group substituted with G 1 (preferably unsubstituted), C1 to substituted with (unsubstituted or G 1 6 alkoxyimino) -C1-6 alkyl group (preferably unsubstituted), halogeno group, cyano group, formyl group is preferable, and unsubstituted C1-6 alkyl group is more preferable preferable.
In the present invention, R 3 is unsubstituted or substituted with G 1 (preferably a hydroxyl group, a halogeno group, a C1-6 alkoxy group, a C1-6 alkylcarbonyloxy group, a C1-6 alkoxycarbonyloxy group) C1-6 alkyl group, unsubstituted or G 1 substituted C1-6 alkoxy group (preferably unsubstituted), unsubstituted C3-8 cycloalkyl group (preferably 3-4 cycloalkyl group), unsubstituted or C1~6 alkylcarbonyloxy group substituted with G 1 (preferably unsubstituted), unsubstituted or C6~10 aryl groups substituted with G 2 (preferably an unsubstituted phenyl group), ( Unsubstituted or G 1 substituted C1-6 alkoxyimino) -C1-6 alkyl group (preferably unsubstituted), halogeno group, cyano group or formyl group Preferably, a C1-6 alkyl group or a halogeno group which is unsubstituted or substituted by G1 (preferably a hydroxyl group, a halogeno group, a C1-6 alkoxy group, a C1-6 alkylcarbonyloxy group, a C1-6 alkoxycarbonyloxy group) is preferable More preferable.
〔R4〕
R4は、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC2〜6アルケニル基、無置換の若しくはG1で置換されたC2〜6アルキニル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、無置換の若しくはG2で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG2で置換された3〜6員ヘテロシクリル基、無置換の若しくはG2で置換された3〜6員ヘテロシクリルC1〜6アルキル基、ホルミル基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニル基、無置換の若しくはG1で置換されたC3〜8シクロアルキルカルボニル基、無置換の若しくはG1で置換されたC1〜6アルケニルカルボニル基、無置換の若しくはG2で置換されたC6〜10アリールカルボニル基、無置換の若しくはG1で置換されたC1〜6アルコキシカルボニル基、無置換の若しくはG1で置換されたC2〜6アルケニルオキシカルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルスルホニル基、無置換の若しくはG1で置換されたC1〜6アルキルアミノカルボニル基、無置換の若しくはG1で置換された(C1〜6アルキルチオ)カルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルアミノ(チオカルボニル)基、または式(IV)で表される基を示す。[R 4 ]
R 4 is a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, which is substituted by unsubstituted or G 1 C2ア ル キ ニ 6 alkynyl group, unsubstituted or G 1 substituted C 3-8 cycloalkyl group, unsubstituted or G 2 substituted C 6 to 10 aryl C 1 6 alkyl group, unsubstituted or substituted G 2 3 to 6 membered heterocyclyl group, unsubstituted or G 2 substituted 3 to 6 membered heterocyclyl C1-6 alkyl group, formyl group, unsubstituted or G 1 substituted C1 to 6 alkyl carbonyl group, unsubstituted or C3~8 cycloalkylcarbonyl group substituted with G 1, unsubstituted or C1~6 alkenylcarbonyl group substituted with G 1, is substituted by unsubstituted or G 2 C6~10 arylcarbonyl group, substituted with unsubstituted or C1~6 alkoxycarbonyl group substituted with G 1, unsubstituted or C2~6 alkenyloxycarbonyl group substituted with G 1, unsubstituted or G 1 been Cl to 6 alkylsulfonyl group, unsubstituted or Cl to 6 alkylaminocarbonyl group substituted with G 1, unsubstituted or substituted with G 1 (Cl to 6 alkylthio) carbonyl group, an unsubstituted or G Cl to 6 alkyl amino (thiocarbonyl) substituted with 1 group or a group represented by the formula (IV),.
R4における、C1〜6アルキル基、C2〜6アルケニル基、C2〜6アルキニル基、C3〜8シクロアルキル基、C6〜10アリールC1〜6アルキル基、3〜6員ヘテロシクリル基、C1〜6アルキルカルボニル基、C1〜6アルコキシカルボニル基、C1〜6アルキルスルホニル基、置換基G1および置換基G2は既に述べたとおりのものである。C1-6 alkyl group, C2-6 alkenyl group, C2-6 alkynyl group, C3-8 cycloalkyl group, C6-10 aryl C1-6 alkyl group, 3-6 membered heterocyclyl group, C1-6 alkyl in R 4 carbonyl group, Cl to 6 alkoxycarbonyl, Cl to 6 alkylsulfonyl group, a substituent G 1 and substituent G 2 is are those as already mentioned.
3〜6員ヘテロシクリルC1〜6アルキル基は、C1〜6アルキル基に、3〜6員ヘテロシクリル基が置換したものである。3〜6員ヘテロシクリルC1〜6アルキル基としては、好ましくは、テトラヒドロフラニルメチル基、テトラヒドロピラニルメチル基、ジオキソラニルメチル基、ジオキサニルメチル基などの5〜6員飽和ヘテロシクリルC1〜6アルキル基;ピラゾリルメチル基、ピリジルメチル基などの5〜6員ヘテロアリールC1〜6アルキル基を挙げることができる。
C3〜8シクロアルキルカルボニル基は、カルボニル基に、前述のC3〜8シクロアルキル基が結合したものである。C3〜8シクロアルキルカルボニル基としては、シクロプロピルカルボニル基、シクロブチルカルボニル基、シクロペンチルカルボニル基、シクロヘキシルカルボニル基などを挙げることができる。
C6〜10アリールカルボニル基としては、カルボニル基に、C6〜10アリール基が結合したものである。C6〜10アリールカルボニル基としては、ベンゾイル基などを挙げることができる。The 3- to 6-membered heterocyclyl C1-6 alkyl group is a C1-6 alkyl group substituted with a 3- to 6-membered heterocyclyl group. As a 3- to 6-membered heterocyclyl C1-6 alkyl group, preferably, 5- to 6-membered saturated heterocyclyl C1-6 alkyl such as tetrahydrofuranylmethyl group, tetrahydropyranylmethyl group, dioxolanylmethyl group, dioxanylmethyl group and the like And 5- to 6-membered heteroaryl C1-6 alkyl groups such as pyrazolylmethyl group and pyridylmethyl group.
The C3-8 cycloalkylcarbonyl group is a carbonyl group to which the aforementioned C3-8 cycloalkyl group is bonded. Examples of the C3-8 cycloalkylcarbonyl group include cyclopropylcarbonyl group, cyclobutylcarbonyl group, cyclopentylcarbonyl group, cyclohexylcarbonyl group and the like.
The C6-10 arylcarbonyl group is a carbonyl group to which a C6-10 aryl group is bonded. A benzoyl group etc. can be mentioned as a C6-10 aryl carbonyl group.
C2〜6アルケニルカルボニル基としては、アクリロイル基、メタクリロイル基などを挙げることができる。
C2〜6アルケニルオキシカルボニル基としては、ビニルオキシカルボニル基、1−プロペニルオキシカルボニル基、2−プロペニルオキシカルボニル基(アリルオキシカルボニル基)などを挙げることができる。
C1〜6アルキルアミノカルボニル基としては、メチルアミノカルボニル基、ジメチルアミノカルボニル基などを挙げることができる。
(C1〜6アルキルチオ)カルボニル基としては、(メチルチオ)カルボニル基、(エチルチオ)カルボニル基などを挙げることができる。
C1〜6アルキルアミノ(チオカルボニル)基としては、メチルアミノ(チオカルボニル)基、ジメチルアミノ(チオカルボニル)基などを挙げることができる。An acryloyl group, a methacryloyl group, etc. can be mentioned as C2-6 alkenyl carbonyl group.
Examples of the C 2-6 alkenyloxycarbonyl group include vinyloxycarbonyl group, 1-propenyloxycarbonyl group, 2-propenyloxycarbonyl group (allyloxycarbonyl group) and the like.
Examples of the C1-6 alkylaminocarbonyl group include a methylaminocarbonyl group, a dimethylaminocarbonyl group and the like.
Examples of the (C1-6 alkylthio) carbonyl group include (methylthio) carbonyl group, (ethylthio) carbonyl group and the like.
Examples of the C1-6 alkylamino (thiocarbonyl) group include a methylamino (thiocarbonyl) group, a dimethylamino (thiocarbonyl) group and the like.
[式(IV)中、
Gaは、それぞれ独立に、水素原子、無置換のもしくはG1で置換されたC1〜6アルキル基、無置換のもしくはG1で置換されたC2〜6アルケニル基、無置換のもしくはG1で置換されたC2〜6アルキニル基、無置換のもしくはG1で置換されたC3〜8シクロアルキル基、または無置換のもしくはG2で置換されたC6〜10アリール基を示す。
Gbは、水素原子、無置換のもしくはG1で置換されたC1〜6アルキル基、無置換のもしくはG1で置換されたC2〜6アルケニル基、無置換のもしくはG1で置換されたC2〜6アルキニル基、無置換のもしくはG1で置換されたC3〜8シクロアルキル基、無置換のもしくはG2で置換されたC6〜10アリール基、または無置換のもしくはG2で置換された3〜6員ヘテロシクリル基を示す。
Tは、酸素原子、オキシカルボニル基、カルボニルオキシ基、オキシカルボニルオキシ基、硫黄原子、(チオ)カルボニル基、カルボニル(チオ)基、(チオ)カルボニルオキシ基、オキシカルボニル(チオ)基、または式:−O−C(=O)−N(Gb)−を示す。
*は式(IV)で表される基の結合位置を示す。][In the formula (IV),
G a independently represents a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, unsubstituted or with G 1 substituted C2~6 alkynyl group, an unsubstituted or C3~8 cycloalkyl group substituted by G 1 or unsubstituted or C6~10 aryl groups substituted with G 2,.
G b represents a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, which is substituted by unsubstituted or G 1 C2 To 6 alkynyl group, unsubstituted or G 1 substituted C 3-8 cycloalkyl group, unsubstituted or G 2 substituted C 6 10 aryl group, or unsubstituted or G 2 substituted 3 Indicates a 6-membered heterocyclyl group.
T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio) carbonyl group, a carbonyl (thio) group, a (thio) carbonyloxy group, an oxycarbonyl (thio) group, or a formula : -O-C (= O) -N (G < b >)-.
* Indicates the bonding position of the group represented by formula (IV). ]
式(IV)で表される基の例として、次に示すものが挙げられる。 Examples of the group represented by formula (IV) include the following.
本発明のおいては、R4としては、水素原子、無置換のもしくはG1(好ましくはC1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、ハロゲノ基)で置換されたC1〜6アルキル基、無置換のもしくはG1で置換されたC2〜6アルケニル基(好ましくは無置換)、無置換のもしくはG2(好ましくはC1〜6アルコキシ基)で置換されたC6〜10アリールC1〜6アルキル基(好ましくはベンジル基)、無置換のもしくはG1(好ましくはC1〜6アルコキシ基、C1〜6アルキルカルボニルオキシ基)で置換されたC1〜6アルキルカルボニル基、無置換のもしくはG1で置換されたC1〜6アルコキシカルボニル基(好ましくは無置換)、無置換のもしくはG1で置換されたC2〜6アルケニルカルボニル基(好ましくは無置換)、無置換のもしくはG1で置換されたC1〜6アルキルアミノカルボニル基(好ましくは無置換)、無置換のもしくはG1で置換された(C1〜6アルキルチオ)カルボニル基(好ましくは無置換)、無置換のもしくはG2(好ましくは、水酸基、ヒドロキシC1〜6アルキル基)で置換されたヘテロシクリル基(好ましくは3〜6員飽和ヘテロシクリル基)、が好ましく、水素原子、無置換のもしくはG1(好ましくはC1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基)で置換されたC1〜6アルキル基、無置換のもしくはG1(好ましくはC1〜6アルコキシ基、C1〜6アルキルカルボニルオキシ基)で置換されたC1〜6アルキルカルボニル基、または無置換のもしくはG1で置換されたC1〜6アルコキシカルボニル基がより好ましい。
〔Q〕
Qは、式(II)または式(III)で表される有機基のいずれかを示す。なお、*は、式(II)または式(III)で表される有機基の結合位置を示す。In the present invention, R 4 is C 1 to C 6 substituted by a hydrogen atom, unsubstituted or G 1 (preferably C 1 to C 6 alkylcarbonyloxy group, C 1 to C 6 alkoxycarbonyloxy group, halogeno group) alkyl group, an unsubstituted or C2~6 alkenyl group substituted with G 1 (preferably unsubstituted), C6-10 aryl C1~ substituted with unsubstituted or G 2 (preferably C1~6 alkoxy group) 6 alkyl group (preferably benzyl group), unsubstituted or C1-6 alkylcarbonyl group substituted with G 1 (preferably C1-6 alkoxy group, C1-6 alkylcarbonyloxy group), unsubstituted or G 1 And C 1-6 alkoxycarbonyl group (preferably unsubstituted) substituted with or C 2-6 alkenyl carbony which is unsubstituted or substituted by G 1 Le group (preferably unsubstituted), unsubstituted or Cl to 6 alkylaminocarbonyl group substituted with G 1 (preferably unsubstituted), substituted with unsubstituted or G 1 (Cl to 6 alkylthio) carbonyl Group (preferably, unsubstituted), heterocyclyl group (preferably, 3 to 6-membered saturated heterocyclyl group) which is unsubstituted or substituted by G 2 (preferably, a hydroxyl group, a hydroxy C1-6 alkyl group) is preferable, and a hydrogen atom is preferable C1-6 alkyl group which is unsubstituted or substituted by G 1 (preferably C1-6 alkylcarbonyloxy group, C1-6 alkoxycarbonyloxy group), unsubstituted or G 1 (preferably C1-6 alkoxy group) , Cl to 6 alkyl carbonyl group substituted by Cl to 6 alkylcarbonyloxy group) or unsubstituted or G 1, Conversion has been C1~6 alkoxycarbonyl group is more preferable.
[Q]
Q represents any one of the organic groups represented by Formula (II) or Formula (III). In addition, * shows the coupling | bonding position of the organic group represented by Formula (II) or Formula (III).
〈Ra〉
Raは、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、アミノ基、C1〜6アルキルカルボニルアミノ基、または無置換の若しくはG2で置換されたC6〜10アリール基を示す。
RaにおけるC1〜6アルキル基、C3〜8シクロアルキル基、C6〜10アリール基、置換基G1および置換基G2はすでに述べたとおりのものである。
C1〜6アルキルカルボニルアミノ基は、アミノ基に、既に述べたC1〜6アルキルカルボニル基が置換したものである。C1〜6アルキルカルボニルアミノ基としては、アセチルアミノ基、プロピオニルアミノ基などを挙げることができる。
本発明においては、Raとしては、水素原子、無置換のアルキル基、無置換のC3〜8シクロアルキル基(好ましくはC3〜4シクロアルキル基)、アミノ基、C1〜6アルキルカルボニルアミノ基、無置換の若しくはG2(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリール基(好ましくはフェニル基)が好ましく、無置換のアルキル基または水素原子がより好ましい。<R a >
R a is a hydrogen atom, an unsubstituted or Cl to 6 alkyl group substituted with G 1, unsubstituted or C3~8 cycloalkyl group substituted with G 1, amino group, Cl to 6 alkylcarbonylamino group , or unsubstituted or showing a C6~10 aryl group substituted by G 2.
C1~6 alkyl group for R a, C3-8 cycloalkyl group, C6-10 aryl group, the substituents G 1 and substituent G 2 is are those as already mentioned.
The C1-6 alkylcarbonylamino group is obtained by substituting an amino group with the already mentioned C1-6 alkylcarbonyl group. As a C1-6 alkyl carbonylamino group, an acetylamino group, a propionylamino group, etc. can be mentioned.
In the present invention, as Ra, a hydrogen atom, an unsubstituted alkyl group, an unsubstituted C3-8 cycloalkyl group (preferably a C3-4 cycloalkyl group), an amino group, a C1-6 alkylcarbonylamino group C6~10 aryl group (preferably a phenyl group) is preferably substituted with unsubstituted or G 2 (preferably C1~6 haloalkyl group), an alkyl group or a hydrogen atom unsubstituted is preferred.
〈Ar1〉
Ar1は、無置換の若しくはG2で置換されたC6〜10アリール基、または無置換の若しくはG2で置換された3〜10員ヘテロシクリル基を示す。
Ar1におけるC6〜10アリール基、および置換基G2はすでに述べたとおりのものである。
3〜10員ヘテロシクリル基は、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1〜4個のヘテロ原子を環の構成原子として含む環状の基である。ヘテロシクリル基は、単環および多環のいずれであってもよい。多環ヘテロシクリル基は、少なくとも一つの環がヘテロシクリルであれば、残りの環が飽和脂環、不飽和脂環または芳香環のいずれであってもよい。3〜10員ヘテロシクリル基としては、3〜10員飽和へテロシクリル基、5〜10員ヘテロアリール基、5〜6員部分不飽和へテロシクリル基などを挙げることができる。<Ar 1 >
Ar 1 represents an unsubstituted or C6~10 aryl groups substituted with G 2 or unsubstituted or 3-10 membered heterocyclyl group which is substituted by G 2,.
The C6-10 aryl group in Ar 1 and the substituent G 2 are as described above.
The 3- to 10-membered heterocyclyl group is a cyclic group containing 1 to 4 heteroatoms selected from the group consisting of nitrogen atoms, oxygen atoms and sulfur atoms as constituent atoms of the ring. The heterocyclyl group may be monocyclic or polycyclic. In the polycyclic heterocyclyl group, when at least one ring is heterocyclyl, the remaining rings may be either saturated alicyclic, unsaturated alicyclic or aromatic rings. As a 3- to 10-membered heterocyclyl group, a 3- to 10-membered saturated heterocyclyl group, a 5- to 10-membered heteroaryl group, a 5- to 6-membered partially unsaturated heterocyclyl group and the like can be mentioned.
3〜10員飽和ヘテロシクリル基としては、
アジリジニル基、オキシラニル基などの3員飽和ヘテロシクリル基;
アゼチジニル基、オキセタニル基などの4員飽和ヘテロシクリル基;
ピロリジニル基、テトラヒドロフラニル基、チアゾリジニル基、イミダゾリジニル基、ピラゾリジニル基、ジオキソラニル基などの5員飽和へテロシクリル基;
ピペリジル基、ピペラジニル基、モルホリニル基、テトラヒドロピラニル基、ジオキサニル基などの6員飽和ヘテロシクリル基;
などが挙げられる。As a 3- to 10-membered saturated heterocyclyl group,
A 3-membered saturated heterocyclyl group such as an aziridinyl group and an oxiranyl group;
A 4-membered saturated heterocyclyl group such as azetidinyl group and oxetanyl group;
5-membered saturated heterocyclyl group such as pyrrolidinyl group, tetrahydrofuranyl group, thiazolidinyl group, imidazolidinyl group, pyrazolidinyl group, dioxolanyl group;
6-membered saturated heterocyclyl groups such as piperidyl group, piperazinyl group, morpholinyl group, tetrahydropyranyl group, dioxanyl group and the like;
Etc.
5〜10員ヘテロアリール基としては、
ピロリル基、フリル基、チエニル基、イミダゾリル基、ピラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、トリアゾリル基、オキサジアゾリル基、チアジアゾリル基、テトラゾリル基などの5員ヘテロアリール基;
ピリジル基、ピラジニル基、ピリミジニル基、ピリダニジル基、トリアジニル基などの6員ヘテロアリール基;
インドリル基、イソインドリル基、ベンゾフラニル基、インダゾリル基、ベンゾオキサゾリル基、ベンゾイソオキサオゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基などの9員ヘテロアリール基;
キノリニル基、イソキノリニル基、シンノリニル基、フタラジニル基、キナゾリニル基、キノキサニル基などの10員ヘテロアリール基;
などが挙げられる。As a 5- to 10-membered heteroaryl group,
5-membered heteroaryl groups such as pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, tetrazolyl group and the like;
A 6-membered heteroaryl group such as pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group and triazinyl group;
9-membered heteroaryl groups such as indolyl group, isoindolyl group, benzofuranyl group, indazolyl group, benzoxazolyl group, benzoisooxaozolyl group, benzothiazolyl group, benzoisothiazolyl group;
10-membered heteroaryl groups such as quinolinyl group, isoquinolinyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group, quinoxanyl group and the like;
Etc.
5〜6員部分不飽和へテロシクリル基としては、
ピロリニル基、ジヒドロフラニル基、イミダゾリニル基、ピラゾリニル基、オキサゾリニル基などの5員部分不飽和ヘテロシクリル基;
イソオキサゾリニル基、ジヒドロピラニル基などの6員部分不飽和へテロシクリル基;
などが挙げられる。As a 5- to 6-membered partially unsaturated heterocyclyl group,
5-membered partially unsaturated heterocyclyl groups such as pyrrolinyl group, dihydrofuranyl group, imidazolinyl group, pyrazolinyl group, oxazolinyl group;
6-membered partially unsaturated heterocyclyl group such as isoxazolinyl group, dihydropyranyl group;
Etc.
Ar1における3〜10員ヘテロシクリル基としては、好ましくは、ピラゾリル基、ピリジル基、ピリミジニル基、キノリニル基などの5〜10員ヘテロアリール基を挙げることができる。Preferred examples of the 3- to 10-membered heterocyclyl group in Ar 1 include 5- to 10-membered heteroaryl groups such as pyrazolyl group, pyridyl group, pyrimidinyl group and quinolinyl group.
本発明においては、Ar1は、無置換のもしくはG2で置換されたC6〜10アリール基(好ましくはフェニル基、ナフチル基)または無置換のもしくはG2で置換された5〜6員ヘテロアリール基(好ましくはピリジル基)であることが好ましく、より好ましくは無置換のもしくはG2で置換されたフェニル基または無置換のもしくはG2で置換されたピリジル基である。
Ar1におけるG2は、C1〜6アルキル基、C1〜6ハロアルキル基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6ハロアルキル基、C1〜6ハロアルコキシ基、C1〜6アルコキシカルボニル基、無置換の若しくはG21(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリール基(好ましくはフェニル基)、無置換の若しくはG21(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリールC1〜6アルキル基(好ましくはベンジル基)、無置換の若しくはG21(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリールオキシ基(好ましくはフェノキシ基)、C1〜6ハロアルキルチオ基、C1〜6ハロアルキルスルフィニル基、C1〜6ハロアルキルスルホニル基、ペンタフルオロスルファニル基、無置換の若しくはG21(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリールチオ基(好ましくはフェニルチオ基)、無置換の若しくはG21(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリールスルフィニル基(好ましくはフェニルスルフィニル基)、無置換の若しくはG21(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリールスルホニル基(好ましくはフェニルスルホニル基)、ニトロ基、C1〜6ハロアルキレンジオキシ基および/またはハロゲノ基であることが好ましく、
より好ましくは、C1〜6アルキル基、C1〜6ハロアルキル基、C1〜6ハロアルコキシ基、無置換の若しくはG21(好ましくはC1〜6ハロアルキル基)で置換されたC6〜10アリールオキシ基(好ましくはフェノキシ基) および/またはハロゲノ基である。In the present invention, Ar 1 is unsubstituted or C6~10 aryl groups substituted with G 2 (preferably a phenyl group, a naphthyl group) or unsubstituted or 5-6 membered heteroaryl substituted with G 2 It is preferably a group (preferably pyridyl group), more preferably an unsubstituted or G 2 -substituted phenyl group or an unsubstituted or G 2 -substituted pyridyl group.
G 2 in Ar 1 is, Cl to 6 alkyl, Cl to 6 haloalkyl, Cl to 6 alkoxy, Cl to 6 alkoxy Cl to 6 haloalkyl, Cl to 6 haloalkoxy group, Cl to 6 alkoxycarbonyl group, no substituted or G 21 (preferably C1~6 haloalkyl group) C6-10 aryl group substituted with (preferably phenyl group), substituted with unsubstituted or G 21 (preferably C1~6 haloalkyl group) C6 -10 aryl C1-6 alkyl group (preferably benzyl group), C6-10 aryloxy group (preferably phenoxy group) unsubstituted or substituted with G 21 (preferably C1-6 haloalkyl group), C1-6 Haloalkylthio group, C1-6 haloalkylsulfinyl group, C1-6 haloalkylsulfonyl group, pentafu Orosurufaniru group, unsubstituted or G 21 (preferably C1~6 haloalkyl group) C6-10 arylthio group (preferably a phenylthio group) that is substituted with, unsubstituted or G 21 (preferably C1~6 haloalkyl group) C6-10 arylsulfinyl group (preferably phenylsulfinyl group) substituted by C6-10 arylsulfonyl group (preferably phenylsulfonyl group) which is unsubstituted or substituted by G 21 (preferably C1-6 haloalkyl group) Preferably a nitro group, a C1-6 haloalkylenedioxy group and / or a halogeno group,
More preferably, a C6-10 aryloxy group (preferably, a C1-6 alkyl group, a C1-6 haloalkyl group, a C1-6 haloalkoxy group, unsubstituted or substituted with G 21 (preferably a C1-6 haloalkyl group) (preferably Is a phenoxy group) and / or a halogeno group.
〈Ar2〉
Ar2は、無置換の若しくはG2で置換されたC6〜10アリール基、無置換の若しくはG2で置換されたC6〜10アリールオキシ基、無置換の若しくはG2で置換されたC6〜10アリールチオ基、無置換の若しくはG2で置換されたC6〜10アリールスルフィニル基、無置換の若しくはG2で置換されたC6〜10アリールスルフォニル基、無置換の若しくはG2で置換された3〜10員ヘテロシクリル基、無置換の若しくはG2で置換された3〜10員ヘテロシクリルオキシ基無置換の若しくはG2で置換された3〜6員ヘテロシクリルチオ基またはフェロセニル基を示す。
Ar2における、C6〜10アリール基は、既に述べた通りのものであり、好ましくはフェニルである。
C6〜10アリールオキシ基、はすでに述べた通りのものであり、好ましくはフェノキシである。
3〜10員ヘテロシクリル基は、既に述べた通りのものであり、好ましくは5〜10員環ヘテロアリール基であり、より好ましくはチアゾリル基、トリアゾリル基、ピラゾリル基、ピリジル基、ピリダジニル基、キノリル基である。
3〜10員ヘテロシクリルオキシ基は、水酸基に、3〜10員ヘテロシクリル基が置換したものである。3〜10員ヘテロシクリルオキシ基としては、5〜6員飽和ヘテロシクリルオキシ基、5〜6員ヘテロアリールオキシ基が好ましい。
5〜6員ヘテロアリールオキシ基としてより好ましくは、ピラゾリルオキシ基、ピリジルオキシ基、ピリダジニルオキシ基、ピリミジニルオキシ基である。
3〜10員ヘテロシクリルチオ基は、SH基に3〜10員ヘテロシクリル基が置換したものである。3〜10員ヘテロシクリルチオ基としては、ピラゾリルチオ基、ピリジルチオ基などの5〜6員ヘテロアリールチオ基を挙げることができ、好ましくはピリジルチオ基である。
C6〜10アリールチオ基は、既に述べた通りのものであり、好ましくはフェニルチオ基である。
アリールスルフィニル基は、既に述べた通りのものであり、好ましくはフェニルスルフィニルである。
アリールスルホニル基は、既に述べた通りのものであり、好ましくはフェニルスルホニルである。<Ar 2 >
Ar 2 is an unsubstituted or G 2 substituted C 6 to 10 aryl group, an unsubstituted or G 2 substituted C 6 to 10 aryloxy group, an unsubstituted or G 2 substituted C 6 to 10 arylthio group, an unsubstituted or C6~10 arylsulfinyl group substituted by G 2, unsubstituted or C6~10 arylsulfonyl group substituted by G 2, 3 to 10 substituted with unsubstituted or G 2 It shows a membered heterocyclyl group, unsubstituted or G 2 in substituted 3- to 10-membered heterocyclyloxy group unsubstituted or 3-6 membered heterocyclylthio group or a ferrocenyl group substituted with G 2.
The C 6-10 aryl group in Ar 2 is as already described, preferably phenyl.
The C6-10 aryloxy group is as described above, preferably phenoxy.
The 3- to 10-membered heterocyclyl group is as already described, preferably a 5- to 10-membered ring heteroaryl group, more preferably a thiazolyl group, a triazolyl group, a pyrazolyl group, a pyridyl group, a pyridazinyl group, a quinolyl group It is.
The 3- to 10-membered heterocyclyloxy group is a hydroxyl group substituted with a 3- to 10-membered heterocyclyl group. As a 3- to 10-membered heterocyclyloxy group, a 5- to 6-membered saturated heterocyclyloxy group and a 5- to 6-membered heteroaryloxy group are preferable.
The 5- or 6-membered heteroaryloxy group is more preferably a pyrazolyloxy group, a pyridyloxy group, a pyridazinyloxy group or a pyrimidinyloxy group.
The 3- to 10-membered heterocyclylthio group is a SH group substituted with a 3- to 10-membered heterocyclyl group. Examples of the 3- to 10-membered heterocyclylthio group include 5- to 6-membered heteroarylthio groups such as pyrazolylthio group and pyridylthio group, with preference given to pyridylthio group.
The C6-10 arylthio group is as already described, preferably a phenylthio group.
The arylsulfinyl group is as already mentioned, preferably phenylsulfinyl.
The arylsulfonyl group is as already described, preferably phenylsulfonyl.
置換基G2はすでに述べたとおりのものであり、好ましくは、C1〜6アルキル基、C1〜6ハロアルキル基、C1〜6アルコキシ基、C3〜8シクロアルキルC1〜6アルコキシ基(好ましくはC3〜4シクロアルキルアルコキシ基)、C1〜6ハロアルコキシ基、無置換のもしくはG21で置換されたC6〜10アリール基(好ましくはフェニル基)、無置換のもしくはG21で置換されたC6〜10アリールオキシ基(好ましくはフェノキシ基)、無置換のもしくはG21で置換された5〜6員ヘテロシクリル基(好ましくはピリジル基)、無置換のもしくはG21で置換された5〜6員ヘテロシクリルオキシ基(好ましくはピリジルオキシ基)、ペンタフルオロスルファニル基、シアノ基、ハロゲノ基、またはC1〜6ハロアルキレンジオキシ基である。
G2として、より好ましくは、C1〜6ハロアルキル基、C1〜6アルコキシ基、C1〜6ハロアルコキシ基、無置換のもしくはG21で置換されたフェニル基、無置換のもしくはG21で置換されたフェノキシ基、無置換のもしくはG21で置換されたピリジル基、無置換のもしくはG21で置換されたピリジルオキシ基、ハロゲノ基、またはC1〜2ハロアルキレンジオキシ基を示す。
置換基G21はすでに述べたとおりのものであり、好ましくは、ハロゲノ基、C1〜6ハロアルキル基またはC1〜6ハロアルコキシ基である。Substituents G 2 is is of as already mentioned, preferably, Cl to 6 alkyl, Cl to 6 haloalkyl, Cl to 6 alkoxy group, is C3~8 cycloalkyl Cl to 6 alkoxy group (preferably C3~ 4 cycloalkylalkoxy group), Cl to 6 haloalkoxy group, an unsubstituted or C6~10 aryl groups (preferably phenyl group substituted with G 21), an unsubstituted or C6~10 aryl substituted with G 21 An oxy group (preferably a phenoxy group), an unsubstituted or G 21 -substituted 5- or 6-membered heterocyclyl group (preferably a pyridyl group), an unsubstituted or G 21 -substituted 5- or 6-membered heterocyclyloxy group Preferably, pyridyloxy group), pentafluorosulfanyl group, cyano group, halogeno group or C1-6 haloalkylene dioxy A group.
As G 2 , more preferably, a C 1 to 6 haloalkyl group, a C 1 to 6 alkoxy group, a C 1 to 6 haloalkoxy group, an unsubstituted or substituted G 21 phenyl group, an unsubstituted or G 21 substituted phenoxy group shown, unsubstituted or pyridyl group substituted with G 21, unsubstituted or pyridyloxy group substituted with G 21, a halogeno group or C1~2 halo alkylenedioxy group.
The substituent G 21 is as described above, preferably a halogeno group, a C1-6 haloalkyl group or a C1-6 haloalkoxy group.
これらの中でも、Ar2として、好ましくは、無置換のもしくはG2で置換されたC6〜10アリール基(好ましくはフェニル基)、無置換のもしくはG2で置換されたC6〜10アリールオキシ基(好ましくはフェノキシ基)、無置換のもしくはG2で置換された3〜10員ヘテロシクリル基(好ましくはチアゾリル基、トリアゾリル基、ピラゾリル基、ピリジル基、ピリダジニル基、キノリル基)、無置換のもしくはG2で置換された3〜10員ヘテロシクリルオキシ基(好ましくはピリジルオキシ基、ピラジニルオキシ基、ピリミジニルオキシ基)である。
また、G2としては、C1〜6ハロアルキル基、C1〜6ハロアルコキシ基、ハロゲノ基がより好ましい。Among these, Ar 2, preferably, unsubstituted or C6~10 aryl groups substituted with G 2 (preferably a phenyl group), an unsubstituted or C6~10 aryloxy group substituted with G 2 ( preferably a phenoxy group), an unsubstituted or 3-10 membered heterocyclyl group (preferably a thiazolyl group which is substituted by G 2, triazolyl group, a pyrazolyl group, a pyridyl group, pyridazinyl group, quinolyl group), unsubstituted or G 2 A 3- to 10-membered heterocyclyloxy group (preferably a pyridyloxy group, a pyrazinyloxy group, a pyrimidinyloxy group) substituted by
As the G 2, Cl to 6 haloalkyl group, Cl to 6 haloalkoxy group, a halogeno group is more preferable.
〈Ba〉
Baは、無置換の若しくはG4で置換されたC1〜C6アルキレン基、無置換の若しくはG4で置換されたC2〜C6アルケニレン基、無置換の若しくはG4で置換されたC2〜C6アルキニレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンオキシC1〜6アルキレン基、無置換の若しくはG4で置換されたC3〜C6シクロアルキレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンC3〜6シクロアルキレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンオキシC3〜6シクロアルキレン基、無置換の若しくはG4で置換されたC4〜C6シクロアルケニレン基、または無置換の若しくはG4で置換された3〜6員ヘテロシクリレン基を示す。
Baにおける、C1〜C6アルキレン基は既に述べたとおりのものである。
C2〜C6アルケニレン基は、C2〜C6アルケン中の水素原子2個が外れてなる2価の基である。C2〜C6アルケニレン基としては、エテニレン基、プロペニレン基、ブテニレン基などを挙げることができる。
C2〜C6アルキニレン基は、C2〜C6アルキン中の水素原子2個が外れてなる2価の基である。C2〜C6アルキニレン基としては、エチニレン基、プロピニレン基、ブチニレン基などを挙げることができる。
C1〜C6アルキレンオキシC1〜6アルキレン基は、2つのC1〜6アルキレン基が、酸素原子を介して結合してなる基である。C1〜C6アルキレンオキシC1〜6アルキレン基としては、メチレンオキシメチレン基、メチレンオキシエチレン基、エチレンオキシメチレン基などを挙げることができる。<B a >
B a is an unsubstituted or G 4 substituted C 1 to C 6 alkylene group, an unsubstituted or G 4 substituted C 2 to C 6 alkenylene group, an unsubstituted or G 4 substituted C 2 to C 6 alkynylene group, an unsubstituted or C1~C6 alkyleneoxy C1~6 alkylene group substituted with G 4, unsubstituted or C3~C6 cycloalkylene group substituted by G 4, which is substituted unsubstituted or at G 4 C1~C6 alkylene C3~6 cycloalkylene group, an unsubstituted or substituted by G 4 a C1~C6 alkyleneoxy C3~6 cycloalkylene group, an unsubstituted or C4~C6 cycloalkenylene group substituted with G 4, Or 3 to 6 membered heterocyclylene group which is unsubstituted or substituted by G 4 .
The C1-C6 alkylene group in B a is as described above.
The C2-C6 alkenylene group is a divalent group formed by removing two hydrogen atoms in a C2-C6 alkene. Examples of the C2 to C6 alkenylene group include an ethenylene group, a propenylene group and a butenylene group.
A C2-C6 alkynylene group is a divalent group formed by removing two hydrogen atoms in a C2-C6 alkyne. Examples of the C2-C6 alkynylene group include ethynylene group, propynylene group and butynylene group.
The C1 to C6 alkyleneoxy C1 to 6 alkylene group is a group formed by combining two C1 to 6 alkylene groups via an oxygen atom. As a C1-C6 alkylene oxy C1-6 alkylene group, a methylene oxy methylene group, a methylene oxy ethylene group, an ethylene oxy methylene group etc. can be mentioned.
C3〜C6シクロアルキレン基は、C3〜C6シクロアルカン中の水素原子2個が外れてなる2価の基である。C3〜C6シクロアルキレン基としては、シクロプロピレン基(1,2−シクロプロピレン基)、シクロブチレン基(1,2−シクロブチレン基、または1,3−シクロペンチレン基)、シクロペンチレン基(1,2−シクロペンチレン基、または1,3−シクロペンチレン基)、シクロヘキシレン基(1,2−シクロヘキシレン基、1,3−シクロヘキシレン基、または1,4−シクロヘキシレン基)などを挙げることができ、好ましくはシクロペンチレン基またはシクロへキシレン基である。
C1〜C6アルキレンC3〜6シクロアルキレン基は、C1〜6アルキレン基とC3〜6シクロアルキレン基が結合してなる基である。
C1〜C6アルキレンC3〜6シクロアルキレン基としては、メチレンシクロプロピレン、メチレンオキシシクロヘキシレン、エチレンオキシシクロヘキシレンなどのC1〜2アルキレンC3〜6シクロアルキレン基が好ましい。
C1〜C6アルキレンオキシC3〜6シクロアルキレン基は、C1〜6アルキレン基とC3〜6シクロアルキレン基が酸素原子を介して結合してなる基である。
C1〜C6アルキレンオキシC3〜6シクロアルキレン基としては、メチレンオキシシクロプロピレン、メチレンオキシシクロヘキシレン、エチレンオキシシクロヘキシレンなどのC1〜2アルキレンオキシC3〜6シクロアルキレン基が好ましい。The C3-C6 cycloalkylene group is a divalent group formed by removing two hydrogen atoms in a C3-C6 cycloalkane. As a C3 to C6 cycloalkylene group, a cyclopropylene group (1,2-cyclopropylene group), a cyclobutylene group (1,2-cyclobutylene group, or a 1,3-cyclopentylene group), a cyclopentylene group (a cyclopentylene group) 1,2-cyclopentylene group or 1,3-cyclopentylene group), cyclohexylene group (1,2-cyclohexylene group, 1,3-cyclohexylene group, or 1,4-cyclohexylene group), etc. And preferably a cyclopentylene group or a cyclohexylene group.
The C1 to C6 alkylene C3 to 6 cycloalkylene group is a group formed by combining a C1 to 6 alkylene group and a C3 to 6 cycloalkylene group.
As the C1 to C6 alkylene C3 to 6 cycloalkylene group, a C1 to 2 alkylene C3 to 6 cycloalkylene group such as methylenecyclopropylene, methyleneoxycyclohexylene, ethyleneoxycyclohexylene and the like is preferable.
The C1 to C6 alkyleneoxy C3 to 6 cycloalkylene group is a group formed by combining a C1 to 6 alkylene group and a C3 to 6 cycloalkylene group via an oxygen atom.
As a C1-C6 alkylene oxy C3-6 cycloalkylene group, C1-2 alkylene oxy C3-6 cycloalkylene groups, such as a methylene oxy cyclopropylene, a methylene oxy cyclohexylene, ethyleneoxy cyclohexylene, etc. are preferable.
C4〜C6シクロアルケニレン基は、C3〜C6シクロアルケン中の水素原子2個が外れてなる2価の基である。C4〜C6シクロアルケニレン基としては、シクロブテニレン基(1,2−シクロブテニレン基、1,3−シクロブテニレン基、1,3−シクロブテニレン基、または3,4-シクロブテニレン基)、シクロペンテニレン基(1,2−シクロペンテニレン基、1,3−シクロペンテニレン基、1,4−シクロペンテニレン基、または1,5-シクロペンテニレン基)、シクロヘキセニレン基(1,2−シクロヘキセニレン基、1,3−シクロヘキセニレン基、1,4−シクロヘキセニレン基、)などを挙げることができ、好ましくはシクロペンテニレン基またはシクロヘキセニレン基が好ましい。 The C4 to C6 cycloalkenylene group is a divalent group formed by removing two hydrogen atoms in a C3 to C6 cycloalkene. As C 4 -C 6 cycloalkenylene group, cyclobutenylene group (1,2-cyclobutenylene group, 1,3-cyclobutenylene group, 1,3-cyclobutenylene group, or 3,4-cyclobutenylene group), cyclopentenylene group (1,1 2-cyclopentenylene group, 1,3-cyclopentenylene group, 1,4-cyclopentenylene group, or 1,5-cyclopentenylene group), cyclohexenylene group (1,2-cyclohexene group) Mention may be made of a enylene group, a 1,3-cyclohexenylene group, a 1,4-cyclohexenylene group, etc., and a cyclopentenylene group or a cyclohexenylene group is preferred.
3〜6員ヘテロシクリレン基は、ヘテロ脂環式化合物中の水素原子2個が外れてなる2価の基である。ヘテロ脂環式化合物は、窒素原子、酸素原子および硫黄原子からなる群から選ばれる1〜4個のヘテロ原子を環の構成原子として含む非芳香族化合物である。
3〜6員ヘテロシクリレン基としては、3〜6員飽和へテロシクリレン基または5〜6員部分不飽和へテロシクリレン基などを挙げることができる。
3〜6員ヘテロシクリレン基としては、ジヒドロフリレン基、テトラヒドロフリレン基、ピロリニレン基、ピロリジニレン基、ピラゾリニレン基、ピラゾリジニレン基、イミダゾリニレン基、イミダゾリジニレン基、オキサゾリニレン基、オキサゾリジニレン基、チアゾリニレン基、チアゾリジニレン基、イソオキサゾリジニレン基、イソチアゾリジニレン基、ジヒドロピラニレン基、テトラヒドロピラニレン基、ピペリジニレン基、ピペラジニレン基、モルホリニレン基などを挙げることができる。
これらの中でも、3〜6員ヘテロシクリレン基としては5〜6員飽和ヘテロシクリレン基が好ましく、ピペリジニレン基が特に好ましい。
なお、特定の実施態様においては、3〜6員ヘテロシクリレン基はC1〜6アルキレン基で、架橋されていてよい。The 3- to 6-membered heterocyclylene group is a divalent group formed by removing two hydrogen atoms in the heteroalicyclic compound. The heteroalicyclic compound is a non-aromatic compound containing 1 to 4 heteroatoms selected from the group consisting of nitrogen atom, oxygen atom and sulfur atom as constituent atoms of the ring.
As a 3- to 6-membered heterocyclylene group, a 3- to 6-membered saturated heterocyclylene group or a 5- to 6-membered partially unsaturated heterocyclylene group can be mentioned.
As a 3- to 6-membered heterocyclylene group, a dihydrofurylene group, a tetrahydrofurylene group, a pyrrolinylene group, a pyrrolidinylene group, a pyrazolinylene group, a pyrazolidinylene group, an imidazolinylene group, an imidazolidinylene group, an oxazolylene group, an oxazolidinylene group Examples include thiazolylene group, thiazolidinylene group, isoxazolidinylene group, isothiazolidinylene group, dihydropyranylene group, tetrahydropyranylene group, piperidinylene group, piperazinylene group, morpholinylene group and the like.
Among these, as a 3- to 6-membered heterocyclylene group, a 5- to 6-membered saturated heterocyclylene group is preferable, and a piperidinylene group is particularly preferable.
In certain embodiments, 3- to 6-membered heterocyclylene groups may be bridged by C1-6 alkylene groups.
これらの中でも、Baは好ましくは、無置換の若しくはG4で置換されたC1〜C6アルキレン基、無置換の若しくはG4で置換されたC2〜C6アルケニレン基、無置換の若しくはG4で置換されたC2〜C6アルキニレン基、無置換の若しくはG4で置換されたC3〜C6シクロアルキレン基、または無置換の若しくはG4で置換された3〜6員ヘテロシクリレン基であり、より好ましくは、無置換の若しくはG4で置換されたC1〜C6アルキレン基、無置換の若しくはG4で置換されたC3〜C6シクロアルキレン基である。Of these, B a is preferably unsubstituted or C1~C6 alkylene group substituted with G 4, unsubstituted or C2~C6 alkenylene group substituted with G 4, unsubstituted or with G 4 substituents A C2 to C6 alkynylene group, an unsubstituted or G 4 substituted C 3 to C 6 cycloalkylene group, or an unsubstituted or G 4 substituted 3 to 6 membered heterocyclylene group, more preferably , an unsubstituted or C1~C6 alkylene group substituted with G 4, unsubstituted or C3~C6 cycloalkylene group substituted with G 4.
G4は、C1〜6アルキル基、C3〜8シクロアルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C2〜6アルケニルオキシC1〜6アルキル基、水酸基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C2〜6アルケニルオキシ基、C1〜6アルコキシカルボニル基、無置換の若しくはG21で置換されたC6〜10アリール基、無置換の若しくはG21で置換された3〜6員ヘテロシクリル基、シアノ基、ハロゲノ基、C1〜6アルキレン基、C1〜6アルキレンジオキシ基、オキソ基、C3〜8シクロアルキルC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルC1〜6アルキル基、C3〜8シクロアルキルオキシC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールオキシC1〜6アルキル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルオキシC1〜6アルキル基、C1〜6アルキリデン基、C1〜6アルコキシイミノ基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルコキシイミノ基、またはC1〜6アルキルヒドラジノ基を示す。G 4 are, Cl to 6 alkyl, C3-8 cycloalkyl, Cl to 6 haloalkyl, Cl to 6 alkoxy Cl to 6 alkyl groups, C2-6 alkenyloxy Cl to 6 alkyl groups, hydroxyl, Cl to 6 alkoxy group, Cl to 6 alkoxy Cl to 6 alkoxy, C2-6 alkenyloxy group, substituted with Cl to 6 alkoxy carbonyl group, an unsubstituted or C6~10 aryl groups substituted with G 21, unsubstituted or G 21 3 to 6 membered heterocyclyl group, cyano group, halogeno group, C1-6 alkylene group, C1-6 alkylenedioxy group, oxo group, C3-8 cycloalkyl C1-6 alkyl group, unsubstituted or G 21 substituted C6~10 aryl C1~6 alkyl, 3-6 membered heterocyclyl C1~6 alkyl substituted with unsubstituted or G 21 Group, C3-8 cycloalkyloxy C1~6 alkyl group, an unsubstituted or C6~10 aryloxy C1~6 alkyl group substituted with G 21, unsubstituted or 3-6 membered heterocyclyl optionally substituted with G 21 oxy Cl to 6 alkyl groups, Cl to 6 alkylidene group, Cl to 6 alkoxyimino group, the unsubstituted or C6~10 aryl Cl to 6 alkoxyimino group substituted with G 21 or Cl to 6 alkyl hydrazino group, Show.
G4における、C1〜6アルキル基、C3〜8シクロアルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6アルコキシカルボニル基、C1〜6アルキレンジオキシ基、C6〜10アリール基、C6〜10アリールC1〜6アルキル基、3〜6員ヘテロシクリル基、3〜6員ヘテロシクリルC1〜6アルキル基、ハロゲノ基、C1〜6アルキレン基、置換基G2および置換基G21は既に述べたとおりのものである。In G 4, Cl to 6 alkyl, C3-8 cycloalkyl, Cl to 6 haloalkyl, Cl to 6 alkoxy Cl to 6 alkyl, Cl to 6 alkoxy, Cl to 6 alkoxy Cl to 6 alkoxy groups, C1 -6 alkoxycarbonyl group, C1-6 alkylenedioxy group, C6-10 aryl group, C6-10 aryl C1-6 alkyl group, 3 to 6 membered heterocyclyl group, 3 to 6 membered heterocyclyl C1-6 alkyl group, halogeno group The C1-6 alkylene group, the substituent G 2 and the substituent G 21 are as described above.
C2〜6アルケニルオキシ基は、水酸基に、C2〜6アルケニル基が置換したものである。C2〜6アルケニルオキシ基としては、ビニルオキシ基、1−プロペニルオキシ基、2−プロペニルオキシ基(アリルオキシ基)などを挙げることができる。
C2〜6アルケニルオキシC1〜6アルキル基は、C1〜6アルキル基に、C2〜6アルケニルオキシ基が置換したものである。C2〜6アルケニルオキシC1〜6アルキル基としては、ビニルオキシメチル基、アリルオキシメチル基などを挙げることができる。
C3〜8シクロアルキルC1〜6アルキル基としては、シクロプロピルメチル基、シクロペンチルメチル基などを挙げることができる。The C2-6 alkenyloxy group is a hydroxyl group substituted with a C2-6 alkenyl group. As C2-6 alkenyloxy group, a vinyloxy group, 1-propenyl oxy group, 2-propenyl oxy group (allyloxy group) etc. can be mentioned.
The C2-6 alkenyloxy C1-6 alkyl group is a C1-6 alkyl group substituted with a C2-6 alkenyloxy group. Examples of the C2-6 alkenyloxy C1-6 alkyl group include a vinyloxymethyl group and an allyloxymethyl group.
As C3-8 cycloalkyl C1-6 alkyl group, a cyclopropyl methyl group, a cyclopentyl methyl group, etc. can be mentioned.
C3〜8シクロアルキルオキシC1〜6アルキル基としては、シクロプロピルオキシメチル基、シクロヘキシルオキシメチル基などを挙げることができる。
C6〜10アリールオキシC1〜6アルキル基としては、フェノキシメチル基、ナフチルオキシメチル基などを挙げることができる。As C3-8 cycloalkyl oxy C1-6 alkyl group, a cyclopropyl oxymethyl group, a cyclohexyl oxymethyl group, etc. can be mentioned.
As a C6-10 aryloxy C1-6 alkyl group, a phenoxymethyl group, a naphthyloxymethyl group, etc. can be mentioned.
3〜6員ヘテロシクリルオキシC1〜6アルキル基としては、好ましくは、ピラゾリルオキシメチル基、ピリジルオキシメチル基などの5〜6員ヘテロアリールメチル基を挙げることができる。
C1〜6アルキリデン基としては、メチリデン基、プロパン−2−イリデン基などを挙げることができる。
C1〜6アルコキシイミノ基としては、メトキシイミノ基(MeO-N=)、エトキシイミノ基(EtO-N=)などを挙げることができる。
C6〜10アリールC1〜6アルコキシイミノ基としては、ベンジルオキシイミノ基(BnO-N=)などを挙げることができる。
C1〜6アルキルヒドラジノ基としては、メチルヒドラジノ基(MeNH-N=)、エチルヒドラジノ基(EtNH-N=)などを挙げることができる。As a 3- to 6-membered heterocyclyloxy C1-6 alkyl group, preferably, a 5- to 6-membered heteroarylmethyl group such as a pyrazolyloxymethyl group or a pyridyloxymethyl group can be mentioned.
Examples of the C1-6 alkylidene group include a methylidene group and a propan-2-ylidene group.
As a C1-6 alkoxy imino group, a methoxy imino group (MeO-N =), an ethoxy imino group (EtO-N =), etc. can be mentioned.
Examples of the C6-10 aryl C1-6 alkoxyimino group include a benzyloxyimino group (BnO-N =) and the like.
As a C1-6 alkyl hydrazino group, a methyl hydrazino group (MeNH-N =), an ethyl hydrazino group (EtNH-N =), etc. can be mentioned.
これらの中でもG4としては、C1〜6アルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C2〜6アルケニルオキシC1〜6アルキル基、水酸基、C1〜6アルコキシ基、C1〜6アルコキシカルボニル基、無置換の若しくはG21で置換されたC6〜10アリール基(好ましくはフェニル基)、無置換の若しくはG21で置換された3〜6員ヘテロシクリル基(好ましくはピリジル基、ピリミジニル基、ジオキソラニル基)、ハロゲノ基、C1〜6アルキレン基、C1〜6アルキレンジオキシ基、オキソ基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルキル基(好ましくはベンジル基)、無置換の若しくはG21で置換された3〜6員ヘテロシクリルC1〜6アルキル基(好ましくはピリジルメチル基、ピラゾリルメチル基、トリアゾリルメチル基)、無置換の若しくはG21で置換されたC6〜10アリールオキシC1〜6アルキル基(好ましくはフェノキシメチル基)、無置換の若しくはG21で置換された3〜6員ヘテロシクリルオキシC1〜6アルキル基(好ましくはピラゾリルオキシメチル基)、C1〜6アルキリデン基、C1〜6アルコキシイミノ基が好ましい。The G 4 Of these, Cl to 6 alkyl, Cl to 6 haloalkyl, Cl to 6 alkoxy Cl to 6 alkyl groups, C2-6 alkenyloxy Cl to 6 alkyl groups, hydroxyl, Cl to 6 alkoxy groups, C1 To 6 alkoxycarbonyl group, unsubstituted or G 21 -substituted C 6-10 aryl group (preferably phenyl group), unsubstituted or G 21 -substituted 3- to 6-membered heterocyclyl group (preferably pyridyl group), Pyrimidinyl group, dioxolanyl group), halogeno group, C1-6 alkylene group, C1-6 alkylenedioxy group, oxo group, C6-10 aryl C1-6 alkyl group unsubstituted or substituted with G 21 (preferably benzyl) Group, 3 to 6 membered heterocyclyl C.sub.1-6 alkyl group (preferably pyri) which is unsubstituted or substituted by G 21. Jirumechiru group, pyrazolyl methyl group, triazolylmethyl group), an unsubstituted or C6~10 aryloxy C1~6 alkyl group substituted with G 21 (preferably phenoxymethyl group), substituted with unsubstituted or G 21 The preferred 3- to 6-membered heterocyclyloxy C1-6 alkyl group (preferably pyrazolyloxymethyl group), C1-6 alkylidene group and C1-6 alkoxyimino group are preferred.
G4における置換基G21は、好ましくはC1〜6ハロアルキル基、C1〜6ハロアルコキシ基、またはハロゲノ基である。Substituent G 21 in G 4 are preferably Cl to 6 haloalkyl group, Cl to 6 haloalkoxy group or a halogeno group.
Baの炭素原子またはBaの置換基G4の一部が、Ar2上の炭素原子と結合して5〜6員環を形成してもよい。係る5〜6員環としては、シクロペンテン環、シクロヘキセン環、ジヒドロフラン環、ジヒドロジオキシン環、ジヒドロピラン環などを挙げることができ、好ましくはシクロペンテン環、シクロヘキセン環、ジヒドロジオキシン環、ジヒドロピラン環である。Part of a substituent G 4 carbon atoms or B a of B a may form a 5- or 6-membered ring with the carbon atom on Ar 2. Examples of the 5- to 6-membered ring include cyclopentene ring, cyclohexene ring, dihydrofuran ring, dihydrodioxin ring, dihydropyran ring and the like, preferably a cyclopentene ring, cyclohexene ring, dihydrodioxin ring, dihydropyran ring .
本発明に係るピリジン化合物には、水和物、各種溶媒和物や結晶多形なども含まれる。さらに、本発明に係るピリジン化合物は、不斉炭素原子、二重結合などに基づく立体異性体およびそれらの混合物、互変異生体を包含する。 The pyridine compound according to the present invention includes hydrates, various solvates, crystal polymorphs and the like. Furthermore, the pyridine compounds according to the present invention include stereoisomers based on asymmetric carbon atoms, double bonds and the like, and mixtures thereof, tautomers.
〔互変異性体〕
本発明に係るピリジン化合物は、R4が水素原子である場合、以下に示す互変異性体 ピリジン−4−オン化合物を生じる。なお、式中のR1、R2、R3、およびQは、式(I)中の規定と同様の意味を示す。本発明においては、当該互変異性体 ピリジン−4−オン化合物も、本発明に包含する。[Tautomers]
The pyridine compound according to the present invention gives the following tautomeric pyridine-4-one compounds when R 4 is a hydrogen atom. In the formulas, R 1 , R 2 , R 3 and Q each have the same meaning as defined in formula (I). In the present invention, the tautomer pyridin-4-one compounds are also included in the present invention.
〔立体異性体〕
本発明においては、同一の構造式で表される化合物であるが、構造中の原子または置換基の空間的配置が異なる化合物、例えば、光学異性体、ジアステレオ異性体、幾何異性体などの全ての立体異性体も、本発明に包含する。立体異性体は、単一物であっても混合物であってもよい。[Stereoisomers]
In the present invention, compounds that are represented by the same structural formula but differ in the spatial arrangement of atoms or substituents in the structure, such as all optical isomers, diastereoisomers, geometric isomers, etc. The stereoisomers of are also included in the present invention. The stereoisomers may be single or in mixtures.
〔塩〕
本発明に係る化合物(I)の塩としては、農園芸学的に許容される塩であれば、特に制限されない。例えば、塩酸、硫酸などの無機酸の塩;酢酸、乳酸などの有機酸の塩;リチウム、ナトリウム、カリウムなどのアルカリ金属の塩;カルシウム、マグネシウムなどのアルカリ土類金属の塩;鉄、銅などの遷移金属の塩;アンモニア、トリエチルアミン、トリブチルアミン、ピリジン、ヒドラジンなどの有機塩基の塩などを挙げることができる。化合物(I)の塩は、化合物(I)から公知の手法によって得ることができる。〔salt〕
The salt of compound (I) according to the present invention is not particularly limited as long as it is an agronomically acceptable salt. For example, salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; iron, copper and the like And salts of transition metals such as ammonia, triethylamine, tributylamine, pyridine, and salts of organic bases such as hydrazine. The salt of compound (I) can be obtained from compound (I) by a known method.
〔農園芸用殺菌剤、有害生物防除剤、および殺虫若しくは殺ダニ剤〕
本発明の農園芸用殺菌剤、有害生物防除剤、および殺虫若しくは殺ダニ剤は、化合物(I)またはその塩(以下「本発明化合物」ということがある。)から選ばれる少なくとも1つを有効成分として含有するものである。[Agricultural and horticultural fungicides, pest control agents, and insecticides or acaricides]
The agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents of the present invention are effective at least one selected from compound (I) or a salt thereof (hereinafter sometimes referred to as "the present compound") It is contained as a component.
本発明の農園芸用殺菌剤は、広範囲の種類の糸状菌、例えば、藻菌類(Oomycetes)、子のう(嚢)菌類(Ascomycetes)、不完全菌類(Deuteromycetes)、担子菌類(Basidiomycetes)、接合菌類(Zygomycetes)に属する菌に由来する植物病害の防除に使用できる。 The agricultural and horticultural fungicides of the present invention may be conjugated to a wide variety of filamentous fungi such as, for example, Oomycetes, Ascomycetes, Deuteromycetes, Basidiomycetes, It can be used to control plant diseases derived from fungi belonging to the fungus (Zygomycetes).
防除の対象となる植物病害と病原菌の例を以下に示す。
テンサイ:褐斑病(Cercospora beticola)、黒根病(Aphanomyces cochlloides)、根腐病(Thanatephorus cucumeris)、葉腐病(Thanatephorus cucumeris)など
ラッカセイ:褐斑病(Mycosphaerella arachidis)、汚斑病(Ascochyta sp.)、さび病(Puccinia arachidis)、立枯病(Pythium debaryanum)、さび斑病(Alternaria alternata)、白絹病(Sclerotium rolfsii)黒渋病(Mycosphaerella berkeleyi)など
キュウリ:うどんこ病(Sphaerotheca fuliginea)、べと病(Pseudoperonospora cubensis)、つる枯病(Mycosphaerella melonis)、つる割病(Fusarium oxysporum)、菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭そ病(Colletotrichum orbiculare)、黒星病(Cladosporium cucumerinum)、褐斑病(Corynespora cassicola)、苗立枯病(Pythium debaryanam、Rhizoctonia solani Kuhn)、ホモプシス根腐病(Phomopsis sp.)斑点細菌病(Pseudomonas syringae pv. Lecrymans)など
トマト:灰色かび病(Botrytis cinerea)、葉かび病(Cladosporium fulvum)、疫病(Phytophthora infestans)、半身萎凋病(Verticillium albo-atrum)、うどんこ病(Oidium neolycopersici)、輪紋病(Alternaria solani)、すすかび病(Pseudocercospora fuligena)など
ナス:灰色かび病(Botrytis cinerea)、黒枯病(Corynespora melongenae)、うどんこ病(Erysiphe cichoracearum)、すすかび病(Mycovellosiella nattrassii)、菌核病(Sclerotinia sclerotiorum)など
イチゴ:灰色かび病(Botrytis cinerea)、うどんこ病(Sohaerotheca humuli)、炭そ病(Colletotrichum acutatum、Colletotrichum fragariae)、疫病(Phytophthora cactorum)、軟腐病(Rhizopus stolonifer)、萎黄病(Fusarium oxysporum)など
タマネギ:灰色腐敗病(Botrytis allii)、灰色かび病(Botrytis cinerea)、白斑葉枯病(Botrytis squamosa)、べと病(Peronospora destructor)、白色疫病(Phytophthora porri)など
キャベツ:根こぶ病(Plasmodiophora brassicae)、軟腐病(Erwinia carotovora)、黒腐病(Xanthomonas campesrtis pv. campestris)、黒斑細菌病(Pseudomonas syringae pv. maculicala、Pseudomonas syringae pv. alisalensis)、べと病(Peronospora parasitica)、菌核病(Sclerotinia sclerotiorum)、黒すす病(Alternaria brassicicola)、灰色かび病(Botrytis cinerea)など
インゲン:菌核病(Sclerotinia sclerotiorum)、灰色かび病(Botrytis cinerea)、炭疽病(Colletotrichum lindemuthianum)、角斑病(Phaeoisariopsis griseola)などExamples of plant diseases and pathogens to be controlled are shown below.
Sugar beet: Brown spot (Cercospora beticola), black root disease (Aphanomyces cochlloides), root rot (Thanatephorus cucumeris), leaf rot (Thanatephorus cucumeris), etc. ), Rust (Puccinia arachidis), damping-off (Pythium debaryanum), rust (Alternaria alternata), white scab (Sclerotium rolfsii), black affliction (Mycosphaerella berkeleyi) etc. Downy mildew (Pseudoperonospora cubensis), vine blight (Mycosphaerella melonis), vine blight (Fusarium oxysporum), sclerotis disease (Sclerotinia sclerotiorum), Botrytis cinerea, Anthracnose (Colletotrichum orbiculare), (Cladosporium cucumerinum), brown spot (Corynespora cassicola), seedling blight (Pythium debaryanam, Rhizoctonia solani Kuhn), homoposis root rot (Phomopsis sp.) Spotted blight (Pseudomonas syringa) e pv. Lecrymans etc. Tomato: Botrytis cinerea, Cladosporium fulvum, Phytophthora infestans, Verticillium albo-atrum, powdery mildew (Oidium neolycopersici), ring crest Diseases (Alternaria solani), sour mildew (Pseudocercospora fuligena), etc. Eggplant: Botrytis cinerea, Corynespora melongenae, powdery mildew (Erysiphe cichoracearum), mildew (Mycovellosiella nattrasci) Diseases (Sclerotinia sclerotiorum), etc. Strawberries: Botrytis cinerea, powdery mildew (Sohaerotheca humuli), anthracnose (Colletotrichum acutatum, Colletotrichum fragariae), plague (Phytophthoracactorum), soft rot (Rhizopulus) (Fusarium oxysporum, etc.) Onion: Gray rot (Botrytis allii), gray mold (Botrytis cinerea), mildew (Botrytis squamosa), downy mildew (Peronospora d) eruptor), white blight (Phytophthora porri), etc. Cabbage: Plasmodiophora brassicae, soft rot (Erwinia carotovora), black rot (Xanthomonas campes rt. pv. syringae pv. alisalensis), downy mildew (Peronospora parasitica), sclerotis disease (Sclerotinia sclerotiorum), black scab (Alternaria brassicicola), gray mold (Botrytis cinerea), etc. Beans: sclerotinia sclerotiorum, gray scab Disease (Botrytis cinerea), anthrax (Colletotrichum lindemuthianum), horny mildew (Phaeoisariopsis griseola), etc.
りんご:うどんこ病(Podosphaera leucotricha)、黒星病(Venturia inaequalis)、モニリア病(Monilinia mali)、黒点病(Mycosphaerella pomi)、腐らん病(Valsa mali)、斑点落葉病(Alternaria mali)、赤星病(Gymnosporangium yamadae)、輪紋病(Botryosphaeria berengeriana)、炭そ病(Glomerella cingulata、Colletotrichum acutatum)、褐斑病(Diplocarpon mali)、すす点病(Zygophiala jamaicensis)、すす斑病(Gloeodes pomigena)、紫紋羽病(Helicobasidium mompa)、灰色かび病(Botrytis cinerea)など
ウメ:黒星病(Cladosporium carpophilum)、灰色かび病(Botrytis cinerea)、灰星病(Monilinia mumecola)など
カキ:うどんこ病(Phyllactinia kakicola)、炭そ病(Gloeosporium kaki)、角斑落葉病(Cercospora kaki)など
モモ:灰星病(Monilinia fructicola)、黒星病(Cladosporium carpophilum)、ホモプシス腐敗病(Phomopsis sp.)、穿孔細菌病(Xanthomonas campestris pv. pruni)など
アーモンド:灰星病(Monilinia laxa)、斑点病(Stigmina carpophila)、黒星病(Cladosporium carpophilum)、葉ぶくれ病(Polystigma rubrum)、斑点落葉病(Alternaria alternata)、炭疽病(Colletotrichum gloeospoides)など
オウトウ:灰星病(Monilinia fructicola)、炭そ病(Colletotrichum acutatum)、黒斑病(Alternaria sp.)、幼果菌核病(Monilinia kusanoi)など
ブドウ:灰色かび病(Botrytis cinerea)、うどんこ病(Uncinula necator)、晩腐病(Glomerella cingulata、Colletotrichum acutatum)、べと病(Plasmopara viticola)、黒とう病(Elsinoe ampelina)、褐斑病(Pseudocercospora vitis)、黒腐病(Guignardia bidwellii)、白腐病(Coniella castaneicola)など
ナシ:黒星病(Venturia nashicola)、赤星病(Gymnosporangium asiaticum)、黒斑病(Alternaria kikuchiana)、輪紋病(Botryosphaeria berengeriana)、うどんこ病(Phyllactinia mali)、胴枯病(Phomopsis fukushii)、褐色斑点病(Stemphylium vesicarium)、炭そ病(Glomerella cingulata)など
チャ:輪斑病(Pestalotia theae)、炭そ病(Colletotrichum theae-sinensis)など
カンキツ:そうか病(Elsinoe fawcetti)、青かび病(Penicillium italicum)、緑かび病(Penicillium digitatum)、灰色かび病(Botrytis cinerea)、黒点病(Diaporthe citri)、かいよう病(Xanthomonas campestris pv.Citri)、うどんこ病(Oidium sp.)などApple: powdery mildew (Podosphaera leucotricha), scab (Venturia inaequalis), Monilia disease (Monilinia mali), black spot disease (Mycosphaerella pomi), scab (Valsa mali), spotted leaf diseases (Alternaria mali), red star disease (Gymnosporangium) yamadae), Botryosphaerus (Botryosphaeria berengeriana), Anthracnose (Glomerella cingulata, Colletotrichum acutatum), Brown Spot Disease (Diplocarpon mali), Soot Spot Disease (Zygophiala jamaicensis), Soot Spot Disease (Gloeodes pomigena), Purple Coat Leaf Disease (Helicobasidium mompa), gray mold (Botrytis cinerea), etc. Ume: scab (Cladosporium carpophilum), gray mold (Botrytis cinerea), scab (Monilinia mumecola), etc. oyster (Phyllactinia kakicola), anthracnose Disease (Gloeosporium kaki), scaly leaf disease (Cercospora kaki), etc. peach: Heliosis (Monilinia fructicola), scab (Cladosporium carpophilum), homoposis rot (Phomopsis sp.), Perforated bacteria Almonds (Xanthomonas campestris pv. Pruni), etc. Almond disease (Monilinia laxa), Spotted disease (Stigmina carpophila), Scab (Cladosporium carpophilum), Leaf blight (Polystigma rubrum), Spotted leaf blight (Alternaria alternata), Anthrax Disease (Colletotrichum gloeospoides), etc. Sweet cherry (Monilinia fructicola), anthracnose (Colletotrichum acutatum), black spot (Alternaria sp.), Juvenile mildew (Monilinia kusanoi), etc. Grape: Botrytis (Botrytis) cinerea), powdery mildew (Uncinula necator), late rot (Glomerella cingulata, Colletotrichum acutatum), downy mildew (Plasmoparaviticola), mildew (Elsinoe ampelina), brown spot (Pseudocercospora vitis), black rot ( Guignardia bidwellii), white rot (Coniella castaneicola) etc. Pear: scab disease (Venturia nashicola), red star disease (Gymnosporangium asiaticum), scab (Alternaria kikuchiana), ring disease (Botyosphaeria berengeriana) Powdery mildew (Phyllactinia mali), blight (Phomopsis fukushii), brown leaf blight (Stemphylium vesicarium), anthracnose (Glomerella cingulata), etc. Tea: Botrytis (Pestalotia theae), anthracnose (Colletotrichum theae-sinensis) And so on) citrus: scab (Elsinoe fawcetti), blue mold (Penicillium italicum), green mold (Penicillium digitatum), gray mold (Botrytis cinerea), black spot (Diaporthe citri), scab (Xanthomonas campestris pv. Citri) ), Powdery mildew (Oidium sp.), Etc.
コムギ:うどんこ病(Erysiphe graminis f.sp.Tritici)、赤かび病(Gibberella zeae)、赤さび病(Puccinia recondita)、褐色雪腐病(Pythium iwayamai)、紅色雪腐病(Monographella nivalis)、眼紋病(Pseudocercosporella herpotrichoides)、葉枯病(Septoria tritici)、ふ枯病(Leptosphaeria nodorum)、雪腐小粒菌核病(Typhula incarnata)、雪腐大粒菌核病(Myriosclerotinia borealis)、立枯病(Gaeumanomyces graminis)、麦角病(Claviceps purpurea)、なまぐさ黒穂病(Tilletia caries)、裸黒穂病(Ustilago nuda)など
オオムギ:斑葉病(Pyrenophora graminea)、網斑病(Pyrenophora teres)、雲形病(Rhynchosporium secalis)、裸黒穂病(Ustilago tritici、U.nuda)など
イネ:いもち病(Pyricularia oryzae)、紋枯病(Rhizoctonia solani)、馬鹿苗病(Gibberella fujikuroi)、ごま葉枯病(Cochliobolus miyabeanus)、苗立枯病(Pythium graminicolum)、白葉枯病(Xanthomonas oryzae)、苗立枯細菌病(Burkholderia plantarii)、褐条病(Acidovorax avenae)、もみ枯細菌病(Burkholderia glumae)、すじ葉枯病(Cercospora oryzae)、稲こうじ病(Ustilaginoidea virens)、褐色米(Alternaria alternata、Curvularia intermedia)、腹黒米(Alternaria padwickii)、紅変米(Epicoccam purpurascenns)など
タバコ:菌核病(Sclerotinia sclerotiorum)、うどんこ病(Erysiphe cichoracearum)、疫病(Phytophthora nicotianae)、など
チューリップ:灰色かび病(Botrytis cinerea)など
ヒマワリ:べと病(Plasmopara halstedii)、菌核病(Sclerotinia sclerotiorum)など
ベントグラス:雪腐大粒菌核病(Sclerotinia borealis)、ラージパッチ(Rhizoctonia solani)、ダラースポット(Sclerotinia homoeocarpa)、いもち病(Pyricularia sp.)、赤焼病(Pythium aphanidermatum)、炭そ病(Colletotrichum graminicola)など
オーチャードグラス:うどんこ病(Erysiphe graminis)など
ダイズ:紫斑病(Cercospora kikuchii)、べと病(Peronospora manshurica)、茎疫病(Phytophthora sojae)、さび病(Phakopsora pachyrhizi)、菌核病(Sclerotinia sclerotiorum)、炭そ病(Colletotrichum truncatum)、灰色かび病(Botrytis cinerea)など
ジャガイモ:疫病(Phytophthora infestans)、夏疫病(Aleternaria solani)、黒あざ病(Thanatephorus cucumeris)など
バナナ:パナマ病(Fusarium oxysporum)、シガトカ病(Mycosphaerella fijiensis、Mycosphaerella musicola)など
ナタネ:菌核病(Sclerotinia sclerotiorum)、根朽病(Phoma lingam)、黒斑病(Alternaria brassicae)など
コーヒー:さび病(Hemileia vastatrix)、炭疽病(Colletotrichum coffeanum)、褐眼病(Cercospora coffeicola)など
サトウキビ:褐さび病(Puccinia melanocephala)など
トウモロコシ:ひょう紋病(Gloecercospora sorghi)、さび病(Puccinia sorghi)、南方さび病(Puccinia polysora)、黒穂病(Ustilago maydis)、ごま葉枯病(Cochliobolus heterostrophus)、すす紋病(Setophaeria turcica)など
ワタ:苗立枯病(Pythium sp)、さび病(Phakopsora gossypii)、白かび病(Mycosphaerella areola)、炭疽病(Glomerella gossypii)などWheat: powdery mildew (Erysiphe graminis f. Sp. Tritici), mildew (Gibberella zeae), red rust (Puccinia recondita), brown snow blight (Pythium iwayamai), red snow blight (Monographella nivalis), eyelid Disease (Pseudocercosporella herpotrichoides), leaf blight (Septoria tritici), blight (Leptosphaeria nodorum), snow blight (Typhula incarnata), snow blight (Myriosclerotinia borealis), blight (Gaeumanomyces graminis graminis) ), Ergot disease (Claviceps purpurea), lumber scab (Tilletia caries), bare black scion (Ustilago nuda), etc. Barley: plague (Pyrenophora graminea), web blight (Pyrenophora teres), cloud disease (Rhynchosporium secalis), Bare scab (Ustilago tritici, U. nuda), etc. Rice: Pyricularia (Pyricularia oryzae), sheath blight (Rhizoctonia solani), fool seedling (Gibberella fujikuroi), sesame leaf blight (Cochliobolus miyabeanus), seedling blight (Pythium graminicolum , Blight leaf blight (Xanthomonas oryzae), seedling blight (Burkholderia plantarii), brown leaf blight (Acidovorax avenae), leaf blight (Burkholderia glumae), leaf blight (Cercospora oryzae), rice blight (Ustiliginoidea) virens), brown rice (Alternaria alternata, Curvularia intermedia), belly black rice (Alternaria padwickii), reddish rice (Epicoccam purpurascens), etc. Tobacco: sclerotinia sclerotiorum, powdery mildew (Erysiphe cichoracearum), epiphylosis ), Etc. Tulip: Gray mold (Botrytis cinerea), etc. Sunflower: Downy mildew (Plasmopara halstedii), sclerotis disease (Sclerotinia sclerotiorum), etc. Bentograss: snowfever sclerotis (Sclerotinia borealis), large patch (Rhizoctonia solani) , Dollar spot (Sclerotinia homoeocarpa), rice blast (Pyricularia sp.), Red burn (Pythium aphanidermatum), anthracnose (Colletotrichum graminicola) Orchardgrass: powdery mildew (Erysiphe graminis) and other soybeans: purpura (Cercospora kikuchii), downy mildew (Peronospora manshurica), stem blight (Phytophthora sojae), rust (Phakopsora pachyrhizi), sclerotis disease (Sclerotinia sclerotirum) Anthracnose (Colletotrichum truncatum), Botrytis cinerea, etc. Potato: Phytophthora infestans, summer plague (Aleternaria solani), black-spot (Thanatophorus cucumeris), etc. Banana: Panama disease (Fusarium oxysporum), Shigatoka disease (Mycosphaerella fijiensis, Mycosphaerella musicola) etc. Rape: Sclerotinia sclerotiorum, Rheumatoid disease (Phoma lingam), black spot (Alternaria brassicae) etc. Coffee: rust (Hemileia vastatrix), anthracnose (Colletotrichum coffeanum, Brown eye disease (Cercospora coffeicola) etc. Sugar cane: Brown rust disease (Puccinia melanocephala etc.) Corn: Hemorrhoids Gloecercospora sorghi), rust (Puccinia sorghi), southern leaf rust (Puccinia polysora), black scab (Ustilago maydis), sesame leaf blight (Cochliobolus heterostrophus), soot disease (Setophaeria turcica) etc. Cotton: Seedling blight Pythium sp), rust (Phakopsora gossypii), mildew (Mycosphaerella areola), anthracnose (Glomerella gossypii), etc.
本発明の殺虫若しくは殺ダニ剤は、植物の生育に影響する各種の農業害虫およびダニ類などの有害生物の防除効果に優れている。本発明の殺虫若しくは殺ダニ剤は、感受性系統のみならず、従来の薬剤、たとえば、有機リン剤やカーバメート剤に対する抵抗性が発達した系統の害虫にも有効である。抵抗性系統の害虫の代表例としては、コナガ、ウンカ、ヨコバイ、アブラムシなどを挙げることができる。 The insecticide or acaricide of the present invention is excellent in the control effect of various agricultural pests and pests such as mites which affect the growth of plants. The insecticidal or acaricidal agent of the present invention is effective not only for susceptible strains, but also for pests of strains in which resistance to conventional drugs such as organophosphorus agents and carbamate agents has developed. As representative examples of the pests of the resistant strain, diamondback moth, planthoppers, leafhoppers, aphids and the like can be mentioned.
本発明の有害生物防除剤は、農業害虫、ダニ類以外の有害生物の防除に効果を示す。有害生物として、たとえば、外部寄生虫、衛生害虫などを挙げることができる。 The pest control agent of the present invention is effective in controlling pests other than agricultural pests and mites. As pests, for example, ectoparasites, hygiene pests and the like can be mentioned.
本発明の農園芸用殺菌剤、有害生物防除剤、および殺虫若しくは殺ダニ剤が、対象とし得る植物としては、穀物類、野菜類、根菜類、イモ類、樹木類、牧草類、芝類などを挙げることができる。
本発明の農園芸用殺菌剤、有害生物防除剤、および殺虫若しくは殺ダニ剤は、植物類の各部位、たとえば、葉、茎、柄、花、蕾、果実、種子、スプラウト、根、塊茎、塊根、苗条、挿し木などに施用することができる。また、これら植物類の改良品種・変種、栽培品種、さらには突然変異体、ハイブリッド体、遺伝子組み換え体(GMO)を対象とすることもできる。The plants to which the agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents of the present invention can be applied include cereals, vegetables, root vegetables, potatoes, trees, grasses, grasses, etc. Can be mentioned.
The agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents of the present invention can be obtained by using various parts of plants, such as leaves, stems, handles, flowers, buds, fruits, seeds, sprouts, roots, tubers, It can be applied to tubers, shoots, cuttings and the like. In addition, improved varieties and varieties, cultivars, mutants, hybrids and genetically modified organisms (GMOs) of these plants can also be targeted.
本発明の農園芸用殺菌剤は、花卉、芝、牧草を含む農園芸作物に発生する種々の病害の防除をするために行われる種子処理、茎葉散布、土壌施用、水面施用などに使用することができる。 The fungicide for agricultural and horticultural use of the present invention is used for seed treatment, foliage application, soil application, water surface application, etc. which are carried out to control various diseases occurring in agricultural and horticultural crops including florets, turf and grass. Can.
本発明の農園芸用殺菌剤、有害生物防除剤、および殺虫若しくは殺ダニ剤農園芸用殺菌剤は、殺菌、殺虫・殺ダニ、殺線虫、殺土壌害虫などの効果を有する他の農園芸用薬剤; 植物生長調節剤、共力剤、肥料、土壌改良剤、動物用飼料などと混用または併用してもよい。
以下にその一例を示す。
殺菌剤:
(1)核酸生合成阻害剤:
(a)RNAポリメラーゼI阻害剤: ベナラキシル、ベナラキシル-M、フララキシル、メタラキシル、メタラキシル-M;オキサジキシル;クロジラコン、オフレース;
(b)アデノシンデアミナーゼ阻害剤: ブピリメート、ジメチリモール、エチリモール;
(c)DNA/RNA合成阻害剤: ハイメキサゾール、オクチリノン;
(d)DNAトポイソメラーゼII阻害剤: オキソリン酸;The agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal fungicides for agricultural and horticultural purposes of the present invention are other agricultural and horticultural products having effects such as sterilization, insecticidal and acaricidal agents, nematodes, insecticidal insect pests, etc. Drugs for use; They may be mixed with or used together with plant growth regulators, synergists, fertilizers, soil conditioners, animal feeds and the like.
An example is shown below.
Fungicide:
(1) Nucleic acid biosynthesis inhibitors:
(A) RNA polymerase I inhibitors: Benalaxil, Benalaxyl-M, fralaxyl, metalaxyl, metalaxyl-M; oxadixyl; cloziracone, off-race;
(B) adenosine deaminase inhibitors: bupirimate, dimethymol, ethylimol;
(C) DNA / RNA synthesis inhibitors: hymexazole, octyrilinone;
(D) DNA topoisomerase II inhibitor: oxophosphate;
(2)有糸核分裂阻害剤および細胞分裂阻害剤:
(a)β−チューブリン重合阻害剤: ベノミル、カルベンダジム、クロルフェナゾール、フベリダゾール、チアベンダゾール;チオファネート、チオファネートメチル(thiophanate-methyl);ジエトフェンカルブ;ゾキサミド;エタボキサム;
(b)細胞分裂阻害剤: ペンシクロン;
(c)スペクトリン様タンパク質の非局在化阻害剤: フルオピコリド;(2) Mitotic proliferation inhibitors and cytostatics:
(A) β-tubulin polymerization inhibitor: benomyl, carbendazim, chlorphenazole, fuberidazole, thiabendazole; thiophanate, thiophanate methyl (thiophanate-methyl); dietophencarb, zoxamide, etaboxam;
(B) cell division inhibitors: penciclone;
(C) Delocalization inhibitors of spectrin-like protein: fluopicolide;
(3)呼吸阻害剤:
(a)複合体I NADH酸化還元酵素阻害剤: ジフルメトリム;トルフェンピラド;
(b)複合体IIコハク酸脱水素酵素阻害剤: ベノダニル、フルトラニル、メプロニル;イソフェタミド;フルオピラム;フェンフラム、フルメシクロックス;カルボキシン、オキシカルボキシン;チフルザミド;ベンゾビンジフルピル、ビキサフェン、フルキサピロキサド、フラメトピル、イソピラザム、ペンフルフェン、ペンチオピラド、セダキサン;ボスカリド;
(c)複合体IIIユビキノールオキシダーゼQo阻害剤: アゾキシストロビン、クモキシストロビン、クメトキシストロビン、エノキサストロビン、フルフェノキシストロビン、ピクオキシストロビン、ピラオキシストロビン;ピラクロストロビン、ピラメトストロビン、トリクロピリカルブ;クレソキシム-メチル、トリフロキシストロビン;ジモキシストロビン、フェナミンストロビン、メトミノストロビン、オリサストロビン;ファモキサドン;フルオキサストロビン;フェンアミドン;ピリベンカルブ;
(d)複合体IIIユビキノール還元酵素Qi阻害剤: シアゾファミド;アミスルブロム;
(e)酸化的リン酸化の脱共役剤: ビナパクリル、メプチルジノカップ、ジノカップ;フルアジナム;フェリムゾン;
(f)酸化的リン酸化阻害剤(ATP 合成酵素の阻害剤): フェンチンアセテート、塩化フェンチン、水酸化フェンチン;
(g)ATP生産阻害剤: シルチオファム;
(h)複合体III:チロクローム bc1(ユビキノン還元酵素)のQx(未知)阻害剤: アメトクトラジン;(3) Respiratory inhibitor:
(A) Complex I NADH oxidoreductase inhibitor: diflumetrim; tolfenpyrad;
(B) Complex II succinate dehydrogenase inhibitors: benodanyl, flutolanil, mepronil; isofetamide; fluopyram; fenfuram, flumeclox; , Flumetopyr, isopyrazam, penflufen, penthiopyrade, sedaxane; boscalid;
(C) complex III ubiquinol oxidase Qo inhibitors: azoxystrobin, spiderxystrobin, quaxitostrobin, enoxastrobin, fluphenoxystrobin, picoxystrobin, pyraxtrobin; pyraclostrobin, Crayoxime-methyl, trifloxystrobin; dimoxystrobin, phenaminstrobin, metominostrobin, orysastrobin; famoxadone; fluoxastrobin; phenamidon; pyribencarb
(D) Complex III ubiquinol reductase Qi inhibitors: Cyazofamid; amisulbrom;
(E) Uncoupling agent for oxidative phosphorylation: vinapacryl, meptylizino cup, dino cup; fluazinam; ferimzone;
(F) Oxidative phosphorylation inhibitors (inhibitors of ATP synthetase): phentin acetate, phentin chloride, phentin hydrochloride;
(G) ATP production inhibitor: silthiofam;
(H) Complex III: Qx (unknown) inhibitor of thyrochrome bc1 (ubiquinone reductase): Amethocrazine;
(4)アミノ酸およびタンパク質合成阻害剤
(a)メチオニン生合成阻害剤: アンドプリム、シプロジニル、メパニピリム、ピリメタニル;
(b)タンパク質合成阻害剤: ブラストサイジン-S;カスガマイシン、カスガマイシン塩酸塩;ストレプトマイシン;オキシテトラサイクリン;(4) Amino acid and protein synthesis inhibitors (a) Methionine biosynthesis inhibitors: Andprim, cyprodinil, mepanipyrim, pyrimethanyl;
(B) Protein synthesis inhibitors: Blasticidin-S; Kasugamycin, Kasugamycin hydrochloride; Streptomycin; Oxytetracycline;
(5)シグナル伝達阻害剤:
(a)シグナル伝達阻害剤: キノキシフェン、プロキナジド;
(b)浸透圧シグナル伝達におけるMAP・ヒスチジンキナーゼ阻害剤: フェンピクロニル、フルジオキソニル;クロゾリメート、イプロジオン、プロシミドン、ビンクロゾリン;(5) Signal transduction inhibitors:
(A) Signal transduction inhibitors: quinoxyfene, proquinazide;
(B) MAP and histidine kinase inhibitors in osmotic signal transduction: fen picronil, fludioxonil; crozolimate, iprodione, procymidone, vinclozolin;
(6)脂質および細胞膜合成阻害剤:
(a)りん脂質生合成、メチルトランス-フェラーゼ阻害剤: エジフェンホス、イプロベンホス、ピラゾホス;イソプロチオラン;
(b)脂質の過酸化剤: ビフェニル、クロロネブ、ジクロラン、キンドゼン、テクナゼン、トルクロホスメチル;エトリジアゾール;
(c)細胞膜に作用する剤: ヨードカルブ、プロパモカルブ、プロパモカルブ塩酸塩、プロパモカルブホセチレート、プロチオカルブ;
(d)病原菌細胞膜を撹乱する微生物: バチルスズブチリス菌、バチルス ズブチリスQST713 株、バチルス ズブチリスFZB24 株、バチルス ズブチリスMBI600 株、バチルス ズブチリスD747株;
(e)細胞膜を撹乱する剤: ゴセイカユプテ(ティーツリー)の抽出物;(6) Lipid and cell membrane synthesis inhibitors:
(A) Phospholipid biosynthesis, methyl trans-ferase inhibitor: edifenphos, iprovenphos, pyrazophos; isoprothiolane;
(B) lipid peroxides: biphenyl, chloroneb, dichlorane, quindozen, technazen, tolclophos methyl; etordiazole;
(C) Agents that act on cell membranes: iodocarb, propamocarb, propamocarb hydrochloride, propamocarb bosecetate, prothiocarb;
(D) Microorganisms that disrupt pathogen cell membranes: Bacillus subtilis, Bacillus subtilis QST713 strain, Bacillus subtilis FZB24 strain, Bacillus subtilis MBI600 strain, Bacillus subtilis D747 strain;
(E) Agents that disrupt cell membranes: extracts of Goseika Jupte (tea tree);
(7)細胞膜のステロール生合成阻害剤:
(a)ステロール生合成におけるC14位の脱メチル化阻害剤: トリホリン;ピリフェノックス、ピリイソキサゾール;フェナリモル、フルルプリミドール、ヌアリモル;イマザリル、イマザリル硫酸塩、オキスポコナゾール、ペフラゾエート、プロクロラズ、トリフルミゾール、ビニコナゾール;
アザコナゾール、ビテルタノール、ブロムコナゾール、シプロコナゾール、ジクロブトラゾール、ジフェノコナゾール、ジニコナゾール、ジニコナゾール-M、エポキシコナゾール、エタコナゾール、フェンブコナゾール、フルキンコナゾール、フルシラゾール、フルトリアホール)、フルコナゾール、フルコナゾール−シス、ヘキサコナゾール、イミベンコナゾール、イプコナゾール、メトコナゾール、ミクロブタニル、ペンコナゾール、プロピコナゾール、キンコナゾール、シメコナゾール、テブコナゾール、テトラコナゾール、トリアジメホン、トリアジメノール、トリチコナゾール;プロチオコナゾール、ボリコナゾール;
(b)ステロール生合成におけるΔ14還元酵素およびΔ8→Δ7−イソメラーゼの阻害剤: アルジモルフ、ドデモルフ、ドデモルフ酢酸塩、フェンプロピモルフ、トリデモルフ;フェンプロピジン、ピペラリン;スピロキサミン;
(c)ステロール生合成系のC4位脱メチル化における3-ケト還元酵素阻害剤: フェンヘキサミド;フェンピラザミン;
(d)ステロール生合成系のスクワレンエポキシダーゼ阻害剤: ピリブチカルブ;ナフチフェン、テルビナフィン;(7) Sterol biosynthesis inhibitor of cell membrane:
(A) Demethylation inhibitors at position C14 in sterol biosynthesis: Trifolin; pyriphenox, pyriisoxazole; phenarimol, flurprimidol, nualimol; imazaryl, imazalil sulfate, oxosconazole, pefrazoate, prochloraz, Triflumizole, biniconazole;
Azaconazole, vitertanol, bromuconazole, cyproconazole, diclobutrazol, difenoconazole, diniconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinonazole, flusilazole, flutriaazole), fluconazole, fluconazole- Cis, hexaconazole, imibenconazole, ipconazole, metconazole, microbutanil, penconazole, propiconazole, quinconazole, cimeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, prothioconazole, voriconazole;
(B) Inhibitors of Δ14 reductase and Δ8 → Δ7-isomerase in sterol biosynthesis: aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph; fenpropidine, piperaline; spiroxamine;
(C) 3-keto reductase inhibitors at C4 demethylation of sterol biosynthesis system: fenhexamid; fenpyrazamine;
(D) squalene epoxidase inhibitors of sterol biosynthesis system: pyributycarb; naftifene, terbinafine;
(8)細胞壁合成阻害
(a)トレハラーゼ阻害剤: バリダマイシン;
(b)キチン合成酵素阻害剤: ポリオキシン、ポリオクソリム;
(c)セルロース合成酵素阻害剤: ジメトモルフ、フルモルフ、ピリモルフ;ベンチアバリカルブ、イプロバリカルブ、トルプロカルブ、バリフェナレート;マンジプロパミド;(8) Cell wall synthesis inhibition (a) Trehalase inhibitor: Validamycin;
(B) Chitin synthetase inhibitors: polyoxins, polyoxolims;
(C) Cellulose synthetase inhibitors: Dimethomorph, flumorph, pirimorph; bench abariculum, iprobicarb, tolprocarb, varifenalate; mandipropamide;
(9)メラニン生合成阻害剤
(a)メラニン生合成の還元酵素阻害剤: フサライド;ピロキロン;トリシクラゾール;
(b)メラニン生合成の脱水酵素阻害剤: カルプロパミド;ジクロシメット;フェノキサニル;(9) Melanin Biosynthesis Inhibitor (a) Reductase Inhibitor of Melanin Biosynthesis: Phthalide; Pyroquirone; Tricyclazole;
(B) Dehydratase inhibitors of melanin biosynthesis: Carpropamide; diclocimet; phenoxanyl;
(10)宿主植物の抵抗性誘導剤:
(a)サリチル酸合成経路に作用する剤: アシベンゾラル-S-メチル;
(b)その他: プロベナゾール;チアジニル;イソチアニル;ラミナリン;オオイタドリ抽出液;(10) Host plant resistance inducer:
(A) Agents that act on the salicylic acid synthesis pathway: acibenzolar-S-methyl;
(B) Others: Probenazole; Thiazinyl; Isotianil; Laminarin;
(11)作用性が不明な剤: シモキサニル、ホセチルアルミニウム、リン酸(リン酸塩)、テクロフタラム、トリアゾキシド、フルスルファミド、ジクロメジン、メタスルホカルブ、シフルフェナミド、メトラフェノン、ピリオフェノン、ドジン、ドジン遊離塩基、フルチアニル; (11) Agents with unknown activity: Shimoxanyl, fosetylaluminum, phosphoric acid (phosphate), teclophthalam, triazoloxide, flusulfamide, diclomedin, metasulfocarb, cyfluphenamide, metrafenone, pyrofenone, dodine, dodine free base, flutianil;
(12)多作用点を有する剤: 銅(銅塩)、ボルドー液、水酸化銅、銅ナフタレート、酸化銅、オキシ塩化銅、硫酸銅、硫黄、硫黄製品、多硫化カルシウム;ファーバム、マンコゼブ、マネブ)、マンカッパー、メチラム、ポリカーバメート、プロピネブ、チラム、ジネブ、ジラム;キャプタン、カプタホール、フォルペット;クロロタロニル;ジクロフルアニド、トリルフルアニド;グアザチン、イミノクタジン酢酸塩、イミノクタジンアルベシル酸塩アルベシレート;アニラジン;ジチアノン;キノメチオネート;フルオルイミド; (12) Agents having multiple action points: copper (copper salt), Bordeaux solution, copper hydroxide, copper naphthalate, copper oxide, copper oxychloride, copper sulfate, sulfur, sulfur product, calcium polysulfide; faram, mancozeb, maneb) , Mankapper, methylam, polycarbamate, propineb, tilam, zineb, ziram; captan, captaphor, phorpet; chlorothalonil; diclofluanid, tolylfluanid; gazatine, iminectazine acetate, iminoctazine albesylate albesylate; anilazine; dithianone Quinomethionate; fluorimide;
(13)その他の剤: DBEDC、フルオロフォルペット、グアザチンアセテート、ビス(8-キノリノラト)銅(II)、プロパミジン、クロロピクリン、シプロフラム、アグロバクテリウム、ベトキサジン、ジフェニルアミン、メチルイソチアネート(MITC)、ミルデオマイシン、カプサイシン、クフラネブ、シプロスルファミド、ダゾメット、デバカルブ、ジクロロフェン、ジフェンゾクワット、ジフェンゾクワットメチルスルホネート、フルメトベル、ホセチルカルシウム、ホセチルナトリウム、イルママイシン、ナタマイシン、ニトロタールイソプロピル、オキサモカルブ、プロパモシンナトリウム、ピロールニトリン、テブフロキン、トルニファニド、ザリラミド、アルゴフェーズ(Algophase)、アミカルチアゾール(Amicarthiazol)、オキサチアピプロリン(Oxathiapiprolin)、メチラム亜鉛、ベンチアゾール、トリクラミド、ユニコナゾール、ミルデオマイシン、オキシフェンチイン(Oxyfenthiin)、ピカルブトラゾクス(picarbutrazox); (13) Other agents: DBEDC, fluorophorpet, gazatine acetate, bis (8-quinolinolato) copper (II), propamidine, chloropicrin, ciprofram, agrobacteria, betoxazine, diphenylamine, methylisothianate (MITC ), Mildeomycin, Capsaicin, Kuflaneb, Cyprosulfamide, Dazomet, Debacarb, Dichlorophen, Diphenzoquat, Diphenzoquat Methylsulfonate, Flumethobel, Fosetyl Calcium, Fosetyl Sodium, Irumamycin, Natamycin, Nitrotal Isopropyl , Oxamocarb, propamocin sodium, pyrrolnitrine, tebufloquine, tornifanide, zalliramide, algophase, amicarthiazole (Amicarthiazol), oxathiathia Piproline (Oxathiapiprolin), methylam zinc, benchazole, trichloramide, uniconazole, mildeomycin, Oxyfenthiin, picarbutrazox (picarbutrazox);
殺虫・殺ダニ剤、殺線虫剤、殺土壌害虫剤:
(1)アセチルコリンエステラーゼ阻害剤:
(a)カーバメート系: アラニカルブ、アルジカルブ、ベンジオカルブ、ベンフラカルブ、ブトカルボキシム、ブトキシカルボキシム、カルバリル、カルボフラン、カルボスルファン、エチオフェンカルブ、フェノブカルブ、ホルメタネート、フラチオカルブ、イソプロカルブ、メチオカルブ、メソミル、オキサミル、ピリミカルブ、プロポキサル、チオジカルブ、チオファノックス、トリアザメート、トリメタカルブ、XMC、キシリルカルブ;フェノチオカルブ、MIPC、MPMC、MTMC、アルドキシカルブ、アリキシカルブ、アミノカルブ、ブフェンカルブ、クロエトカルブ、メタム・ナトリウム、プロメカルブ;Insecticides, acaricides, nematocides, soil pesticides:
(1) Acetylcholinesterase inhibitors:
(A) Carbamate system: Alanicarb, aldiocarb, benzocarb, benfracarb, butocarboxim, butoxy carboxim, carbaryl, carbofuran, carbosulfan, carbohephan, ethiophene carb, fenobucarb, formetanate, furaiocarb, isocarb, methiocarb, methoyl, oxamyl, piromicarb, propoxal, Thiodicarb, thiophanox, triazamate, trimetacarb, XMC, xylylcarb; phenothiocarb, MIPC, MPMC, MTMC, aldoxycarb, alixicarb, aminocarb, bufencarb, cloetocarb, metame sodium, promecarb;
(b)有機リン系: アセフェート、アザメチホス、アジンホス-エチル、アジンホス-メチル、カズサホス、クロルエトキシホス、クロルフェンビンホス、クロルメホス、クロルピリホス、クロルピリホス-メチル、クマホス、シアノホス、ジメトン-S-メチル、ダイアジノン、ジクロルボス/DDVP、ジクロトホス、ジメトエート、ジメチルビンホス、ジスルホトン、EPN、エチオン、エトプロホス、ファムフール、フェナミホス、フェニトロチオン、フェンチオン、ホスチアゼート、ヘプテノホス、イミシアホス、イソフェンホス、イソカルボホス、イソキサチオン、マラチオン、メカルバム、メタミドホス、メチダチオン、メビンホス、モノクロトホス、ナレド、オメトエート、オキシジメトン-メチル、パラチオン、パラチオン-メチル、フェントエート、ホレート、ホサロン、ホスメット、ホスファミドン、ホキシム、ピリミホス-メチル、プロフェノホス、プロペタムホス、プロチオホス、ピラクロホス、ピリダフェンチオン、キナルホス、スルホテップ、テブピリンホス、テメホス、テルブホス、テトラクロルビンホス、チオメトン、トリアゾホス、トリクロルホン、バミドチオン;ブロモホス・エチル、BRP、カルボフェノチオン、シアノフェンホス、CYAP、ジメトン-S-メチルスルホン、ジアリホス、ジクロフェンチオン、ジオキサベンゾホス、エトリムホス、フェンスルホチオン、フルピラゾホス、ホノホス、ホルモチオン、ホスメチラン、イサゾホス、ヨードフェンホス、メタクリホス、ピリミホス−エチル、ホスホカルブ、プロパホス、プロトエート、スルプロホス; (B) Organophosphorus: Acephate, azamethyphos, azinphos-ethyl, azinphos-methyl, kazzaphos, chlorethoxyphos, chlorphenphos, chlormephos, chlorpyrifos, chlorpyriphos-methyl, coumaphos, cyanophos, dimetone-S-methyl, diazinon, Dichlorvos / DDVP, Dicrotophos, Dimethoate, Dimethylphosphine, Disulfoton, EPN, Ethion, Ethoprophos, Pham Fool, Fenamiphos, Fenitrothion, Fenthione, Fosciate, Heptenophos, Imicifoss, Isophenphos, Isocarbophos, Isoxathion, Malathion, Mecarbammethizophos Methiomethone, Monocrotophos, Naredo, Omethoate, Oxydimethone-Methyl, Parathion, Parathion-Methyl, Fent Tol, Foleto, Phosalone, Phosmet, Phosphamidon, Hoximme, Pirimiphos-Methyl, Profenophos, Propetamphos, Prothiophos, Pyracophos, Pyridafenthion, Quinalphos, Sulfotep, Tebupillinphos, Temephos, Terbuphos, Tetrachlorvinphos, Thiometone, Trichophos, Trichlorophos, Vamidothion; Bromophos Ethyl, BRP, Carbophenothione, Cyanophenphos, CYAP, Dimetone-S-Methylsulfone, Diariphos, Diclofenthion, Dioxabenzophos, Etriphos, Phensulfothion, Flupirazophos, Honophos, Formothion, Phosmethyrane, Isazophos, Iodophenphos, Methacrylos, pyrimiphos-ethyl, phosphocarb, propaphos, protoate, sulprofos;
(2)GABA-作動性塩素イオンチャネルアンタゴニスト: クロルデン、エンドスルファン、エチプロール、フィプロニル、ピラフルプロール、ピリプロール;カンフェクロル、ヘプタクロル;
(3)ナトリウムチャンネルモジュレーター: アクリナトリン、d-シス-トランス アレスリン、d-トランスアレスリン、ビフェントリン、ビオアレスリン、ビオアレスリンS-シクロペンチル異性体、ビオレスメトリン、シクロプロトリン、シフルトリン、ベータ-シフルトリン、シハロトリン、ラムダ-シハロトリン、ガンマ-シハロトリン、シペルメトリン、アルファ-シペルメトリン、ベータ-シペルメトリン、シータ-シペルメトリン、ゼータ-シペルメトリン、シフェノトリン[(1R)-トランス異性体]、デルタメトリン、エンペントリン[(EZ)-(1R)-異性体]、エスフェンバレレート、エトフェンプロックス、フェンプロパトリン、フェンバレレート、フルシトリネート、フルメトリン、タウ-フルバリネート、ハルフェンプロックス、イミプリトリン、カデスリン、ペルメトリン、フェノトリン[(1R)-トランス異性体]、プラレトリン、ピレスラム、レスメトリン、シラフルオフェン、テフルスリン、テトラメスリン、テトラメトリン[(1R)-異性体]、トラロメトリン、トランスフルトリン;アレスリン、ピレトリン、ピレトリンI、ピレトリンII、プロフルトリン、ジメフルトリン、ビオエタノメトリン、ビオペルメトリン、トランスペルメトリン、フェンフルトリン、フェンピリトリン、フルブロシトリネート、フルフェンプロックス、メトフルトリン、プロトリフェンブト、ピレスメトリン、テラレトリン;(2) GABA-agonizing chloride channel antagonist: chlordene, endosulfan, ethiprole, fipronil, pyrafluprol, pyriprol; campechlor, heptachlor;
(3) Sodium channel modulators: acrolinathrin, d-cis-trans arethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda- Cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cypophothrin [(1R) -trans isomer], deltamethrin, enpentrin [(EZ)-( 1R)-isomer], esfenvalerate, etofenprox, fenpropatrin, fenvalerate, flucithinate, flumethrin, tau-fluvalinate, halfenprox, imipuri Phosphorus, cadestrin, permethrin, phenothrin [(1R) -trans isomer], prarethrin, pyrethrum, resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R) -isomer], tralomethrin, transfluthrin; allethrin, pyrethrin, pyrethrin I, pyrethrin II, profluthrin, dimefluthrin, bioethanomethrin, biopermethrin, transpermethrin, fenfluthrin, phenpyritrin, flubrositrinate, flufenprox, metfluthrin, protrifenbuto, pyrethmethrin, terraretrin;
(4)ニコチン性アセチルコリン受容体アゴニスト: アセタミプリド、クロチアニジン、ジノテフラン、イミダクロプリド、ニテンピラム、ニチアジン、チアクロプリド、チアメトキサム、スルフォキサフロール、ニコチン;フルピラジフロン;
(5)ニコチン性アセチルコリン受容体アロステリックモジュレーター: スピネトラム、スピノサド;
(6)クロライドチャンネル活性化剤: アバメクチン、エマメクチン安息香酸塩、レピメクチン、ミルベメクチン;イベルメクチン、セラメクチン、ドラメクチン、エプリノメクチン、モキシデクチン、ミルベマイシン、ミルベマイシンオキシム;
(7)幼若ホルモン様物質: ヒドロプレン、キノプレン、メソプレン、フェノキシカルブ、ピリプロキシフェン;ジオフェノラン、エポフェノナン、トリプレン;
(8)その他非特異的阻害剤: 臭化メチル、クロルピクリン、フッ化スルフリル、ホウ砂、吐酒石;
(9)同翅目選択的摂食阻害剤: フロニカミド、ピメトロジン、ピリフルキナゾン;(4) Nicotinic acetylcholine receptor agonists: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam, sulfoxaflor, nicotine; flupyradifurone;
(5) Nicotinic acetylcholine receptor allosteric modulators: spinetoram, spinosad;
(6) Chloride channel activators: Abamectin, emamectin benzoate, lepimectin, milbemectin; ivermectin, selamectin, doramectin, eprinomectin, moxidectin, milbemycin, milbemycin oxime;
(7) Juvenile hormone-like substances: hydroprene, quinoprene, mesoprene, phenoxycarb, pyriproxyfen; diofenolan, epofenonan, triprene;
(8) Other nonspecific inhibitors: methyl bromide, chlorpicrin, sulfuryl fluoride, borax, tartaric acid;
(9) Homoptera order selective antifeedants: flonicamide, pimetrodine, pyrifluquinazone;
(10)ダニ類生育阻害剤: クロフェンテジン、ジフロビダジン、ヘキシチアゾクス、エトキサゾール;
(11)微生物由来昆虫中腸内膜破壊剤: バチルス・チューリンゲンシス亜種イスラエレンシ、バチルス・スファエリクス、バチルス・チューリンゲンシス亜種アイザワイ、バチルス・チューリンゲンシス亜種クルスタキ、バチルス・チューリンゲンシス亜種テネブリオニス、Bt作物タンパク質:Cry1Ab、Cry1Ac、Cry1Fa、Cry1A.105、Cry2Ab、Vip3A、mCry3A、Cry3Ab、Cry3Bb、Cry34Ab1/Cry35Ab1;
(12)ミトコンドリアATP生合成酵素阻害剤: ジアフェンチウロン、アゾシクロチン、サイヘキサチン、酸化フェンブタスズ、プロパルギット、テトラジホン;
(13)酸化的リン酸化脱共役剤: クロルフェナピル、スルフラミド、DNOC;ビナパクリル、ジノブトン、ジノカップ;
(14)ニコチン性アセチルコリン受容体チャンネルブロッカー: ベンスルタップ、カルタップ塩酸塩;ネライストキシン;チオスルタップ一ナトリウム塩、チオシクラム;
(15)キチン合成阻害剤: ビストリフルロン、クロルフルアズロン、ジフルベンズロン、フルシクロクスロン、フルフェノクスロン、ヘキサフルムロン、ルフェヌロン、ノバルロン、ノビフルムロン、テフルベンズロン、トリフルムロン、ブプロフェジン、フルアズロン;
(16)双翅目脱皮かく乱剤: シロマジン;
(17)脱皮ホルモン受容体アゴニスト: クロマフェノジド、ハロフェノジド、メトキシフェノジド、テブフェノジド;
(18)オクトパミン受容体アゴニスト: アミトラズ、デミジトラズ、クロルジメホルム;
(19)ミトコンドリア電子伝達系複合体III阻害剤: アセキノシル、フルアクリピリム、ヒドラメチルノン;
(20)ミトコンドリア電子伝達系複合体I阻害剤: フェナザキン、フェンプロキシメート、ピリミジフェン、ピリダベン、テブフェンピラド、トルフェンピラド、ロテノン;(10) Acaricide growth inhibitors: clofenthezin, difrobidazine, hexythiazox, etoxazole;
(11) Microorganisms derived from insect midgut inner membrane disrupter: Bacillus thuringiensis subsp. Islaerensis, Bacillus sphaericus, Bacillus thuringiensis subsp. Eiwai, Bacillus thuringiensis subsp. Kurstaki, Bacillus thuringiensis subsp. Teneburionis, Bt Crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1 / Cry35Ab1;
(12) Mitochondrial ATP biosynthetic enzyme inhibitors: diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, propargite, tetradiphone;
(13) Oxidative phosphorylation uncoupling agent: chlorfenapyr, sulframide, DNOC; binapacryl, dinobuton, dinocup;
(14) Nicotinic acetylcholine receptor channel blocker: bensultap, cartap hydrochloride; nereistoxin; thiosultap monosodium salt, thiocyclam;
(15) Chitin synthesis inhibitors: bistrifluron, chlorfluazuron, diflubenzuron, flucycloxulon, flufenoxuron, hexaflumuron, lufenuron, novallone, noviflumuron, teflubenzurone, triflumuron, buprofezin, fluazulon;
(16) Dipteran molt-disrupting agents: cyromazine;
(17) molting hormone receptor agonists: chromafenozide, halofenozide, methoxyfenozide, tebufenozide;
(18) Octopamine receptor agonists: amitraz, demiditraz, chlordimeform;
(19) Mitochondrial electron transport complex III inhibitor: acequinosyl, fluacripyrim, hydramethylnon;
(20) Mitochondrial electron transport complex I inhibitor: phenazaquin, fenproximate, pyrimidifen, pyridaben, tebufenpyrade, tolfenpyrade, rotenone;
(21)電位依存性ナトリウムチャネルブロッカー: インドキサカルブ、メタフルミゾン;
(22)アセチルCoAカルボキシラーゼ阻害剤: スピロジクロフェン、スピロメシフェン、スピロテトラマト;
(23)ミトコンドリア電子伝達系複合体IV阻害剤: リン化アルミニウム、リン化カルシウム、ホスフィン、リン化亜鉛、シアニド;
(24)ミトコンドリア電子伝達系複合体II阻害剤: シエノピラフェン、シフルメトフェン、ピフルブミド;
(25)リアノジン受容体モジュレーター: クロラントラニリプロール、シアントラニプロール、フルベンジアミド、シクラニリプロール、テトラニリプロール;
(26)混合機能オキシダーゼ阻害剤化合物: ピペロニルブトキシド;
(27)ラトロフィリン受容体作用薬: デプシペプチド、環状デプシペプチド、24員環状デプシペプチド、エモデプシド;
(28)その他の剤(作用機構が未知): アザジラクチン、ベンゾキシメート、ビフェナゼート、ブロモプロピレート、キノメチオネート、クリオライト、ジコホル、ピリダリル、;ベンクロチアズ、硫黄、アミドフルメット、1,3−ジクロロプロペン、DCIP、フェニソブロモレート、ベンゾメート、メタアルデヒド、クロルベンジレート、クロチアゾベン、ジシクラニル、フェノキサクリム、フェントリファニル、フルベンジミン、フルフェナジン、ゴシップルア、ジャポニルア、メトキサジアゾン、石油、オレイン酸カリウム、テトラスル、トリアラセン;アフィドピロペン(afidopyropen)、フロメトキン、フルフィプロル(flufiprole)、フルエンスルフォン、メペルフルスリン、テトラメチルフルスリン、トラロピリル、ジメフルスリン、メチルネオデカンアミド;フルララネル、アフォキソラネル、フルキサメタミド、5−[5−(3,5−ジクロロフェニル)−5−トリフルオロメチル−4,5−ジヒドロイソオキサゾール−3−イル]−2−(1H−1,2,4−トリアゾール−1−イル)ベンゾニトリル(CAS:943137-49-3)、ブロフラニリド、その他のメタジアミド類、;(21) Voltage-gated sodium channel blockers: indoxacarb, metaflumizone;
(22) Acetyl-CoA carboxylase inhibitors: spirodiclofen, spiromesifen, spirtetramat;
(23) Mitochondrial electron transport complex IV inhibitor: aluminum phosphide, calcium phosphide, phosphine, zinc phosphide, cyanide;
(24) Mitochondrial electron transport complex II inhibitor: sienopyrafen, ciflumethofen, piflubumid;
(25) Ryanodine receptor modulators: chloranthraniliprole, cyantraniprole, flubendiamide, cyclaniliprole, tetraniliprole;
(26) Mixed function oxidase inhibitor compound: piperonyl butoxide;
(27) Latrophin receptor agonist: depsipeptide, cyclic depsipeptide, 24-membered cyclic depsipeptide, emodepside;
(28) Other agents (the mechanism of action is unknown): azadirachtin, benzoxmate, biphenazate, bromopropilate, quinomethionate, cryolite, dichophor, pyridalyl; benclothiaz, sulfur, amidoflumet, 1,3-dichloropropene, DCIP , Phenisobromolate, benzomate, methaldehyde, chlorobenzylate, crothiazoben, dicyclanyl, phenoxacrim, phentrifanyl, flubenzamine, fluphenadine, gossypua, japonirua, methoxadiazon, petroleum, potassium oleate, tetrasul, triaracene; afidopyropen), flomethoquin, flufiprole, fluensulphone, meperfursulin, tetramethylfursulin, tralopyril, dimeflusulin, meme Fluneolane, afoxolane, fluxamethamide, 5- [5- (3,5-dichlorophenyl) -5-trifluoromethyl-4,5-dihydroisoxazol-3-yl] -2- (1H-1,2 , 4-Triazol-1-yl) benzonitrile (CAS: 943137-49-3), brofuranilide, and other metadiamides;
〔製剤処方〕
本発明の農園芸用殺菌剤、有害生物防除剤、および殺虫若しくは殺ダニ剤は、剤型によって特に限定されない。たとえば、水和剤、乳剤、水溶剤、顆粒水和剤、粉剤、錠剤などの剤型を挙げることができる。製剤への調製方法は、特に制限されず、剤形に応じて公知の調製方法を採用することができる。
以下に、製剤処方を若干示すが、添加物および添加割合は、これら実施例に限定されるべきものではなく、広範囲に変化させることが可能である。製剤処方中の部は質量部を示す。[Formulation prescription]
The agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents of the present invention are not particularly limited by the dosage form. For example, dosage forms such as wettable powders, emulsions, aqueous solvents, water dispersible granules, powders, tablets and the like can be mentioned. The preparation method for the preparation is not particularly limited, and known preparation methods can be adopted depending on the dosage form.
Although some formulations are shown below, the additives and the addition ratio should not be limited to these examples, but can be widely varied. Parts in the formulation indicate parts by weight.
製剤実施例を若干示す。なお、以下に示す製剤処方は単なる例示であり、本発明の主旨に反しない範囲で、修正することができる。 Some formulation examples are shown. In addition, the pharmaceutical formulation shown below is a mere illustration, and can be corrected in the range which does not violate the main point of this invention.
(製剤1:水和剤)
本発明化合物 40部
珪藻土 53部
高級アルコール硫酸エステル 4部
アルキルナフタレンスルホン酸塩 3部
以上を均一に混合して微細に粉砕して、有効成分40%の水和剤を得た。(Formulation 1: wettable powder)
The compound of the present invention 40 parts Diatomaceous earth 53 parts Higher alcohol sulfuric acid ester 4 parts Alkyl naphthalene sulfonate 3 parts The above components are uniformly mixed and finely ground to obtain a wettable powder with an active ingredient of 40%.
(製剤2:乳剤)
本発明化合物 30部
キシレン 33部
ジメチルホルムアミド 30部
ポリオキシエチレンアルキルアリルエーテル 7部
以上を混合溶解して、有効成分30%の乳剤を得た。(Formulation 2: Emulsion)
The compound of the present invention 30 parts Xylene 33 parts Dimethylformamide 30 parts Polyoxyethylene alkyl allyl ether 7 parts The above were mixed and dissolved to obtain an emulsion having an active ingredient of 30%.
(製剤3:粒剤)
本発明化合物 5部
タルク 40部
クレー 38部
ベントナイト 10部
アルキル硫酸ソーダ 7部
以上を均一に混合して微細に粉砕後、直径0.5〜1.0mmの粒状に造粒して有効成分5%の粒剤を得る。(Formulation 3: granules)
The compound of the present invention 5 parts Talc 40 parts Clay 38 parts Bentonite 10 parts Sodium alkyl sulfate 7 parts The above are uniformly mixed and finely ground, and then granulated into particles of 0.5 to 1.0 mm in diameter to obtain 5% active ingredient Obtain granules of
(製剤4:粒剤)
本発明化合物 5部
クレー 73部
ベントナイト 20部
ジオクチルスルホサクシネートナトリウム塩 1部
リン酸カリウム 1部
以上をよく粉砕混合し、水を加えてよく練り合せた後、造粒乾燥して有効成分5%の粒剤を得る。(Formulation 4: granules)
The compound of the present invention 5 parts Clay 73 parts Bentonite 20 parts Dioctyl sulfosuccinate sodium salt 1 part Potassium phosphate 1 part The above is well ground and mixed well, water is added and thoroughly mixed, then it is granulated and dried to have 5% active ingredient Obtain granules of
(製剤5:懸濁剤)
本発明化合物 10部
ポリオキシエチレンアルキルアリルエーテル 4部
ポリカルボン酸ナトリウム塩 2部
グリセリン 10部
キサンタンガム 0.2部
水 73.8部
以上を混合し、粒度が3ミクロン以下になるまで湿式粉砕し、有効成分10%の懸濁剤を得る。(Formulation 5: suspension agent)
The compound of the present invention 10 parts Polyoxyethylene alkyl allyl ether 4 parts Polycarboxylic acid sodium salt 2 parts Glycerin 10 parts Xanthan gum 0.2 parts Water 73.8 parts The above are mixed and wet-pulverized until the particle size becomes 3 microns or less A 10% suspension of the active ingredient is obtained.
実施例
次に、実施例を示し、本発明をより具体的に説明する。ただし、本発明は以下の実施例によって何ら制限されるものではない。EXAMPLES Next, the present invention will be described more specifically by showing examples. However, the present invention is not limited at all by the following examples.
(実施例1)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルベンジル)オキシムの製造Example 1
Preparation of 1- (4-Acetoxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylbenzyl) oxime
(工程1)
1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノンの合成(Step 1)
Synthesis of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone
4−アミノ−3−ペンテン−2−オン3.2gと2,2,5,6−テトラメチル−4H−1,3−ジオキシン−4−オン10.0gを混合し、120〜130℃で2.5時間撹拌した。その後、反応液を室温まで冷却し、ジエチルエーテルを加えたところ結晶が析出した。この結晶を濾別し、目的化合物を得た。収率は38%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.99(3H, s), 2.29(3H, s), 2.34(3H, s), 2.58(3H, s), 10.42(1H, br.s)Mix 3.2 g of 4-amino-3-penten-2-one and 10.0 g of 2,2,5,6-tetramethyl-4H-1,3-dioxin-4-one, and mix at 120 to 130 ° C. Stir for .5 hours. Thereafter, the reaction solution was cooled to room temperature, and diethyl ether was added to precipitate crystals. The crystals were separated by filtration to obtain the desired compound. The yield was 38%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.99 (3H, s), 2.29 (3H, s), 2.34 (3H, s), 2.58 (3H, s), 10.42 (1H, br.s)
(工程2)
N−{(4−トリフルオロメチルベンジル)オキシ}カルバミン酸 tert−ブチルの合成(Step 2)
Synthesis of tert-butyl N-{(4-trifluoromethylbenzyl) oxy} carbamate
4−トリフルオロメチルベンジル ブロミド1.5gをアセトニトリル20mlに溶解させた。この溶液にN−ヒドロキシカルバミン酸 tert−ブチル1.2gと1, 8−ジアザビシクロ[5.4.0]−ウンデカ−7−エン1.7gを加え、室温にて1時間撹拌した。その後、反応液を1N塩酸に注ぎ、酢酸エチルで抽出した。有機層を飽和塩化アンモニウム水溶液で洗浄し、次に10%水酸化ナトリウム水溶液で洗浄し、最後に無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、目的化合物2.28gを得た。収率は100%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.48(9H, s), 4.91(2H, s), 7.15(1H, br.s), 7.51(2H, d), 7.63(2H, d)1.5 g of 4-trifluoromethylbenzyl bromide were dissolved in 20 ml of acetonitrile. To this solution was added 1.2 g of tert-butyl N-hydroxycarbamate and 1.7 g of 1,8-diazabicyclo [5.4.0] -undec-7-ene, and the mixture was stirred at room temperature for 1 hour. After that, the reaction solution was poured into 1 N hydrochloric acid and extracted with ethyl acetate. The organic layer was washed with saturated aqueous ammonium chloride solution, then with 10% aqueous sodium hydroxide solution and finally dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 2.28 g of the objective compound. The yield was 100%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.48 (9 H, s), 4.91 (2 H, s), 7. 15 (1 H, br. S), 7.51 (2 H, d), 7.63 (2 H, d)
(工程3)
1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルベンジル)オキシムの合成(Step 3)
Synthesis of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylbenzyl) oxime
N−{(4−トリフルオロメチルベンジル)オキシ}カルバミン酸 tert−ブチル0.65gを1,2−ジクロロエタン15mlに溶解させた。この溶液に1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)−エタノン0.30gとトリフルオロ酢酸1mlを加えて、50〜60℃で1時間撹拌した。その後、反応液を飽和塩化アンモニウム水溶液に注ぎ、酢酸エチルで抽出した。有機層を飽和重曹水で洗浄し、次いで無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣を酢酸エチルで洗浄して、目的化合物0.20gを得た。収率は34%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (DMSO-d6, δppm) 1.78(3H, s), 1.96(3H, s), 2.00(3H, s), 2.17(3H, s), 5.16(2H, s), 7.56(2H, d), 7.71(2H, d), 10.92(1H, br.s)0.65 g of tert-butyl N-{(4-trifluoromethylbenzyl) oxy} carbamate was dissolved in 15 ml of 1,2-dichloroethane. To this solution was added 0.30 g of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) -ethanone and 1 ml of trifluoroacetic acid, and the mixture was stirred at 50 to 60 ° C. for 1 hour. Thereafter, the reaction solution was poured into a saturated aqueous ammonium chloride solution and extracted with ethyl acetate. The organic layer was washed with saturated aqueous sodium bicarbonate and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with ethyl acetate to obtain 0.20 g of the objective compound. The yield was 34%.
Physical properties of the objective compound were as follows.
1 H-NMR (DMSO-d 6 , δ ppm) 1.78 (3H, s), 1.96 (3H, s), 2.00 (3H, s), 2.17 (3H, s), 5.16 (2H, s), 7.56 (2H) , d), 7.71 (2H, d), 10.92 (1H, br.s)
(工程4)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルベンジル)オキシムの合成(Step 4)
Synthesis of 1- (4-Acetoxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylbenzyl) oxime
1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルベンジル)オキシム0.16gをクロロホルム10mlに溶解させた。この溶液にピリジン45mgと塩化アセチル43mgを加えて、室温で一晩撹拌した。その後、反応液をクロロホルムで希釈し、1N塩酸で洗浄し、次に飽和重曹水で洗浄し、最後に無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、目的化合物0.19gを得た。収率は100%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.03(3H, s), 2.07(3H, s), 2.11(3H, s), 2.37(3H, s), 2.50(3H, s), 5.22(2H, s), 7.49(2H, d), 7.62(2H, d)0.16 g of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylbenzyl) oxime was dissolved in 10 ml of chloroform. To this solution were added 45 mg of pyridine and 43 mg of acetyl chloride, and the mixture was stirred overnight at room temperature. Thereafter, the reaction solution was diluted with chloroform, washed with 1 N hydrochloric acid, then washed with saturated aqueous sodium bicarbonate solution, and finally dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 0.19 g of the objective compound. The yield was 100%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.03 (3H, s), 2.07 (3H, s), 2.11 (3H, s), 2.37 (3H, s), 2.50 (3H, s), 5.22 (2H, s) ), 7.49 (2H, d), 7.62 (2H, d)
(実施例2)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−{2−(4−トリフルオロメチルフェニル)エチル}オキシムの製造(Example 2)
Preparation of 1- (4-Acetoxy-2,5,6-trimethylpyridin-3-yl) ethanone O- {2- (4-trifluoromethylphenyl) ethyl} oxime
(工程1)
N−{2−(4−トリフルオロメチルフェニル)エトキシ}フタルイミドの合成(Step 1)
Synthesis of N- {2- (4-trifluoromethylphenyl) ethoxy} phthalimide
4−トリフルオロメチルフェネチルアルコール1.0gとN-ヒドロキシフタルイミド1.28gをテトラヒドロフラン12mlに溶解させた。この溶液にトリフェニルホスフィン2.07gを加えた。この溶液に、氷冷下、アゾジカルボン酸ジエチルエステルの40%トルエン溶液3.43gを滴下した。反応液を室温まで昇温し、一晩撹拌した。その後、溶媒を減圧留去した。得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n−ヘキサン/酢酸エチル=4/1(体積比))にて精製し、目的化合物1.94gを得た。収率は100%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 3.21(2H, t), 4.47(2H, t), 7.45(2H, d), 7.56(2H, d), 7.72-7.78(2H, m), 7.80-7.86(2H, m)1.0 g of 4-trifluoromethylphenethyl alcohol and 1.28 g of N-hydroxyphthalimide were dissolved in 12 ml of tetrahydrofuran. To this solution was added 2.07 g of triphenylphosphine. To this solution was dropped 3.43 g of a 40% toluene solution of diethyl azodicarboxylate under ice-cooling. The reaction was warmed to room temperature and stirred overnight. Thereafter, the solvent was distilled off under reduced pressure. The resulting residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate = 4/1 (volume ratio)) to obtain 1.94 g of the objective compound. The yield was 100%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 3.21 (2H, t), 4.47 (2H, t), 7.45 (2H, d), 7.56 (2H, d), 7.72-7.78 (2H, m), 7.80-7.86 (2H, m)
(工程2)
O−{2−(4−トリフルオロメチルフェニル)エチル}ヒドロキシルアミンの合成(Step 2)
Synthesis of O- {2- (4-Trifluoromethylphenyl) ethyl} hydroxylamine
N−{2−(4−トリフルオロメチルフェニル)エトキシ}フタルイミド1.44gをジクロロメタン20mlに溶解させた。この溶液を0℃に冷却し、メチルヒドラジン0.22gを滴下した。反応液を0℃にて1.5時間撹拌した。その後、ジエチルエーテルを加えて、不溶物を濾別した。溶媒を減圧留去し、目的化合物0.83gを得た。収率は94%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.96(2H, t), 3.90(2H, t), 5.43(2H, br.s), 7.33(2H, d), 7.55(2H, d)1.44 g of N- {2- (4-trifluoromethylphenyl) ethoxy} phthalimide were dissolved in 20 ml of dichloromethane. The solution was cooled to 0 ° C. and 0.22 g of methylhydrazine was added dropwise. The reaction was stirred at 0 ° C. for 1.5 hours. Thereafter, diethyl ether was added and the insoluble matter was separated by filtration. The solvent was distilled off under reduced pressure to obtain 0.83 g of the objective compound. The yield was 94%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.96 (2 H, t), 3. 90 (2 H, t), 5.43 (2 H, br. S), 7.33 (2 H, d), 7.55 (2 H, d)
(工程3)
1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−{2−(4−トリフルオロメチルフェニル)エチル}オキシムの合成(Step 3)
Synthesis of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone O- {2- (4-trifluoromethylphenyl) ethyl} oxime
O−{2−(4−トリフルオロメチルフェニル)エチル}ヒドロキシルアミン0.83gを1,2−ジクロロエタン10mlに溶解させた。この溶液に1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノン0.50gとトリフルオロ酢酸1mlを加え、室温で一晩撹拌した。その後、反応液を飽和重曹水に注ぎ、クロロホルムで抽出した。有機層を無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をジエチルエーテルで洗浄して、目的化合物0.68gを得た。収率は67%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (DMSO-d6, δppm) 1.79(3H, s), 1.88(3H, s), 2.11(3H, s), 2.19(3H, s), 3.00(2H, t), 4.23(2H, t), 7.49(2H, d), 7.64(2H, d), 10.96(1H, br.s)0.83 g of O- {2- (4-trifluoromethylphenyl) ethyl} hydroxylamine was dissolved in 10 ml of 1,2-dichloroethane. To this solution was added 0.50 g of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone and 1 ml of trifluoroacetic acid, and the mixture was stirred overnight at room temperature. Thereafter, the reaction solution was poured into saturated aqueous sodium bicarbonate and extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to obtain 0.68 g of the objective compound. The yield was 67%.
Physical properties of the objective compound were as follows.
1 H-NMR (DMSO-d 6 , δ ppm) 1.79 (3 H, s), 1. 88 (3 H, s), 2. 11 (3 H, s), 2. 19 (3 H, s), 3.00 (2 H, t), 4.23 (2 H) , t), 7.49 (2H, d), 7.64 (2H, d), 10.96 (1H, br.s)
(工程4)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−{2−(4−トリフルオロメチルフェニル)エチル}オキシムの合成(Step 4)
Synthesis of 1- (4-Acetoxy-2,5,6-trimethylpyridin-3-yl) ethanone O- {2- (4-trifluoromethylphenyl) ethyl} oxime
1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−{2−(4−トリフルオロメチルフェニル)エチル}オキシム0.48gをジクロロメタン10mlに溶解させた。この溶液にトリエチルアミン0.19gと塩化アセチル0.13gを加えて、室温で一晩撹拌した。その後、反応液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n−ヘキサン/酢酸エチル)にて精製し、目的化合物0.38gを得た。収率は72%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.04(3H, s), 2.06(3H, s), 2.21(3H, s), 2.44(3H, s), 2.51(3H, s), 3.06(2H, t), 4.36(2H, t), 7.35(2H, d), 7.56(2H, d)0.48 g of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone O- {2- (4-trifluoromethylphenyl) ethyl} oxime was dissolved in 10 ml of dichloromethane. 0.19 g of triethylamine and 0.13 g of acetyl chloride were added to this solution and stirred overnight at room temperature. After that, the reaction solution was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.38 g of the objective compound. The yield was 72%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.04 (3H, s), 2.06 (3H, s), 2.21 (3H, s), 2.44 (3H, s), 2.51 (3H, s), 3.06 (2H, t) ), 4.36 (2H, t), 7.35 (2H, d), 7.56 (2H, d)
(実施例3)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルフェニル)オキシムの製造(Example 3)
Preparation of 1- (4-Acetoxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylphenyl) oxime
(工程1)
N−(4−トリフルオロメチルフェノキシ)カルバミン酸 tert−ブチルの合成(Step 1)
Synthesis of tert-butyl N- (4-trifluoromethylphenoxy) carbamate
4−フルオロベンゾトリフルオリド2.0gをジメチルスルホキシド24mlに溶解させた。この溶液に、N−ヒドロキシカルバミン酸 tert−ブチル1.95gと水酸化カリウム1.05gを加えて、室温で一晩撹拌した。その後、反応液を水に注ぎ、酢酸エチルで抽出した。有機層を飽和食塩水で洗浄し、最後に無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n−ヘキサン/酢酸エチル=4/1(体積比))にて精製し、目的化合物1.5gを得た。収率は44%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.50(9H, s), 7.19(2H, d), 7.50(1H, s), 7.56(2H, d)2.0 g of 4-fluorobenzotrifluoride were dissolved in 24 ml of dimethyl sulfoxide. To this solution, 1.95 g of tert-butyl N-hydroxycarbamate and 1.05 g of potassium hydroxide were added, and the mixture was stirred overnight at room temperature. Then, the reaction solution was poured into water and extracted with ethyl acetate. The organic layer was washed with brine and finally dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate = 4/1 (volume ratio)) to obtain 1.5 g of the objective compound. The yield was 44%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.50 (9 H, s), 7. 19 (2 H, d), 7. 50 (1 H, s), 7.56 (2 H, d)
(工程2)
1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルフェニル)オキシムの合成(Step 2)
Synthesis of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylphenyl) oxime
N−(4−トリフルオロメチルフェノキシ)カルバミン酸 tert−ブチル0.85gを1,2−ジクロロエタン10mlに溶解させた。この溶液に1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)−エタノン0.50gとトリフルオロ酢酸1mlを加えて、50℃で1時間撹拌した。その後、反応液を飽和重曹水に注ぎ、クロロホルムで抽出した。有機層を飽和食塩水で洗浄し、最後に無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をジエチルエーテルで洗浄して、目的化合物0.39gを得た。収率は41%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (DMSO-d6, δppm) 1.83(3H, s), 2.21(3H, s), 2.22(3H, s), 2.24(3H, s), 7.32(2H, d), 7.68(2H, d), 11.14(1H, br.s)0.85 g of tert-butyl N- (4-trifluoromethylphenoxy) carbamate was dissolved in 10 ml of 1,2-dichloroethane. To this solution, 0.50 g of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) -ethanone and 1 ml of trifluoroacetic acid were added and stirred at 50 ° C. for 1 hour. Thereafter, the reaction solution was poured into saturated aqueous sodium bicarbonate and extracted with chloroform. The organic layer was washed with brine and finally dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to obtain 0.39 g of the objective compound. The yield was 41%.
Physical properties of the objective compound were as follows.
1 H-NMR (DMSO-d 6 , δ ppm) 1.83 (3H, s), 2.21 (3H, s), 2.22 (3H, s), 2.24 (3H, s), 7.32 (2H, d), 7.68 (2H) , d), 11.14 (1H, br.s)
(工程3)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルフェニル)オキシムの合成(Step 3)
Synthesis of 1- (4-Acetoxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylphenyl) oxime
1−(4−ヒドロキシ−2,5,6−トリメチルピリジン−3−イル)エタノン O−(4−トリフルオロメチルフェニル)オキシム0.25gをジクロロメタン8mlに溶解させた。この溶液にトリエチルアミン0.10gと塩化アセチル70mgを加えて、室温で一晩撹拌した。その後、反応液を減圧濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n−ヘキサン/酢酸エチル)にて精製し、目的化合物0.14gを得た。収率は49%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.10(3H, s), 2.23(3H, s), 2.32(3H, s), 2.50(3H, s), 2.55(3H, s), 7.27(2H, d), 7.57(2H, d)0.25 g of 1- (4-hydroxy-2,5,6-trimethylpyridin-3-yl) ethanone O- (4-trifluoromethylphenyl) oxime was dissolved in 8 ml of dichloromethane. Triethylamine 0.10g and 70 mg of acetyl chlorides were added to this solution, and it stirred at room temperature overnight. Then, the reaction liquid was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.14 g of the objective compound. The yield was 49%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.10 (3 H, s), 2.23 (3 H, s), 2. 32 (3 H, s), 2.50 (3 H, s), 2.55 (3 H, s), 7. 27 (2 H, d) ), 7.57 (2H, d)
(実施例4)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)カルバルデヒド O−{2−(4−トリフルオロメチルフェニル)エチル}オキシムの製造(Example 4)
Preparation of 1- (4-Acetoxy-2,5,6-trimethylpyridin-3-yl) carbaldehyde O- {2- (4-trifluoromethylphenyl) ethyl} oxime
(工程1)
4−ヒドロキシ−2,5,6−トリメチルニコチン酸エチルの合成(Step 1)
Synthesis of ethyl 4-hydroxy-2,5,6-trimethylnicotinate
3−アミノクロトン酸エチル45g、および2−メチルアセト酢酸エチル50gをキシレン100mlに溶解させた。この溶液を一晩、加熱還流した。その後、室温まで冷却した。析出した結晶をろ過し、ジエチルエーテルで洗浄し、最後に乾燥させて、目的化合物24.2gを得た。収率は33%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.21(3H, t), 2.14(3H, s), 2.46(3H, s), 2.71(3H, s), 4.45(2H, q), 12.14(3H, s)45 g of ethyl 3-aminocrotonate and 50 g of ethyl 2-methylacetoacetate were dissolved in 100 ml of xylene. The solution was heated to reflux overnight. Then, it cooled to room temperature. The precipitated crystals were filtered, washed with diethyl ether and finally dried to obtain 24.2 g of the objective compound. The yield was 33%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.21 (3H, t), 2.14 (3H, s), 2.46 (3H, s), 2.71 (3H, s), 4.45 (2H, q), 12.14 (3H, s) )
(工程2)
4−メトキシ−2,5,6−トリメチルニコチン酸エチルの合成(Step 2)
Synthesis of ethyl 4-methoxy-2,5,6-trimethylnicotinate
4−ヒドロキシ−2,5,6−トリメチルニコチン酸エチル12.2gをアセトン120mlに溶解させた。この溶液に、炭酸セシウム21.0g、次いでヨウ化メチル10.0gを加え、8時間加熱還流した。その後、反応液を室温まで冷却し、水に注ぎ、酢酸エチルで抽出した。有機層を飽和食塩水で洗浄し、最後に無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、目的化合物10.0gを得た。収率は77%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.40(3H, t), 2.17(3H, s), 2.48(6H, s), 3.86(3H, s)4.41(2H, q)12.2 g of ethyl 4-hydroxy-2,5,6-trimethylnicotinate were dissolved in 120 ml of acetone. 21.0 g of cesium carbonate and then 10.0 g of methyl iodide were added to this solution, and the mixture was heated to reflux for 8 hours. After that, the reaction solution was cooled to room temperature, poured into water and extracted with ethyl acetate. The organic layer was washed with brine and finally dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 10.0 g of the objective compound. The yield was 77%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.40 (3H, t), 2.17 (3H, s), 2.48 (6H, s), 3.86 (3H, s) 4.41 (2H, q)
(工程3)
(4−メトキシ−2,5,6−トリメチルピリジン−3−イル)−メタノールの合成(Step 3)
Synthesis of (4-methoxy-2,5,6-trimethylpyridin-3-yl) -methanol
水素化アルミニウムリチウム2.8gをテトラヒドロフラン300mlに加えた。この液に、氷冷下、4−メトキシ−2,5,6−トリメチルニコチン酸エチル10.0gを滴下した。滴下終了後、室温で2時間攪拌した。その後、反応液を氷冷し、未反応の水素化アルミニウムリチウムが分解するまで水を加え、最後に無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、目的化合物7.9gを得た。収率は97%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.18(3H, s), 2.48(3H, s), 2.56(3H, s), 3.81(3H, s), 4.72(2H, s)2.8 g of lithium aluminum hydride was added to 300 ml of tetrahydrofuran. Under ice cooling, 10.0 g of ethyl 4-methoxy-2,5,6-trimethylnicotinate was added dropwise to this solution. After the addition was completed, the mixture was stirred at room temperature for 2 hours. Thereafter, the reaction solution was ice-cooled, water was added until unreacted lithium aluminum hydride was decomposed, and finally dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 7.9 g of the objective compound. The yield was 97%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.18 (3H, s), 2.48 (3H, s), 2.56 (3H, s), 3.81 (3H, s), 4.72 (2H, s)
(工程4)
4−メトキシ−2,5,6−トリメチルピリジン−3−カルバルデヒドの合成(Step 4)
Synthesis of 4-methoxy-2,5,6-trimethylpyridine-3-carbaldehyde
(4−メトキシ−2,5,6−トリメチルピリジン−3−イル)−メタノール7.9gをベンゼン90mlに溶解させた。この溶液に二酸化マンガン15.2gを加え、一晩加熱還流した。その後、反応液を室温まで冷却し、セライトろ過した。このろ液を減圧濃縮し、目的化合物5.98gを得た。収率は77%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.22(3H, s), 2.53(3H, s), 2.73(3H, s), 3.87(3H, s), 10.50(1H, s)7.9 g of (4-methoxy-2,5,6-trimethylpyridin-3-yl) -methanol were dissolved in 90 ml of benzene. To this solution was added 15.2 g of manganese dioxide, and the mixture was heated to reflux overnight. Thereafter, the reaction solution was cooled to room temperature and filtered through celite. The filtrate was concentrated under reduced pressure to obtain 5.98 g of the objective compound. The yield was 77%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.22 (3 H, s), 2.53 (3 H, s), 2. 73 (3 H, s), 3. 87 (3 H, s), 10. 50 (1 H, s)
(工程5)
4−ヒドロキシ−2,5,6−トリメチルピリジン−3−カルバルデヒドの合成(Step 5)
Synthesis of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde
4−メトキシ−2,5,6−トリメチルピリジン−3−カルバルデヒド3.0gをジクロロメタン50mlに溶解させた。この溶液に、氷冷下、1N三臭化ホウ素・ジクロロメタン溶液33mlを滴下した。滴下終了後、室温で一晩撹拌した。その後、反応液を氷冷し、10%炭酸水素ナトリウム水溶液を加えて中和した。析出した結晶をろ過し、最後に乾燥させて、目的化合物0.9gを得た。収率は33%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.18(3H, s), 2.43(3H, s), 2.53(3H, s), 10.46(1H, s)3.0 g of 4-methoxy-2,5,6-trimethylpyridine-3-carbaldehyde was dissolved in 50 ml of dichloromethane. To this solution was added dropwise 33 ml of 1N boron tribromide-dichloromethane solution under ice-cooling. After the addition was completed, the mixture was stirred overnight at room temperature. Thereafter, the reaction solution was ice-cooled and neutralized by adding a 10% aqueous sodium hydrogen carbonate solution. The precipitated crystals were filtered and finally dried to obtain 0.9 g of the objective compound. The yield was 33%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.18 (3 H, s), 2.43 (3 H, s), 2.53 (3 H, s), 10. 46 (1 H, s)
(工程6)
4−ヒドロキシ−2,5,6−トリメチルピリジン−3−カルバルデヒド O−{2−(4−トリフルオロメチルフェニル)エチル}オキシムの合成(Step 6)
Synthesis of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde O- {2- (4-trifluoromethylphenyl) ethyl} oxime
O−{2−(4−トリフルオロメチルフェニル)エチル}ヒドロキシルアミン0.32gを1,2−ジクロロエタン10mlに溶解させた。この溶液に4−ヒドロキシ−2,5,6−トリメチルピリジン−3−カルバルデヒド0.26gとトリフルオロ酢酸数滴を加え、室温で一晩撹拌した。その後、反応液を飽和重曹水に注ぎ、クロロホルムで抽出した。次いで有機層を無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をジエチルエーテルで洗浄して、目的化合物0.42gを得た。収率は76%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.15(3H, s), 2.45(3H, s), 2.51(3H, s), 3.11(2H, d), 4.42(2H, d), 7.36(2H, d), 7.57(2H, d), 8.47(1H, s)0.32 g of O- {2- (4-trifluoromethylphenyl) ethyl} hydroxylamine was dissolved in 10 ml of 1,2-dichloroethane. To this solution was added 0.26 g of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde and a few drops of trifluoroacetic acid, and the mixture was stirred overnight at room temperature. Thereafter, the reaction solution was poured into saturated aqueous sodium bicarbonate and extracted with chloroform. The organic layer was then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to obtain 0.42 g of the objective compound. The yield was 76%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.15 (3H, s), 2.45 (3H, s), 2.51 (3H, s), 3.11 (2H, d), 4.42 (2H, d), 7.36 (2H, d) ), 7.57 (2H, d), 8.47 (1 H, s)
(工程7)
1−(4−アセトキシ−2,5,6−トリメチルピリジン−3−イル)カルバルデヒド O−{2−(4−トリフルオロメチルフェニル)エチル}オキシムの合成(Step 7)
Synthesis of 1- (4-acetoxy-2,5,6-trimethylpyridin-3-yl) carbaldehyde O- {2- (4-trifluoromethylphenyl) ethyl} oxime
4−ヒドロキシ−2,5,6−トリメチルピリジン−3−カルバルデヒド O−{2−(4−トリフルオロメチルフェニル)エチル}オキシム0.42gをジクロロメタン20mlに溶解させた。この溶液にトリエチルアミン0.22gを加えた。次いで、氷冷下、塩化アセチル0.14gを加えて、室温で一晩撹拌した。その後、反応液を飽和重曹水に注ぎ、クロロホルムで抽出した。次いで有機層を無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n−ヘキサン/酢酸エチル)にて精製し、目的化合物0.37gを得た。収率は79%であった。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 2.09(3H, s), 2.33(3H, s), 2.54(3H, s), 2.61(3H, s), 3.09(2H, d), 4.39(2H, d), 7.35(2H, d), 7.57(2H, d), 8.17(1H, s)0.42 g of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde O- {2- (4-trifluoromethylphenyl) ethyl} oxime was dissolved in 20 ml of dichloromethane. 0.22 g of triethylamine was added to this solution. Then, under ice cooling, 0.14 g of acetyl chloride was added, and the mixture was stirred overnight at room temperature. Thereafter, the reaction solution was poured into saturated aqueous sodium bicarbonate and extracted with chloroform. The organic layer was then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.37 g of the objective compound. The yield was 79%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 2.09 (3H, s), 2.33 (3H, s), 2.54 (3H, s), 2.61 (3H, s), 3.09 (2H, d), 4.39 (2H, d) ), 7.35 (2H, d), 7.57 (2H, d), 8.17 (1 H, s)
(実施例5)
メチル[2,3,6−トリメチル−5−[[4−(4−トリフルオロメトキシ)フェニル]シクロヘキソキシ]−4−ピリジル]カーボネートの製造(Example 5)
Preparation of methyl [2,3,6-trimethyl-5-[[4- (4-trifluoromethoxy) phenyl] cyclohexoxy] -4-pyridyl] carbonate
(工程1)
4−ヒドロキシ−2−エチル−5,6−ジメチルニコチン酸メチルの合成(Step 1)
Synthesis of methyl 4-hydroxy-2-ethyl-5,6-dimethyl nicotinate
メチル−3−アミノペント−2−エノエート13.6g、及び2,2,5,6−テトラメチル−4H-1,3−ジオキシン−4−オン20.0gを混合し、150℃で、5時間攪拌した。室温まで冷却した後、析出した結晶をろ過、ジエチルエーテルで洗浄した後、乾燥させ、目的化合物13.7gを得た。収率31%
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.21(3H,t),2.14(3H,s),2.46(3H,s),2.71(2H,q),3.89(3H,s)Mix 13.6 g of methyl-3-aminopent-2-enoate and 20.0 g of 2,2,5,6-tetramethyl-4H-1,3-dioxin-4-one and stir at 150 ° C. for 5 hours did. After cooling to room temperature, the precipitated crystals were filtered, washed with diethyl ether and dried to obtain 13.7 g of the objective compound. 31% yield
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.21 (3H, t), 2.14 (3H, s), 2.46 (3H, s), 2.71 (2H, q), 3.89 (3H, s)
(工程2)
4−アリルオキシ−2−エチル−5,6−ジメチルニコチン酸メチルの合成(Step 2)
Synthesis of methyl 4-allyloxy-2-ethyl-5,6-dimethyl nicotinate
4−ヒドロキシ−2−エチル−5,6−ジメチルニコチン酸メチル13.7gをアセトニトリル150mlに溶解させた。この反応液に、炭酸カリウム18.2g、次いで臭化アリル15.8gを加え、8時間加熱還流した。反応液を室温まで冷却し、水に注加、酢酸エチルで抽出した。有機層を飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、目的化合物16.6gを得た。収率100%。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.25(3H,t),2.16(3H,s),2.48(3H,s),2.69(2H,q),3.88(3H,s),4.39(2H,d),5.23-5.39(2H,m),5.93-6.05(1H,m)13.7 g of methyl 4-hydroxy-2-ethyl-5,6-dimethyl nicotinate were dissolved in 150 ml of acetonitrile. To this reaction solution, 18.2 g of potassium carbonate and then 15.8 g of allyl bromide were added, and the mixture was heated to reflux for 8 hours. The reaction solution was cooled to room temperature, poured into water and extracted with ethyl acetate. The organic layer was washed with saturated brine and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 16.6 g of the objective compound. 100% yield.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.25 (3H, t), 2.16 (3H, s), 2.48 (3H, s), 2.69 (2H, q), 3.88 (3H, s), 4.39 (2H, d) ), 5.23-5. 39 (2H, m), 5.93-6. 05 (1 H, m)
(工程3)
(4−アリルオキシ−2−エチル−5,6−ジメチルピリジン−3−イル)−メタノールの合成(Step 3)
Synthesis of (4-allyloxy-2-ethyl-5,6-dimethylpyridin-3-yl) -methanol
水素化リチウムアルミニウム2.8gをテトラヒドロフラン300mlに加えた。この反応液に、氷冷下、4−アリルオキシ−2−エチル−5,6−ジメチルニコチン酸メチル16.6gを滴下し、滴下終了後、室温で2時間攪拌した。その後、反応液を氷冷し、未反応の水素化リチウムナトリウムが分解するまで水を加え、無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、目的化合物11.3gを得た。収率77%。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.26(3H,t),2.16(3H,s),2.46(3H,s),2.84(2H,q),4.39(2H,d),4.70(2H,d),5.29-5.45(2H,m),6.03-6.14(1H,m)2.8 g of lithium aluminum hydride was added to 300 ml of tetrahydrofuran. To this reaction solution was added dropwise 16.6 g of methyl 4-allyloxy-2-ethyl-5,6-dimethyl nicotinate under ice cooling, and after completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours. Thereafter, the reaction solution was ice-cooled, water was added until unreacted lithium sodium hydride was decomposed, and the solution was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain 11.3 g of the objective compound. 77% yield.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.26 (3 H, t), 2.16 (3 H, s), 2. 46 (3 H, s), 2. 84 (2 H, q), 4. 39 (2 H, d), 4. 70 (2 H, d) ), 5.29-5.45 (2H, m), 6.03-6. 14 (1 H, m)
(工程4)
4−アリルオキシ−2−エチル−5,6−ジメチルピリジン−3−カルバルデヒドの合成(Step 4)
Synthesis of 4-allyloxy-2-ethyl-5,6-dimethylpyridine-3-carbaldehyde
(4−アリルオキシ−2−エチル−5,6−ジメチルピリジン−3−イル)−メタノール11.3gをジクロロメタン120mlに溶解させ、氷冷下、飽和重曹水120ml、臭化カリウム0.6g及び、4−オキソ−TEMPO 0.4gを加えた。この反応液に、氷冷下、5%次亜塩素酸ナトリウム溶液91gを30分以上かけて滴下した。滴下終了後、0℃で30分間攪拌し、反応液を氷水に注加した。ジクロロメタンで抽出、チオ硫酸ナトリウム水溶液、飽和食塩水で洗浄し、有機層を無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)にて精製し、目的化合物11.1gを得た。収率99%。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.25(3H,t),2.21(3H,s),2.52(3H,s),3.06(2H,q),4.42(2H,d),5.32-5.43(2H,m),6.01-6.11(1H,m),10.47(1H,s)Dissolve 11.3 g of (4-allyloxy-2-ethyl-5,6-dimethylpyridin-3-yl) -methanol in 120 ml of dichloromethane, and under ice-cooling 120 ml of saturated aqueous sodium bicarbonate solution, 0.6 g of potassium bromide, 0.4 g of -oxo-TEMPO was added. To this reaction solution, 91 g of a 5% sodium hypochlorite solution was added dropwise over 30 minutes under ice-cooling. After completion of the dropwise addition, the mixture was stirred at 0 ° C. for 30 minutes, and the reaction solution was poured into ice water. The mixture was extracted with dichloromethane, washed with aqueous sodium thiosulfate solution and saturated brine, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 11.1 g of the objective compound. 99% yield.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.25 (3 H, t), 2.21 (3 H, s), 2.52 (3 H, s), 3.06 (2 H, q), 4.42 (2 H, d), 5.32-5. 43 (2 H) , m), 6.01-6.11 (1 H, m), 10. 47 (1 H, s)
(工程5)
1−(4−アリルオキシ−2−エチル−5,6−ジメチル−3−ピリジル)−N−[2−[[3−クロロ−5−(トリフルオロメチル)−2−ピリジル]オキシ]−1−メチル−プロポキシ]メタニミンの合成(Step 5)
1- (4-Allyloxy-2-ethyl-5,6-dimethyl-3-pyridyl) -N- [2-[[3-chloro-5- (trifluoromethyl) -2-pyridyl] oxy] -1- Synthesis of methyl-propoxy] methanimine
4−アリルオキシ−2−エチル−5,6−ジメチルピリジン−3−カルバルデヒド0.5gをジクロロメタン10mlに溶解させた。この反応液に、氷冷下、O−[2−[[3−クロロ−5−(トリフルオロメチル)−2−ピリジル]オキシ]−1−メチル−プロピル]ヒドロキシルアミン0.8g、トリフルオロ酢酸 数滴を加え、室温で一晩攪拌した。反応液を飽和重曹水に注ぎ、クロロホルムで抽出した後、有機層を無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣を得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)にて精製し、目的化合物0.75gを得た。収率68%。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.19-1.43(9H,m),2.21(3H,s),2.52(3H,s),3.06(2H,q),4.33-4.42(3H,m),5.32-5.43(2H,m),5.57-5.61(1H,m),6.01-6.11(1H,m),7.79-8.25(3H,m)0.5 g of 4-allyloxy-2-ethyl-5,6-dimethylpyridine-3-carbaldehyde was dissolved in 10 ml of dichloromethane. Into this reaction solution, under ice-cooling, O- [2-[[3-chloro-5- (trifluoromethyl) -2-pyridyl] oxy] -1-methyl-propyl] hydroxylamine 0.8 g, trifluoroacetic acid Add a few drops and stir overnight at room temperature. The reaction solution was poured into saturated aqueous sodium bicarbonate solution and extracted with chloroform, and then the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.75 g of the target compound. Yield 68%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.19-1.43 (9 H, m), 2.21 (3 H, s), 2.52 (3 H, s), 3.06 (2 H, q), 4.33-4. 42 (3 H, m), 5.32 -5.43 (2H, m), 5.57-5.61 (1 H, m), 6.01-6.11 (1 H, m), 7.79-8.25 (3 H, m)
(工程6)
3−[2−[[3−クロロ−5−(トリフルオロメチル)−2−ピリジルオキシ]−1−メチル−プロポキシ]イミノメチル]−2−エチル−5,6−ジメチル−ピリジン−4−オールの合成(Step 6)
3- [2-[[3-chloro-5- (trifluoromethyl) -2-pyridyloxy] -1-methyl-propoxy] iminomethyl] -2-ethyl-5,6-dimethyl-pyridin-4-ol Synthesis
1−(4−アリルオキシ−2−エチル−5,6−ジメチル−3−ピリジル)−N−[2−[[3−クロロ−5−(トリフルオロメチル)−2−ピリジル]オキシ]−1−メチル−プロポキシ]メタニミン0.5gをメタノール10mlに溶解させた。この溶液にテトラキストリフェニルホスフィンパラジウム0.012g、炭酸カリウム0.28gを加え、室温で2時間攪拌した。反応液を氷水に注ぎ、クロロホルムで抽出、飽和食塩水で洗浄し、有機層を無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をジエチルエーテルで洗浄して、目的化合物0.4gを得た。収率87%。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.17-1.41(9H,m),1.99(3H,s),2.22(3H,s),2.85(2H,q),4.33-4.42(1H,m),5.57-5.61(1H,m),7.78-8.22(3H,m)1- (4-Allyloxy-2-ethyl-5,6-dimethyl-3-pyridyl) -N- [2-[[3-chloro-5- (trifluoromethyl) -2-pyridyl] oxy] -1- 0.5 g of methyl-propoxy] methanimine was dissolved in 10 ml of methanol. 0.012 g of tetrakistriphenylphosphine palladium and 0.28 g of potassium carbonate were added to this solution, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into ice water, extracted with chloroform, washed with saturated brine, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to obtain 0.4 g of the objective compound. Yield 87%.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.17-1.41 (9 H, m), 1.99 (3 H, s), 2.22 (3 H, s), 2. 85 (2 H, q), 4.33-4. 42 (1 H, m), 5.57 -5.61 (1 H, m), 7.78-8.22 (3 H, m)
(工程7)
[3−[2−[[3−クロロ−5−(トリフルオロメチル)−2−ピリジル]オキシ−1−メチル−プロポキシ]イミノメチル]−2−エチル−5,6−ジメチル−4−ピリジル]アセテートの合成(Step 7)
[3- [2-[[3-Chloro-5- (trifluoromethyl) -2-pyridyl] oxy-1-methyl-propoxy] iminomethyl] -2-ethyl-5,6-dimethyl-4-pyridyl] acetate Synthesis of
3−[2−[[3−クロロ−5−(トリフルオロメチル)−2−ピリジルオキシ]−1−メチル−プロポキシ]イミノメチル]−2−エチル−5,6−ジメチル−ピリジン−4−オール0.4gをクロロホルム10mlに溶解した。この溶液にトリエチルアミン0.2gを加えた後、氷冷下、塩化アセチル0.16gを加えて、室温で一晩撹拌した。反応液を飽和重曹水に注ぎ、クロロホルムで抽出した後、有機層を無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(展開溶媒:n-ヘキサン/酢酸エチル)にて精製し、目的化合物0.37gを得た。収率84%。
目的化合物の物性は以下のとおりであった。
1H-NMR (CDCl3, δppm) 1.19-1.43(9H,m),2.06(3H,s),2.30(3H,s),2.51(3H,s),2.86(2H,q),4.43-4.45(1H,m),5.59-5.62(1H,m),7.82-8.26(3H,m)3- [2-[[3-chloro-5- (trifluoromethyl) -2-pyridyloxy] -1-methyl-propoxy] iminomethyl] -2-ethyl-5,6-dimethyl-pyridin-4-ol 0 .4 g was dissolved in 10 ml chloroform. After 0.2 g of triethylamine was added to this solution, 0.16 g of acetyl chloride was added under ice cooling, and the mixture was stirred overnight at room temperature. The reaction solution was poured into saturated aqueous sodium bicarbonate solution and extracted with chloroform, and then the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.37 g of the objective compound. 84% yield.
Physical properties of the objective compound were as follows.
1 H-NMR (CDCl 3 , δ ppm) 1.19-1.43 (9 H, m), 2.06 (3 H, s), 2.30 (3 H, s), 2.51 (3 H, s), 2.86 (2 H, q), 4.43-4. 45 (1 H, m), 5.59-5. 62 (1 H, m), 7.82-8. 26 (3 H, m)
上記の実施例と同様の方法で製造した化合物を第1表〜第10表に示す。
併せて、化合物の物性データを「物性」の欄に記載した。物性データとしては、融点(℃)屈折率(nD)またはその性状を記載した。
「立体配置」の欄に示す、「E」は化合物中のイミンの二重結合がE配置であることを示し、「Z」はZ配置であることを示し、「EZ」は化合物が両配置の化合物の混合物であることを示す。
表中の、Phはフェニル基を、Meはメチル基を、Etはエチル基を、nPrはn−プロピル基を、iPrはイソプロピル基を、cPrはシクロプロピル基を、nBuはn−ブチル基を、tBu基はt−ブチル基を、Pyはピリジル基を、Acはアセチル基を、Bnはベンジル基をPMBはパラメトキシベンジル基をそれぞれ示す。The compounds produced in the same manner as the above examples are shown in Tables 1 to 10.
In addition, physical property data of the compound are described in the "physical properties" column. As physical property data, melting point (° C.) refractive index (n D ) or its property was described.
As shown in the "configuration" column, "E" indicates that the imine double bond in the compound is in the E configuration, "Z" indicates that it is in the Z configuration, and "EZ" indicates that the compound is in both configurations It is shown that it is a mixture of the compounds of
In the table, Ph is phenyl, Me is methyl, Et is ethyl, n Pr is n-propyl, i Pr is isopropyl, c Pr is cyclopropyl, n Bu is n The t Bu group is a t-butyl group, the Py is a pyridyl group, the Ac is an acetyl group, the Bn is a benzyl group, and the PMB is a paramethoxybenzyl group.
第1表は、式(I)で表される化合物のうちで、Qが式(I)で表される有機基である化合物(以下に示す式(I-1)で表される化合物)を開示する。 Table 1 shows, among the compounds represented by the formula (I), compounds in which Q is an organic group represented by the formula (I) (compounds represented by the formula (I-1) shown below) Disclose.
第2表〜第6表は、式(I)で表される化合物のうちで、Qが式(II)で表される有機基である化合物(以下に示す式(I-2)で表される化合物)を開示する。ここで第2表〜第6表に記載する化合物は、R1、R2およびR3がメチル基である化合物である。
「Ba」における構造式中の*の付された炭素原子は、オキシムの酸素と結合する炭素原子を示す(以後の表においても同様の意味を示す)。さらに、「Ba」における構造式中の**付された炭素原子または窒素原子は、「Ar2」と結合する炭素原子または窒素原子を示す(以後の表においても同様の意味を示す)。
尚、第3表中の化合物c-187は、N−オキサイドである。Tables 2 to 6 show, among the compounds represented by the formula (I), compounds represented by the formula (I-2 shown below) in which Q is an organic group represented by the formula (II) Compounds) are disclosed. Here, the compounds described in Tables 2 to 6 are compounds in which R 1 , R 2 and R 3 are methyl groups.
The carbon atom to which * is attached in the structural formula of “B a ” indicates a carbon atom to be bonded to the oxygen of oxime (the same meaning is indicated in the following tables). Furthermore, the carbon atom or nitrogen atom with ** in the structural formula of “B a ” indicates a carbon atom or nitrogen atom to be bonded to “Ar 2 ” (the same meaning is shown in the following tables).
Compound c-187 in Table 3 is an N-oxide.
第7表〜第8表は、式(I-3)で表される化合物中の置換基を示す。 Tables 7 to 8 show substituents in the compound represented by formula (I-3).
第9表は、式(I-4)で表される化合物中の置換基を示す。 Table 9 shows the substituents in the compound represented by formula (I-4).
上記の第1表〜第10表に記載した化合物のいくつかについて、1H−NMRデータを第11表に示す。
1 H-NMR data are given in Table 11 for some of the compounds listed in Tables 1 to 10 above.
〔生物試験〕
本発明化合物が、農園芸用殺菌剤の有効成分として有用であることを以下の試験例で示す。[Biological test]
The following test examples show that the compound of the present invention is useful as an active ingredient of agricultural and horticultural fungicides.
(試験例1)コムギうどんこ病防除試験−1
ポリオキシエチレンソルビタンモノラウレート1.5%を含有するジメチルホルムアミド溶液95質量部に本発明化合物5質量部を溶解させて有効成分5%の乳剤を調製した。
前記の乳剤をポリオキシエチレンソルビタンモノラウレート0.02%を含有する水溶液で希釈して、化合物濃度100ppmの薬液を得た。続いて、該薬液を、素焼きポットで栽培したコムギ幼苗(品種「チホク」、1.0〜1.2葉期)に散布した。葉を風乾させた。その後、コムギうどんこ病菌(Erysiphe graminis f.sp.tritici)の分生胞子を振り払い接種し、22〜25℃の温室で7日間保持した(処理)。一方、薬液を散布せず、コムギ幼苗にコムギうどんこ病の分生胞子を振り払い接種し、22〜25℃の温室で7日間保持した(無処理)。葉上の病斑出現状態を無処理区と比較調査し。防除価を算出した。
防除価(%)=100−{病斑が出現した面積(処理)/病斑が出現した面積(無処理)}×100Test Example 1 Wheat powdery mildew control test 1
5 parts by mass of the compound of the present invention was dissolved in 95 parts by mass of a dimethylformamide solution containing 1.5% of polyoxyethylene sorbitan monolaurate to prepare an emulsion of 5% of the active ingredient.
The above emulsion was diluted with an aqueous solution containing 0.02% polyoxyethylene sorbitan monolaurate to obtain a chemical solution having a compound concentration of 100 ppm. Then, the said chemical | medical solution was sprayed to the wheat seedling (cultivar "Chihoku", 1.0-1.2 leaf stage) grown by the unglazed pot. The leaves were allowed to air dry. Thereafter, conidia of wheat powdery mildew (Erysiphe graminis f. Sp. Tritici) were shaken off and inoculated, and kept in a greenhouse at 22-25 ° C. for 7 days (treatment). On the other hand, wheat seedling was shaken off and inoculated with conidia of wheat powdery mildew without spraying with a chemical solution, and was maintained in a greenhouse at 22-25 ° C. for 7 days (untreated). The appearance of lesions on the leaves was compared with the untreated area. The control value was calculated.
Control value (%) = 100− {area on which a lesion appeared (treatment) / area on which a lesion appeared (no treatment)} × 100
第12表に示す化合物についてコムギうどんこ病防除試験を行った。いずれの化合物も防除価が75%以上であった。 The wheat powdery mildew control test was conducted on the compounds shown in Table 12. All compounds had a control value of 75% or more.
(試験例2)コムギ赤さび病防除試験−1
試験例1と同じ方法で乳剤を調製した。該乳剤をポリオキシエチレンソルビタンモノラウレート0.02%を含有する水溶液で希釈して、化合物濃度100ppmの薬液を得た。該薬液を、素焼きポットで栽培したコムギ幼苗(品種「農林61号」、1.0〜1.2葉期)に散布した。葉を風乾させた。その後、コムギ赤さび病菌(Puccinia recondita)の夏胞子を振り払い接種し、22〜25℃の温室で10日間保持した。試験例1と同様に葉上の病斑出現状態を無処理と比較調査し、防除価を算出した。Test Example 2 Wheat leaf rust control test 1
An emulsion was prepared in the same manner as in Test Example 1. The emulsion was diluted with an aqueous solution containing 0.02% polyoxyethylene sorbitan monolaurate to obtain a chemical solution having a compound concentration of 100 ppm. The said chemical | medical solution was sprayed on the wheat seedling (variety "Agriculture No. 61", 1.0-1.2 leaf stage) grown by the unglazed pot. The leaves were allowed to air dry. Thereafter, N. spores of wheat rust fungus (Puccinia recondita) were shaken off and inoculated, and kept in a greenhouse at 22 to 25 ° C. for 10 days. In the same manner as in Test Example 1, the appearance of lesions on the leaves was compared with that in the non-treated case, and the control value was calculated.
第13表に示す化合物についてコムギ赤さび病防除試験を行った。いずれの化合物も防除価が75%以上であった。 A wheat leaf rust control test was conducted on the compounds shown in Table 13. All compounds had a control value of 75% or more.
(試験例3)コムギうどんこ病防除試験−2
本発明化合物5.62質量部、界面活性剤4.49質量部、ジメチルホルムアミド89.89質量部を混合溶解して、有効成分5.62%の乳剤を得た。
前記の乳剤を有効成分125ppmになるように水で希釈し薬液を得た。素焼きポットで栽培したコムギ幼苗(品種「チホク」、1.0〜1.2葉期)に前記薬液を散布した。葉を風乾させた後、コムギうどんこ病菌(Erysiphe graminis f.sp.tritici)の分生胞子を振り払い接種し、20〜25℃の温室で7日間保持した。試験例1と同様に葉上の病斑出現状態を無処理と比較調査し、防除価を算出した。Test Example 3 Wheat powdery mildew control test 2
5.62 parts by mass of the compound of the present invention, 4.49 parts by mass of a surfactant and 89.89 parts by mass of dimethylformamide were mixed and dissolved to obtain an emulsion having an active ingredient of 5.62%.
The above emulsion was diluted with water to an active ingredient of 125 ppm to obtain a drug solution. The said chemical | medical solution was sprayed to the wheat seedling (variety "chihoku", 1.0-1.2 leaf stage) grown by the unglazed pot. After leaves were air-dried, conidia of wheat powdery mildew (Erysiphe graminis f. Sp. Tritici) were shaken off and inoculated, and kept in a greenhouse at 20 to 25 ° C for 7 days. In the same manner as in Test Example 1, the appearance of lesions on the leaves was compared with that in the non-treated case, and the control value was calculated.
第14表に示す化合物について病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 Disease control tests were conducted for the compounds shown in Table 14. All compounds showed a control value of 75% or more.
(試験例4)コムギ赤さび病防除試験−2
試験例3と同じ方法で乳剤を調製した。該乳剤を有効成分125ppmになるように水で希釈し薬液を得た。素焼きポットで栽培したコムギ幼苗(品種「農林61号」、1.0〜1.2葉期)に前記薬液を散布した。葉を風乾させた後、コムギ赤さび病菌(Puccinia recondita)の夏胞子を振り払い接種し、20〜25℃の温室で10日間保持した。試験例1と同様に葉上の病斑出現状態を無処理と比較調査し、防除価を算出した。(Test Example 4) Wheat leaf rust control test-2
An emulsion was prepared in the same manner as in Test Example 3. The emulsion was diluted with water to an active ingredient of 125 ppm to obtain a chemical solution. The said chemical | medical solution was sprayed to the wheat seedling (variety "Agriculture No. 61", 1.0-1.2 leaf stage) grown by the unglazed pot. After air-drying the leaves, N. spores of wheat rust fungus (Puccinia recondita) were shaken off and inoculated, and kept in a greenhouse at 20-25 ° C for 10 days. In the same manner as in Test Example 1, the appearance of lesions on the leaves was compared with that in the non-treated case, and the control value was calculated.
第15表に示す前記コムギ赤さび病防除試験を行った。いずれの化合物も75%以上の防除価を示した。 The wheat leaf rust control test shown in Table 15 was conducted. All compounds showed a control value of 75% or more.
次に、本発明化合物が殺虫剤または殺ダニ剤の有効成分として有用であることを以下の試験例で示す。 The following test examples show that the compounds of the present invention are useful as an active ingredient of insecticides or acaricides.
(試験例5)ハスモンヨトウに対する効力確認試験
本発明化合物5質量部、ジメチルホルムアミド93.6質量部、およびポリオキシエチレンアルキルアリールエーテル1.4質量部を混合溶解して、有効成分5%の乳剤を調製した。
前記乳剤を水で希釈して化合物濃度125ppmの薬剤を得た。その薬液にキャベツ葉を30秒間浸漬し、次いで風乾した。その後、ろ紙を敷いたシャーレにキャベツ葉を入れ、ハスモンヨトウ2齢幼虫5頭を接種した。ガラス蓋をして、温度25℃、湿度65%の恒温恒湿室内に置き、5日後にハスモンヨトウの生死を調べ、殺虫率を算出した。試験は2反復で行った。Test Example 5 Test for Confirming Efficacy against Hastomone spp. 5 parts by mass of the compound of the present invention, 93.6 parts by mass of dimethylformamide, and 1.4 parts by mass of polyoxyethylene alkyl aryl ether are mixed and dissolved to obtain an emulsion of active ingredient 5% Prepared.
The emulsion was diluted with water to obtain a drug having a compound concentration of 125 ppm. The cabbage leaves were dipped in the solution for 30 seconds and then air-dried. Thereafter, cabbage leaves were placed in a petri dish covered with filter paper, and five second-instar larvae of the lotus root were inoculated. The glass lid was placed and placed in a constant temperature and humidity chamber with a temperature of 25 ° C. and a humidity of 65%, and after 5 days, the life and death of the cassava was examined to calculate the insecticidal rate. The test was performed in duplicate.
第16表に示す化合物についてハスモンヨトウに対する効力確認試験を行った。いずれの化合物も殺虫率が100%であった。 The compounds shown in Table 16 were subjected to the efficacy confirmation test against the Japanese mustard spider. All compounds had an insecticidal rate of 100%.
(試験例6)ワタアブラムシに対する効力確認試験
試験例5と同じ方法で調製した乳剤を水で希釈して化合物濃度125ppmの薬液を得た。
3寸鉢に播種した発芽10日の経過したキュウリの第一本葉上に、ワタアブラムシ成虫を接種した。1日後に成虫を除去し、産下された若虫が寄生するキュウリに、前記薬液を散布した。温度25℃、湿度65%の恒温恒湿室内に置き、5日後にワタアブラムシの生死を調べ、殺虫率を算出した。試験は2反復で行った。Test Example 6 Efficacy Confirmation Test for Cotton Aphid An emulsion prepared by the same method as that of Test Example 5 was diluted with water to obtain a chemical solution having a compound concentration of 125 ppm.
Adult cotton aphids were inoculated on the first true leaves of 10-day-old sprouted cucumber which were sown in a 3-inch bowl. One day later, the adults were removed, and the solution was sprayed onto cucumbers which are parasitic to the born juveniles. It was placed in a constant temperature and humidity chamber with a temperature of 25 ° C. and a humidity of 65%, and after 5 days, life and death of cotton aphids were examined to calculate the insecticidal rate. The test was performed in duplicate.
第17表に示す化合物についてワタアブラムシに対する効力確認試験を行った。いずれの化合物も殺虫率が100%であった。 The compounds shown in Table 17 were tested for efficacy against cotton aphid. All compounds had an insecticidal rate of 100%.
(試験例7)ナミハダニに対する効力確認試験
試験例5と同じ方法で調製した乳剤を水で希釈して化合物濃度125ppmの薬液を得た。3寸鉢に播種した発芽10日が経過したインゲンの第一本葉上に、ナミハダニ雌成虫10頭接種した。1日後に前記薬液を散布した。温度25℃、湿度65%の恒温恒湿室内に置き、3日後にナミハダニの生死を調べ、殺虫率を算出した。試験は2反復で行った。Test Example 7 Test for Confirming Efficacy against Nami spider mite The emulsion prepared by the same method as in Test Example 5 was diluted with water to obtain a chemical solution having a compound concentration of 125 ppm. Ten adult female spider spider mites were inoculated on the first true leaves of green beans which had been germinated 10 days after sowing in three-inch pots. One day later, the drug solution was sprayed. It was placed in a constant temperature and humidity chamber with a temperature of 25 ° C. and a humidity of 65%, and after 3 days, the mortality of the spider spider mite was examined to calculate the insecticidal rate. The test was performed in duplicate.
第18表に示す化合物についてナミハダニに対する効力確認試験を行った。いずれの化合物も殺虫率が100%であった。 The compounds shown in Table 18 were subjected to efficacy confirmation tests against two-spotted spider mite. All compounds had an insecticidal rate of 100%.
(試験例8)マメアブラムシに対する効力確認試験
試験例5と同じ方法で調製した乳剤を水で希釈して化合物濃度125ppmの薬液を得た。3寸鉢でササゲを育苗し、初生葉上にマメアブラムシ若虫を接種した。マメアブラムシ若虫が寄生するササゲに前記薬液を散布した。該ササゲを温度25℃、湿度60%の恒温室内に置き、4日後にマメアブラムシの生死を調べた。試験は2反復で行った。Test Example 8 Test for Confirming Efficacy against Bean Aphid The emulsion prepared by the same method as in Test Example 5 was diluted with water to obtain a chemical solution having a compound concentration of 125 ppm. The cowpea was raised in a 3-inch bowl and inoculated with bean aphid nymphs on primary leaves. The above drug solution was sprayed on cowpea which is infested with the black-and-white bream beetle nymphs. The cowpea was placed in a constant temperature room at a temperature of 25 ° C. and a humidity of 60%, and after 4 days, the aphids were checked for life and death. The test was performed in duplicate.
第19表に示す化合物についてマメアブラムシに対する効力確認試験を行った。いずれの化合物も殺虫率が80%以上であった。 The compounds shown in Table 19 were tested for efficacy against bean aphid. All compounds had an insecticidal rate of 80% or more.
(試験例9)カンザワハダニに対する効力確認試験
試験例5と同じ方法で調製した乳剤を水で希釈して化合物濃度125ppmの薬液を得た。3寸鉢でインゲンを育苗し、初生葉上に、カンザワハダニ雌成虫を10頭接種した。前記薬液をインゲン幼苗に散布した。該インゲンを、温度25℃、湿度65%の恒温室内に置き、散布から10日後に成虫の生死を調べた。Test Example 9 Efficacy Confirmation Test for Kanzawa spider mite The emulsion prepared by the same method as that of Test Example 5 was diluted with water to obtain a chemical solution having a compound concentration of 125 ppm. The green beans were raised in a 3-inch bowl, and 10 adult females of the red spider mite Kanzawa spider mite were inoculated on the primary leaves. The medicinal solution was sprayed on green bean seedlings. The green beans were placed in a temperature-controlled room at a temperature of 25 ° C. and a humidity of 65%, and 10 days after spraying, adults were examined for life and death.
第20表に示す化合物についてカンザワハダニに対する効力確認試験を行った。いずれの化合物も殺虫率が90%以上であった。 The compounds shown in Table 20 were subjected to efficacy confirmation tests against Kanzawa spider mite. Each compound had an insecticidal rate of 90% or more.
本発明に係るピリジン化合物は、有害生物防除、殺菌、殺ダニ、殺虫などの効果を有し、植物体に薬害を生じることがなく、人畜魚類に対する毒性や環境への影響が少ない新規化合物である。特に、ムギ病害に対して優れた防除効果を示す。本発明に係るピリジン化合物は、農園芸用殺菌剤、有害生物防除剤、および殺虫または殺ダニ剤の有効成分として有用である。したがって、本発明のピリジン化合物は、産業上有用である。 The pyridine compound according to the present invention is a novel compound having the effects of pest control, sterilization, acaricide, insecticidal and the like, causing no adverse effects on plants, and having little toxicity to human and fish and environmental impact. . In particular, it exhibits excellent control effects against wheat diseases. The pyridine compound according to the present invention is useful as an active ingredient of agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents. Therefore, the pyridine compound of the present invention is industrially useful.
Claims (4)
R1は、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基、無置換の若しくはG2で置換されたC6〜10アリール基、無置換の若しくはG2で置換された3〜6員ヘテロシクリル基、シアノ基またはハロゲノ基を示す。
R2およびR3は、それぞれ独立に、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、無置換の若しくはG1で置換されたC1〜6アルコキシ基、ホルミル基、ホルミルオキシ基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニルオキシ基、無置換の若しくはG2で置換されたC6〜10アリール基、(無置換の若しくはG1で置換されたC1〜6アルコキシイミノ)−C1〜6アルキル基、シアノ基、またはハロゲノ基を示す。
ここで、R1とR2は一緒になってR1およびR2のそれぞれが結合する炭素原子と共に5〜6員環を形成してもよい。
R4は、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC2〜6アルケニル基、無置換の若しくはG1で置換されたC2〜6アルキニル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、無置換の若しくはG2で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG2で置換された3〜6員ヘテロシクリル基、無置換の若しくはG2で置換された3〜6員ヘテロシクリル基C1〜6アルキル基、ホルミル基、無置換の若しくはG1で置換されたC1〜6アルキルカルボニル基、無置換の若しくはG1で置換されたC3〜8シクロアルキルカルボニル基、無置換の若しくはG1で置換されたC1〜6アルケニルカルボニル基、無置換の若しくはG2で置換されたC6〜10アリールカルボニル基、無置換の若しくはG1で置換されたC1〜6アルコキシカルボニル基、無置換の若しくはG1で置換されたC2〜6アルケニルオキシカルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルスルホニル基、無置換の若しくはG1で置換されたC1〜6アルキルアミノカルボニル基、無置換の若しくはG1で置換された(C1〜6アルキルチオ)カルボニル基、無置換の若しくはG1で置換されたC1〜6アルキルアミノ(チオカルボニル)基、または式(IV)で表される基を示す。
式(IV)中、Gbは、水素原子、無置換のもしくはG1で置換されたC1〜6アルキル基、無置換のもしくはG1で置換されたC2〜6アルケニル基、無置換のもしくはG1で置換されたC2〜6アルキニル基、無置換のもしくはG1で置換されたC3〜8シクロアルキル基、無置換のもしくはG2で置換されたC6〜10アリール基、または無置換のもしくはG2で置換された3〜6員ヘテロシクリル基を示す。
式(IV)中、Tは、酸素原子、オキシカルボニル基、カルボニルオキシ基、オキシカルボニルオキシ基、硫黄原子、(チオ)カルボニル基、カルボニル(チオ)基、(チオ)カルボニルオキシ基、オキシカルボニル(チオ)基、または−O−C(=O)−N(Gb)−で表される二価の基を示す。
*は式(IV)で表される基の結合位置を示す。
Qは、式(II)または式(III)で表される有機基のいずれかを示す。
Ar1は、無置換の若しくはG2で置換されたC6〜10アリール基、または無置換の若しくはG2で置換された3〜10員ヘテロシクリル基を示す。
Ar2は、無置換の若しくはG2で置換されたC6〜10アリール基、無置換の若しくはG2で置換されたC6〜10アリールオキシ基、無置換の若しくはG2で置換されたC6〜10アリールチオ基、無置換の若しくはG2で置換されたC6〜10アリールスルフィニル基、無置換の若しくはG2で置換されたC6〜10アリールスルホニル基、無置換の若しくはG2で置換された3〜10員ヘテロシクリル基、無置換の若しくはG2で置換された3〜10員ヘテロシクリルオキシ基、無置換の若しくはG2で置換された3〜10員ヘテロシクリルチオ基またはフェロセニル基を示す。
Raは、水素原子、無置換の若しくはG1で置換されたC1〜6アルキル基、無置換の若しくはG1で置換されたC3〜8シクロアルキル基、アミノ基、C1〜6アルキルカルボニルアミノ基、または無置換の若しくはG2で置換されたC6〜10アリール基を示す。
Baは、無置換の若しくはG4で置換されたC2〜C6アルキレン基、無置換の若しくはG4で置換されたC2〜C6アルケニレン基、無置換の若しくはG4で置換されたC2〜C6アルキニレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンオキシC1〜6アルキレン基、無置換の若しくはG4で置換されたC3〜C6シクロアルキレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンC3〜6シクロアルキレン基、無置換の若しくはG4で置換されたC1〜C6アルキレンオキシC3〜6シクロアルキレン基、無置換の若しくはG4で置換されたC4〜C6シクロアルケニレン基、または無置換の若しくはG4で置換された3〜6員ヘテロシクリレン基を示す。
また、Baの炭素原子またはBa上の置換基G4の一部が、Ar2上の炭素原子と結合して5〜6員環を形成してもよい。
*は、式(II)または式(III)で表される有機基の結合位置を示す。]
G1は、水酸基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6アルコキシカルボニル基、ホルミルオキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、シアノ基、またはハロゲノ基を示す。R1、R2、R3、R4またはRaのうちの2つ以上がG1で置換された前記の基である場合、係るG1は、相互に同じであっても異なってもよい。
G2は、C1〜6アルキル基、ヒドロキシC1〜6アルキル基、C2〜6アルケニル基、C2〜6アルキニル基、C3〜8シクロアルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C1〜6アルコキシC1〜6ハロアルキル基、C2〜6ハロアルケニル基、C2〜6ハロアルキニル基、水酸基、C1〜6アルコキシ基、C3〜8シクロアルキルC1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C1〜6ハロアルコキシ基、C1〜6ハロアルコキシC1〜6ハロアルコキシ基、ホルミル基、C1〜6アルキルカルボニル基、C1〜6アルコキシカルボニル基、ホルミルオキシ基、C1〜6アルキルカルボニルオキシ基、C1〜6アルコキシカルボニルオキシ基、C1〜6アルコキシカルボニルアミノ基、無置換の若しくはG21で置換されたC6〜10アリール基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールオキシ基、無置換の若しくはG21で置換された3〜6員ヘテロシクリル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルオキシ基、C1〜6アルキルチオ基、C1〜6アルキルスルフィニル基、C1〜6アルキルスルホニル基、C1〜6ハロアルキルチオ基、C1〜6ハロアルキルスルフィニル基、C1〜6ハロアルキルスルホニル基、ペンタフルオロスルファニル基、無置換の若しくはG21で置換されたC6〜10アリールチオ基、無置換の若しくはG21で置換されたC6〜10アリールスルフィニル基、無置換の若しくはG21で置換されたC6〜10アリールスルホニル基、ニトロ基、シアノ基、ハロゲノ基、C1〜6アルキレン基、C1〜6アルキレンジオキシ基、またはC1〜6ハロアルキレンジオキシ基を示す。R1、R2、R3、R4、Ra、G4、Ar1またはAr2のうちの2つ以上がG2で置換された前記の基である場合、係るG2は、相互に同じであっても異なってもよい。
G21は、C1〜6アルキル基、C1〜6ハロアルキル基、C1〜6アルコキシ基、C1〜6ハロアルコキシ基、またはハロゲノ基を示す。G2またはG4のうちの2つ以上がG21で置換された前記の基である場合、係るG21は、相互に同じであっても異なってもよい。
G4は、C1〜6アルキル基、C3〜8シクロアルキル基、C1〜6ハロアルキル基、C1〜6アルコキシC1〜6アルキル基、C2〜6アルケニルオキシC1〜6アルキル基、水酸基、C1〜6アルコキシ基、C1〜6アルコキシC1〜6アルコキシ基、C2〜6アルケニルオキシ基、C1〜6アルコキシカルボニル基、無置換の若しくはG21で置換されたC6〜10アリール基、無置換の若しくはG21で置換された3〜6員ヘテロシクリル基、シアノ基、ハロゲノ基、C1〜6アルキレン基、C1〜6アルキレンジオキシ基、オキソ基、C3〜8シクロアルキルC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルキル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルC1〜6アルキル基、C3〜8シクロアルキルオキシC1〜6アルキル基、無置換の若しくはG21で置換されたC6〜10アリールオキシC1〜6アルキル基、無置換の若しくはG21で置換された3〜6員ヘテロシクリルオキシC1〜6アルキル基、C1〜6アルキリデン基、C1〜6アルコキシイミノ基、無置換の若しくはG21で置換されたC6〜10アリールC1〜6アルコキシイミノ基、またはC1〜6アルキルヒドラジノ基を示す。〕 The compound or its salt represented by a formula (I).
R 1 is hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C1~6 alkoxy group substituted with G 1, which is substituted by unsubstituted or G 2 C6 And an aryl group of 10 to 10, a 3 to 6 membered heterocyclyl group which is unsubstituted or substituted by G 2 , a cyano group or a halogeno group.
R 2 and R 3 are each independently a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C3~8 cycloalkyl group substituted by G 1, the unsubstituted Or a G 1 substituted C1-6 alkoxy group, a formyl group, a formyloxy group, an unsubstituted or G 1 substituted C1-6 alkylcarbonyl group, an unsubstituted or G 1 substituted C1-6 alkylcarbonyloxy group, an unsubstituted or C6~10 aryl groups substituted with G 2, (unsubstituted or substituted with G 1 a C1~6 alkoxyimino)-C1-6 alkyl group, a cyano group or a halogeno, Indicates a group.
Here, R 1 and R 2 may be combined to form a 5- to 6-membered ring together with the carbon atom to which each of R 1 and R 2 is bonded.
R 4 is a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, which is substituted by unsubstituted or G 1 C2ア ル キ ニ 6 alkynyl group, unsubstituted or G 1 substituted C 3-8 cycloalkyl group, unsubstituted or G 2 substituted C 6 to 10 aryl C 1 6 alkyl group, unsubstituted or substituted G 2 3 to 6 membered heterocyclyl group, unsubstituted or G 2 substituted 3 to 6 membered heterocyclyl group C1-6 alkyl group, formyl group, unsubstituted or G 1 substituted C1-6 alkyl carbonyl group , unsubstituted or C3~8 cycloalkylcarbonyl group substituted with G 1, unsubstituted or C1~6 alkenylcarbonyl group substituted with G 1, unsubstituted or with G 2 is substituted And C6~10 aryl carbonyl group, an unsubstituted or C1~6 alkoxycarbonyl group substituted with G 1, unsubstituted or C2~6 alkenyloxycarbonyl group substituted with G 1, unsubstituted or with G 1 substituted Cl to 6 alkylsulfonyl group, unsubstituted or Cl to 6 alkylaminocarbonyl group substituted with G 1, unsubstituted or substituted with G 1 a (Cl to 6 alkylthio) carbonyl group, the unsubstituted Or a C1-6 alkylamino (thiocarbonyl) group substituted by G 1 or a group represented by formula (IV).
Wherein (IV), G b represents a hydrogen atom, an unsubstituted or C1~6 alkyl group substituted with G 1, unsubstituted or C2~6 alkenyl group substituted with G 1, unsubstituted or G C2~6 alkynyl group substituted with 1, unsubstituted or C3~8 cycloalkyl group substituted with G 1, unsubstituted or C6~10 aryl groups substituted with G 2 or unsubstituted or G, The 3- to 6-membered heterocyclyl group substituted by 2 is shown.
In the formula (IV), T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio) carbonyl group, a carbonyl (thio) group, a (thio) carbonyloxy group, an oxycarbonyl ( It represents a divalent group represented by a thio) group or -O-C (= O) -N ( Gb )-.
* Indicates the bonding position of the group represented by formula (IV).
Q represents any one of the organic groups represented by Formula (II) or Formula (III).
Ar 1 represents an unsubstituted or C6~10 aryl groups substituted with G 2 or unsubstituted or 3-10 membered heterocyclyl group which is substituted by G 2,.
Ar 2 is an unsubstituted or G 2 substituted C 6 to 10 aryl group, an unsubstituted or G 2 substituted C 6 to 10 aryloxy group, an unsubstituted or G 2 substituted C 6 to 10 arylthio group, an unsubstituted or C6~10 arylsulfinyl group substituted by G 2, unsubstituted or C6~10 arylsulfonyl group substituted with G 2, substituted with unsubstituted or G 2 3 to 10 membered heterocyclyl group, an unsubstituted or 3-10 membered heterocyclyloxy group which is substituted by G 2, unsubstituted or 3-10 membered heterocyclylthio group or a ferrocenyl group substituted with G 2.
R a is a hydrogen atom, an unsubstituted or Cl to 6 alkyl group substituted with G 1, unsubstituted or C3~8 cycloalkyl group substituted with G 1, amino group, Cl to 6 alkylcarbonylamino group , or unsubstituted or showing a C6~10 aryl group substituted by G 2.
B a is a C 2 to C 6 alkylene group which is unsubstituted or substituted by G 4 , a C 2 to C 6 alkenylene group which is unsubstituted or substituted by G 4 , C 2 to C 6 alkynylene which is unsubstituted or substituted by G 4 group, an unsubstituted or C1~C6 alkyleneoxy C1~6 alkylene group substituted with G 4, unsubstituted or C3~C6 cycloalkylene group substituted by G 4, which is substituted unsubstituted or at G 4 C1~C6 alkylene C3~6 cycloalkylene group, an unsubstituted or substituted by G 4 a C1~C6 alkyleneoxy C3~6 cycloalkylene group, an unsubstituted or C4~C6 cycloalkenylene group substituted with G 4, Or 3 to 6 membered heterocyclylene group which is unsubstituted or substituted by G 4 .
In addition, a carbon atom of B a or a part of the substituent G 4 on B a may be bonded to a carbon atom on Ar 2 to form a 5- to 6-membered ring.
* Represents the bonding position of the organic group represented by Formula (II) or Formula (III). ]
G 1 represents a hydroxyl group, a C1-6 alkoxy group, a C1-6 alkoxy C1-6 alkoxy group, a C1-6 alkoxycarbonyl group, a formyloxy group, a C1-6 alkylcarbonyloxy group, a C1-6 alkoxycarbonyloxy group, a cyano Group or a halogeno group is shown. R 1, R 2, R 3, when two or more of R 4 or R a is the radical which is substituted by G 1, G 1 according may be the same or different from each other .
G 2 is, Cl to 6 alkyl group, hydroxyalkyl Cl to 6 alkyl groups, C2-6 alkenyl groups, C2-6 alkynyl groups, C3-8 cycloalkyl groups, Cl to 6 haloalkyl, Cl to 6 alkoxy Cl to 6 alkyl Group, C1-6 alkoxy C1-6 haloalkyl group, C2-6 haloalkenyl group, C2-6 haloalkynyl group, hydroxyl group, C1-6 alkoxy group, C3-8 cycloalkyl C1-6 alkoxy group, C1-6 alkoxy C1 -6 alkoxy group, C1-6 haloalkoxy group, C1-6 haloalkoxy C1-6 haloalkoxy group, formyl group, C1-6 alkylcarbonyl group, C1-6 alkoxycarbonyl group, formyloxy group, C1-6 alkylcarbonyl Oxy group, C1-6 alkoxy carbonyloxy group, C1-6 alkoxy carbonyl Amino group, an unsubstituted or C6~10 aryl groups substituted with G 21, unsubstituted or C6~10 aryl C1~6 alkyl group substituted with G 21, which is substituted by unsubstituted or G 21 C6 To 10 aryloxy group, an unsubstituted or G 21 -substituted 3- to 6-membered heterocyclyl group, an unsubstituted or G 21 -substituted 3- to 6-membered heterocyclyloxy group, a C 1-6 alkylthio group, C 1 to 6 Alkylsulfinyl group, C1-6 alkylsulfonyl group, C1-6 haloalkylthio group, C1-6 haloalkylsulfinyl group, C1-6 haloalkylsulfonyl group, pentafluorosulfanyl group, unsubstituted or C6-10 substituted with G 21 Arylthio group, unsubstituted or G 21 substituted C 6-10 arylsulfinyl group, unsubstituted or Shows C6~10 arylsulfonyl group substituted with G 21, a nitro group, a cyano group, a halogeno group, Cl to 6 alkylene group, a Cl to 6 alkylenedioxy group or a Cl to 6 halo alkylenedioxy group. R 1, R 2, R 3 , R 4, R a, if two or more of G 4, Ar 1 or Ar 2 is said group substituted with G 2, G 2 according are mutually It may be the same or different.
G 21 represents a C1-6 alkyl group, a C1-6 haloalkyl group, a C1-6 alkoxy group, a C1-6 haloalkoxy group, or a halogeno group. If more than one of G 2 or G 4 is a said group substituted with G 21, G 21 according may be the same or different from each other.
G 4 are, Cl to 6 alkyl, C3-8 cycloalkyl, Cl to 6 haloalkyl, Cl to 6 alkoxy Cl to 6 alkyl groups, C2-6 alkenyloxy Cl to 6 alkyl groups, hydroxyl, Cl to 6 alkoxy group, Cl to 6 alkoxy Cl to 6 alkoxy, C2-6 alkenyloxy group, substituted with Cl to 6 alkoxy carbonyl group, an unsubstituted or C6~10 aryl groups substituted with G 21, unsubstituted or G 21 3 to 6 membered heterocyclyl group, cyano group, halogeno group, C1-6 alkylene group, C1-6 alkylenedioxy group, oxo group, C3-8 cycloalkyl C1-6 alkyl group, unsubstituted or G 21 substituted C6~10 aryl C1~6 alkyl, 3-6 membered heterocyclyl C1~6 alkyl substituted with unsubstituted or G 21 Group, C3-8 cycloalkyloxy C1~6 alkyl group, an unsubstituted or C6~10 aryloxy C1~6 alkyl group substituted with G 21, unsubstituted or 3-6 membered heterocyclyl optionally substituted with G 21 oxy Cl to 6 alkyl groups, Cl to 6 alkylidene group, Cl to 6 alkoxyimino group, the unsubstituted or C6~10 aryl Cl to 6 alkoxyimino group substituted with G 21 or Cl to 6 alkyl hydrazino group, Show. ]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014129726 | 2014-06-24 | ||
JP2014129726 | 2014-06-24 | ||
PCT/JP2015/068009 WO2015199065A1 (en) | 2014-06-24 | 2015-06-23 | Pyridine compound and use of same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2015199065A1 JPWO2015199065A1 (en) | 2017-04-20 |
JP6508540B2 true JP6508540B2 (en) | 2019-05-08 |
Family
ID=54938147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016529594A Active JP6508540B2 (en) | 2014-06-24 | 2015-06-23 | Pyridine compound and use thereof |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP6508540B2 (en) |
TW (1) | TW201605800A (en) |
WO (1) | WO2015199065A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019083008A1 (en) * | 2017-10-27 | 2019-05-02 | 住友化学株式会社 | Pyridine compound and pest control composition containing same |
WO2019083007A1 (en) * | 2017-10-27 | 2019-05-02 | 住友化学株式会社 | Pyridine compound and harmful-arthropod control agent containing same |
JP2021028298A (en) * | 2017-11-30 | 2021-02-25 | 日本曹達株式会社 | 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound, and agricultural and horticultural fungicide |
JP2022515953A (en) * | 2018-10-17 | 2022-02-24 | デューク・ユニヴァーシティ | Quinone reductase 2 inhibitor compound and its use |
CN110642748B (en) * | 2019-09-20 | 2023-03-31 | 华南理工大学 | O- (2-trifluoromethyl-2-hydroxyethyl) oxime ether derivative and synthetic method and application thereof |
WO2024127829A1 (en) * | 2022-12-12 | 2024-06-20 | 日本曹達株式会社 | Phenoxycarbamoyl chloride compound and method for producing same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4213149A1 (en) * | 1992-04-22 | 1993-10-28 | Hoechst Ag | Acaricidal, insecticidal and nematicidal substituted (hetero) aryl-alkyl-ketone oxime-O-ether, process for their preparation, compositions containing them and their use as pesticides |
JP3874434B2 (en) * | 1995-06-21 | 2007-01-31 | 日本曹達株式会社 | Ketone oxime ether derivative, production method thereof, and agricultural and horticultural fungicide |
SK5992002A3 (en) * | 1999-11-05 | 2003-02-04 | Nippon Soda Co | Oxime O-ether compounds and fungicides for agricultural and horticultural use |
JP2001138166A (en) * | 1999-11-08 | 2001-05-22 | Nippei Toyama Corp | Tool changing device, and tool changing method |
JPWO2002064566A1 (en) * | 2001-02-14 | 2004-06-10 | 日本曹達株式会社 | Oxime O-ether compounds and agricultural and horticultural fungicides |
JPWO2003006432A1 (en) * | 2001-07-09 | 2004-11-04 | 日本曹達株式会社 | Oxime ether compounds and fungicides for agricultural and horticultural use |
TW200307669A (en) * | 2002-04-15 | 2003-12-16 | Nippon Soda Co | Novel oxime o-ether compound, production process thereof, and agricultural or horticultural bactericide |
CN100560574C (en) * | 2006-03-22 | 2009-11-18 | 南开大学 | Thiazole oxime ether derivatives and preparation and application thereof |
BRPI0921776A2 (en) * | 2008-11-17 | 2015-08-18 | Ishihara Sangyo Kaisha | Pyridine derivative or its salt, pesticide containing them and process for their production |
-
2015
- 2015-06-23 TW TW104120127A patent/TW201605800A/en unknown
- 2015-06-23 JP JP2016529594A patent/JP6508540B2/en active Active
- 2015-06-23 WO PCT/JP2015/068009 patent/WO2015199065A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015199065A1 (en) | 2015-12-30 |
TW201605800A (en) | 2016-02-16 |
JPWO2015199065A1 (en) | 2017-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6508540B2 (en) | Pyridine compound and use thereof | |
JP7158386B2 (en) | Oxadiazole compounds and agricultural and horticultural fungicides | |
JP2021028298A (en) | 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound, and agricultural and horticultural fungicide | |
JP2021008403A (en) | 1,3,5,6-TETRA-SUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND AND AGRICULTURAL/HORTICULTURAL FUNGICIDE | |
JP6507398B2 (en) | Guanidine compounds and fungicides | |
WO2019031384A1 (en) | 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4-(1h,3h)dione compound and agricultural or horticultural bactericide | |
JP6837052B2 (en) | Pyridine compounds and their uses | |
WO2019065516A1 (en) | Quinoline compound, and bactericidal agent for agricultural and horticultural use | |
WO2016039048A1 (en) | Pyridine compound and use thereof | |
JP6221189B2 (en) | Pyridine compounds and uses thereof | |
JP5322296B2 (en) | Method for using plant disease control agent containing tetrazoyloxime derivative | |
JP2016079175A (en) | Germicide for agriculture and horticulture containing amidinopyridine compound | |
JPWO2016047550A1 (en) | Agricultural and horticultural fungicides containing arylamidine compounds | |
JP2020097575A (en) | 1,3,5,6-TETRA SUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND AND HORTICULTURAL BACTERICIDE | |
JP2020147544A (en) | Quinoline compound and fungicide for agricultural and horticultural use | |
JP2019163223A (en) | 1,3,5,6-TETRASUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL BACTERICIDE | |
WO2018097172A1 (en) | Phenylguanidine compound and fungicide | |
WO2018097126A1 (en) | Guanidine compound and fungicide | |
JP2022035834A (en) | 2,4-dioxo-1,4-dihydrothienopyrimidine compound and bactericide for agricultural and horticultural use | |
JP2023078623A (en) | Bactericide for agricultural and horticultural use comprising 3-substituted thienopyrimidinedione compound | |
JP2020040947A (en) | 1,3,5,6-tetra-substituted thieno [2,3-d]pyrimidine-2,4(1h,3h) dione compound and bactericide for agricultural and horticultural use | |
WO2024143338A1 (en) | Five-membered heteroaryl compound and agricultural and horticultural bactericide | |
WO2020189525A1 (en) | Heterocyclic compound and agricultural or horticultural bactericide | |
WO2021112213A1 (en) | 2,4-dioxo-1,4-dihydrothienopyrimidine compound, agricultural or horticultural fungicidal agent, or medical/animal antifungal agent, containing this | |
JP2020203883A (en) | 2,4-dioxo-1,4-dihydro thieno pyrimidine compound and bactericide for agricultural and horticultural use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180214 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20181116 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181218 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190205 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190305 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190320 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6508540 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |